QUARTERLY REPORT
Q1 2020 — Quarterly report (Form 10-Q)
Q1 2020PDF · 93 pages6.0 MB
Table of Contents
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended March 31, 2020
Commission File Number 1-11758
(Exact name of Registrant as specified in its charter)
Delaware 1585 Broadway 36-3145972 (212) 761-4000
(State or other jurisdiction of
incorporation or organization) New York, NY 10036 (I.R.S. Employer Identification No.) (Registrant’s telephone number,
including area code) (Address of principal executive
offices, including zip code)
Securities registered pursuant to Section 12(b) of the Act:
Title of each class Trading
Symbol(s) Name of exchange on
which registered
Common Stock, $0.01 par value MS New York Stock Exchange
Depositary Shares, each representing 1/1,000th interest in a share of Floating Rate
MS/PA New York Stock Exchange Non-Cumulative Preferred Stock, Series A, $0.01 par value
Depositary Shares, each representing 1/1,000th interest in a share of Fixed-to-Floating Rate
MS/PE New York Stock Exchange Non-Cumulative Preferred Stock, Series E, $0.01 par value
Depositary Shares, each representing 1/1,000th interest in a share of Fixed-to-Floating Rate
MS/PF New York Stock Exchange Non-Cumulative Preferred Stock, Series F, $0.01 par value
Depositary Shares, each representing 1/1,000th interest in a share of Fixed-to-Floating Rate
MS/PI New York Stock Exchange Non-Cumulative Preferred Stock, Series I, $0.01 par value
Depositary Shares, each representing 1/1,000th interest in a share of Fixed-to-Floating Rate
MS/PK New York Stock Exchange Non-Cumulative Preferred Stock, Series K, $0.01 par value
Depository Shares, each representing 1/1000th interest in a share of 4.875% MS/PL New York Stock Exchange Non-Cumulative Preferred Stock, Series L, $0.01 par value
Global Medium-Term Notes, Series A, Fixed Rate Step-Up Senior Notes Due 2026
MS/26C New York Stock Exchange of Morgan Stanley Finance LLC (and Registrant’s guarantee with respect thereto)
Morgan Stanley Cushing® MLP High Income Index ETNs due March 21, 2031 MLPY NYSE Arca, Inc.
Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities
Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such
reports), and (2) has been subject to such filing requirements for the past 90 days. Yes No
Indicate by check mark whether the Registrant has submitted electronically every Interactive Data File required to be submitted
pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that
the Registrant was required to submit such files). Yes No
Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller
reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller
reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act. (Check one):
Large accelerated filer Accelerated filer Non-accelerated filer Smaller reporting company Emerging growth company
If an emerging growth company, indicate by check mark if the Registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes No
As of April 30, 2020, there were 1,575,656,380 shares of the Registrant’s Common Stock, par value $0.01 per share, outstanding.
-- 1 of 93 --
Table of Contents
i
QUARTERLY REPORT ON FORM 10-Q
For the quarter ended March 31, 2020
Table of Contents Part Item Page
Risk Factors II 1A
Financial Information I
Management’s Discussion and Analysis of Financial Condition and Results of Operations I 2
Introduction
Executive Summary
Business Segments
Supplemental Financial Information
Other Matters
Accounting Development Updates
Critical Accounting Policies
Liquidity and Capital Resources
Balance Sheet
Regulatory Requirements
Quantitative and Qualitative Disclosures about Risk I 3
Market Risk
Credit Risk
Country and Other Risks
Report of Independent Registered Public Accounting Firm
Consolidated Financial Statements and Notes I 1
Consolidated Income Statements (Unaudited)
Consolidated Comprehensive Income Statements (Unaudited)
Consolidated Balance Sheets (Unaudited at March 31, 2020)
Consolidated Statements of Changes in Total Equity (Unaudited)
Consolidated Cash Flow Statements (Unaudited)
Notes to Consolidated Financial Statements (Unaudited)
1. Introduction and Basis of Presentation
2. Significant Accounting Policies
3. Cash and Cash Equivalents
4. Fair Values
5. Fair Value Option
6. Derivative Instruments and Hedging Activities
7. Investment Securities
8. Collateralized Transactions
9. Loans, Lending Commitments and Related Allowance for Credit Losses
10. Other Assets—Equity Method Investments
11. Deposits
12. Borrowings and Other Secured Financings
13. Commitments, Guarantees and Contingencies
14. Variable Interest Entities and Securitization Activities
15. Regulatory Requirements
16. Total Equity
17. Interest Income and Interest Expense
18. Income Taxes
19. Segment, Geographic and Revenue Information
Financial Data Supplement (Unaudited)
Glossary of Common Terms and Acronyms
Other Information II
Legal Proceedings II 1
Unregistered Sales of Equity Securities and Use of Proceeds II 2
Controls and Procedures I 4
Exhibits II 6
Signatures
1
2
2
2
3
7
15
15
15
16
16
16
21
28
28
30
35
38
39
39
40
41
42
43
44
44
45
47
47
54
55
59
62
63
67
67
67
68
71
73
76
78
78
78
81
82
84
84
84
84
84
S-1
-- 2 of 93 --
Table of Contents
ii
Available Information
We file annual, quarterly and current reports, proxy statements and other information with the SEC. The SEC maintains a website,
www.sec.gov, that contains annual, quarterly and current reports, proxy and information statements and other information that issuers
file electronically with the SEC. Our electronic SEC filings are available to the public at the SEC’s website.
Our website is www.morganstanley.com. You can access our Investor Relations webpage at www.morganstanley.com/about-us-ir.
We make available free of charge, on or through our Investor Relations webpage, our proxy statements, annual reports on Form 10-
K, quarterly reports on Form 10-Q, current reports on Form 8-K and any amendments to those reports filed or furnished pursuant to
the Securities Exchange Act of 1934, as amended (“Exchange Act”), as soon as reasonably practicable after such material is
electronically filed with, or furnished to, the SEC. We also make available, through our Investor Relations webpage, via a link to the
SEC’s website, statements of beneficial ownership of our equity securities filed by our directors, officers, 10% or greater shareholders
and others under Section 16 of the Exchange Act.
You can access information about our corporate governance at www.morganstanley.com/about-us-governance and our sustainability
initiatives at www.morganstanley.com/about-us/sustainability-at-morgan-stanley. Our webpages include:
• Amended and Restated Certificate of Incorporation;
• Amended and Restated Bylaws;
• Charters for our Audit Committee, Compensation, Management Development and Succession Committee, Nominating
and Governance Committee, Operations and Technology Committee, and Risk Committee;
• Corporate Governance Policies;
• Policy Regarding Corporate Political Activities;
• Policy Regarding Shareholder Rights Plan;
• Equity Ownership Commitment;
• Code of Ethics and Business Conduct;
• Code of Conduct;
• Integrity Hotline Information;
• Environmental and Social Policies; and
• Sustainability Report.
Our Code of Ethics and Business Conduct applies to all directors, officers and employees, including our Chief Executive Officer,
Chief Financial Officer and Deputy Chief Financial Officer. We will post any amendments to the Code of Ethics and Business Conduct
and any waivers that are required to be disclosed by the rules of either the SEC or the New York Stock Exchange LLC (“NYSE”)
on our website. You can request a copy of these documents, excluding exhibits, at no cost, by contacting Investor Relations,
1585 Broadway, New York, NY 10036 (212-761-4000). The information on our website is not incorporated by reference into this
report.
-- 3 of 93 --
Table of Contents
1 March 2020 Form 10-Q
Risk Factors
In addition to “Risk Factors” in Part I, Item 1A of the 2019 Form
10-K, please refer to the risk factor under Item 8.01. “Other
Matters,” in the Current Report on Form 8-K filed with the SEC
on April 16, 2020 and the additional risk factors under “Risk
Factors” in the Registration Statement on Form S-4 filed with
the SEC on April 17, 2020.
-- 4 of 93 --
Table of Contents
March 2020 Form 10-Q 2
Management’s Discussion and Analysis of Financial Condition and Results of Operations
Introduction
Morgan Stanley is a global financial services firm that maintains
significant market positions in each of its business segments—
Institutional Securities, Wealth Management and Investment
Management. Morgan Stanley, through its subsidiaries and
affiliates, provides a wide variety of products and services to a
large and diversified group of clients and customers, including
corporations, governments, financial institutions and
individuals. Unless the context otherwise requires, the terms
“Morgan Stanley,” “Firm,” “us,” “we” or “our” mean Morgan
Stanley (the “Parent Company”) together with its consolidated
subsidiaries. See the “Glossary of Common Terms and
Acronyms” for the definition of certain terms and acronyms used
throughout this Form 10-Q.
A description of the clients and principal products and services
of each of our business segments is as follows:
Institutional Securities provides investment banking, sales
and trading, lending and other services to corporations,
governments, financial institutions and high to ultra-high net
worth clients. Investment banking services consist of capital
raising and financial advisory services, including services
relating to the underwriting of debt, equity and other
securities, as well as advice on mergers and acquisitions,
restructurings, real estate and project finance. Sales and
trading services include sales, financing, prime brokerage and
market-making activities in equity and fixed income products,
including foreign exchange and commodities. Lending
activities include originating corporate loans and commercial
real estate loans, providing secured lending facilities, and
extending financing to sales and trading customers. Other
activities include Asia wealth management services,
investments and research.
Wealth Management provides a comprehensive array of
financial services and solutions to individual investors and
small to medium-sized businesses and institutions covering:
brokerage and investment advisory services; financial and
wealth planning services; stock plan administration services;
annuity and insurance products; securities-based lending,
residential real estate loans and other lending products;
banking; and retirement plan services.
Investment Management provides a broad range of investment
strategies and products that span geographies, asset classes,
and public and private markets to a diverse group of clients
across institutional and intermediary channels. Strategies and
products, which are offered through a variety of investment
vehicles, include equity, fixed income, liquidity and
alternative/other products. Institutional clients include
defined benefit/defined contribution plans, foundations,
endowments, government entities, sovereign wealth funds,
insurance companies, third-party fund sponsors and
corporations. Individual clients are generally served through
intermediaries, including affiliated and non-affiliated
distributors.
Management’s Discussion and Analysis includes certain metrics
which we believe to be useful to us, investors, analysts and other
stakeholders by providing further transparency about, or an
additional means of assessing, our financial condition and
operating results. Such metrics, when used, are defined and may
be different from or inconsistent with metrics used by other
companies.
The results of operations in the past have been, and in the future
may continue to be, materially affected by: competition; risk
factors; legislative, legal and regulatory developments; and
other factors. These factors also may have an adverse impact on
our ability to achieve our strategic objectives. Additionally, the
discussion of our results of operations herein may contain
forward-looking statements. These statements, which reflect
management’s beliefs and expectations, are subject to risks and
uncertainties that may cause actual results to differ materially.
For a discussion of the risks and uncertainties that may affect
our future results, see “Forward-Looking Statements,”
“Business—Competition,” “Business—Supervision and
Regulation,” and “Risk Factors” in the 2019 Form 10-K, and
“Liquidity and Capital Resources—Regulatory Requirements”
herein. In addition, see “Executive Summary” herein and “Risk
Factors” for information on the current and possible future
effects of the COVID-19 pandemic on our results.
-- 5 of 93 --
Table of Contents
Management’s Discussion and Analysis
3 March 2020 Form 10-Q
Executive Summary
Overview of Financial Results
Consolidated Results
Net Revenues
($ in millions)
Net Income Applicable to Morgan Stanley
($ in millions)
Earnings per Common Share1
1. For further information on basic and diluted EPS, see Note 16 to the financial
statements.
We reported net revenues of $9,487 million in the quarter ended
March 31, 2020 (“current quarter,” or “1Q 2020”), compared
with $10,286 million in the quarter ended March 31, 2019 (“prior
year quarter,” or “1Q 2019”). For the current quarter, net income
applicable to Morgan Stanley was $1,698 million, or $1.01 per
diluted common share, compared with $2,429 million or $1.39
per diluted common share, in the prior year quarter.
See “Coronavirus Disease (COVID-19) Pandemic” herein for
information on the current and possible future effects of the
COVID-19 pandemic on our results.
Non-interest Expenses1
($ in millions)
1. The percentages on the bars in the chart represent the contribution of compensation
and benefits expenses and non-compensation expenses to the total.
• Compensation and benefits expenses of $4,283 million in the
current quarter decreased 8% from $4,651 million in the prior
year quarter. The decrease was primarily due to decreases in
the fair value of investments to which certain deferred
compensation plans are referenced and compensation
associated with carried interest, partially offset by increases
in discretionary incentive compensation, and the formulaic
payout to Wealth Management representatives driven by the
mix of revenues.
• Non-compensation expenses of $3,058 million in the current
quarter increased 14% from $2,680 million in the prior year
quarter. The increase was primarily due to higher volume-
related expenses and an increase in the provision for credit
losses for lending commitments.
Income Taxes
The prior year quarter included intermittent net discrete tax
benefits of $101 million, primarily associated with
remeasurement of reserves and related interest as a result of new
information pertaining to the resolution of multi-jurisdiction tax
examinations. For further information, see “Supplemental
Financial Information—Income Tax Matters” herein.
-- 6 of 93 --
Table of Contents
Management’s Discussion and Analysis
March 2020 Form 10-Q 4
Selected Financial Information and Other Statistical Data
Three Months Ended March 31,
$ in millions 2020 2019
Net income applicable to Morgan Stanley $ 1,698 $ 2,429
Preferred stock dividends 108 93
Earnings applicable to Morgan Stanley
common shareholders $ 1,590 $ 2,336
Expense efficiency ratio1 77.4% 71.3%
ROE2 8.5% 13.1%
Adjusted ROE3 8.3% 12.5%
ROTCE2,3 9.7% 14.9%
Adjusted ROTCE3 9.5% 14.2%
Pretax margin4 22.6% 28.7%
Pre-tax margin by segment4
Institutional Securities 19% 31%
Wealth Management 26% 27%
Investment Management 21% 22%
in millions, except per share and employee data
At
March 31,
2020
At
December 31,
2019
Liquidity resources5 $ 255,134 $ 215,868
Loans6 $ 148,697 $ 130,637
Total assets $ 947,795 $ 895,429
Deposits $ 235,239 $ 190,356
Borrowings $ 194,856 $ 192,627
Common shares outstanding 1,576 1,594
Common shareholders' equity $ 77,340 $ 73,029
Tangible common shareholders’ equity3 $ 68,194 $ 63,780
Book value per common share7 $ 49.09 $ 45.82
Tangible book value per common share3,7 $ 43.28 $ 40.01
Worldwide employees 60,670 60,431
At
March 31,
2020
At
December 31,
2019
Capital ratios8
Common Equity Tier 1 capital 15.2% 16.4%
Tier 1 capital 17.3% 18.6%
Total capital 19.6% 21.0%
Tier 1 leverage 8.1% 8.3%
SLR 6.2% 6.4%
1. The expense efficiency ratio represents total non-interest expenses as a percentage
of net revenues.
2. ROE and ROTCE represent annualized earnings applicable to Morgan Stanley
common shareholders as a percentage of average common equity and average
tangible common equity, respectively.
3. Represents a non-GAAP measure. See “Selected Non-GAAP Financial Information”
herein.
4. Pre-tax margin represents income from continuing operations before income taxes
as a percentage of net revenues.
5. For a discussion of Liquidity resources, see “Liquidity and Capital Resources—
Liquidity Risk Management Framework—Liquidity Resources” herein.
6. Amounts include loans held for investment (net of allowance) and loans held for sale
but exclude loans at fair value, which are included in Trading assets in the balance
sheets (see Note 9 to the financial statements).
7. Book value per common share and tangible book value per common share equal
common shareholders’ equity and tangible common shareholders’ equity, respectively,
divided by common shares outstanding.
8. At March 31, 2020 and December 31, 2019, our risk-based capital ratios are based
on the Advanced Approach and the Standardized Approach rules, respectively. For a
discussion of our capital ratios, see “Liquidity and Capital Resources—Regulatory
Requirements” herein.
Business Segment Results
Net Revenues by Segment1
($ in millions)
Net Income Applicable to Morgan Stanley by Segment1
($ in millions)
1. The percentages on the bars in the charts represent the contribution of each business
segment to the total of the applicable financial category and may not total to 100%
due to intersegment eliminations. See Note 19 to the financial statements for details
of intersegment eliminations.
• Institutional Securities net revenues of $4,905 million in the
current quarter decreased 6% from $5,196 million in the prior
year quarter primarily reflecting losses on loans and lending
commitments held for sale and an increase in the provision
for credit losses on loans and lending commitments held for
investment, as well as losses related to investments associated
with certain employee deferred cash-based compensation
plans, partially offset by increases in Fixed Income and Equity
sales and trading revenues driven by increased volumes and
volatility.
• Wealth Management net revenues of $4,037 million in the
current quarter decreased 8% from $4,389 million in the prior
year quarter, primarily reflecting losses related to investments
associated with certain employee deferred cash-based
compensation plans, partially offset by higher Asset
management revenues and higher commissions driven by
market volatility.
-- 7 of 93 --
Table of Contents
Management’s Discussion and Analysis
5 March 2020 Form 10-Q
• Investment Management net revenues of $692 million in the
current quarter decreased 14% from $804 million in the prior
year quarter, primarily reflecting lower Investments revenues,
partially offset by higher Asset management revenues.
Net Revenues by Region1, 2
($ in millions)
1. The percentages on the bars in the charts represent the contribution of each region
to the total.
2. For a discussion of how the geographic breakdown of net revenues is determined,
see Note 19 to the financial statements.
Both the 34% increase in revenues in Asia and the 33% decrease
in revenues in EMEA were primarily attributable to Equity sales
and trading within the Institutional Securities business segment.
The Equity sales and trading revenues increase in Asia reflects
higher client volumes, while in EMEA market volatility and
reduced dividend expectations weighed on revenues in the
derivatives and financing businesses. Additionally, EMEA
results reflected markdowns of held-for-sale loans and lending
commitments.
Coronavirus Disease (COVID-19) Pandemic
The coronavirus disease (“COVID-19”) pandemic and related
government-imposed shelter-in-place restrictions have had, and
will likely continue to have, a severe impact on global economic
conditions and the environment in which we operate our
businesses.
In responding to this unprecedented situation, we have taken
measures to prioritize the health of our employees and their
families, and to be prepared operationally to serve our clients,
leveraging our business continuity planning and historical
investments in technology. More than 90% of our employees
are currently working from home, and to date, we have not
experienced any significant loss of operational capability, as we
have implemented our pandemic-related responses. We believe
we are prepared to continue to operate with the vast majority of
our workforce working remotely for as long as health guidelines
and prudence require, with limited impact to our operational
capabilities.
The coronavirus disease has impacted many people’s health
around the world, including many of our employees. Our
Chairman and CEO was diagnosed with the coronavirus in
March, but has fully recovered. The rest of the Firm’s Operating
Committee remain healthy and are sheltering in place.
With the COVID-19 impacts on individuals, communities and
organizations continuing to evolve, governments around the
world have reacted to the health crisis caused by the pandemic,
and central banks have taken steps to proactively address market
disruptions by cutting interest rates and providing liquidity
sources and other stimulus programs. See “Regulatory
Developments in Response to COVID-19” herein for further
details.
We also have taken several direct steps to provide assistance.
Our balance sheet has increased as we: support market and client
activity; take in increased deposits from our Wealth
Management clients; extend credit to our institutional and retail
clients to provide them with additional liquidity; and provide
financing to support COVID-19 impacted clients across
multiple sectors. Along with the seven other U.S. Banks
comprising the Financial Services Forum, we voluntarily ceased
our Share Repurchase Program to keep this capital available to
help clients and took action on the Federal Reserve's
encouragement to use its discount window by borrowing from
it. We have also taken steps to participate in other Federal
Reserve programs, notably the Primary Dealer Credit Facility
(“PDCF”).
Our financial condition, balance sheet, capital and liquidity have
remained strong. In March 2020, we saw deposit inflows of $38
billion as customers sought relative safety away from volatile
markets, and we raised more than $5 billion in new long-term
debt supplementing our liquidity position.
As further discussed in “Business Segments” herein, towards
the end of the current quarter, we observed the impact of the
pandemic on our business. The decline of asset prices, reduction
in interest rates, widening of credit spreads, borrower and
counterparty credit deterioration, market volatility and reduced
investment banking activity had the most immediate negative
impacts on our current quarter performance. Related to these
effects, the Firm experienced mark-to-market losses, net of
economic hedges of $610 million on loans and lending
commitments held for sale, provisions of $407 million for credit
losses on loans and lending commitments held for investment,
and losses of $384 million on fund and business-related
investments, net of hedges. At the same time, high levels of
client trading activity, related to market volatility, significantly
increased revenues for global macro products and Commodities
in Institutional Securities, and the transactional businesses in
Wealth Management.
Though we are unable to estimate the extent of the impact, the
continuing pandemic and related global economic crisis will
adversely impact our future operating results. Additionally, with
the continuance of many of the same negative impacts, without
the benefit of higher client trading activity experienced in the
-- 8 of 93 --
Table of Contents
Management’s Discussion and Analysis
March 2020 Form 10-Q 6
current quarter, it is uncertain that our financial objectives will
be attained within the originally stated two year time frame.
We continue to use the elements of our Enterprise Risk
Management framework manage the significant uncertainty in
the present economic and market conditions. See “Quantitative
and Qualitative Disclosures about Risk” in the 2019 Form 10-
K for further information about our Enterprise Risk
Management Framework.
In addition, refer to “Risk Factors” herein and Forward Looking
Statements in the 2019 Form 10-K.
Selected Non-GAAP Financial Information
We prepare our financial statements using U.S. GAAP. From
time to time, we may disclose certain “non-GAAP financial
measures” in this document or in the course of our earnings
releases, earnings and other conference calls, financial
presentations, definitive proxy statement and otherwise. A “non-
GAAP financial measure” excludes, or includes, amounts from
the most directly comparable measure calculated and presented
in accordance with U.S. GAAP. We consider the non-GAAP
financial measures we disclose to be useful to us, investors,
analysts and other stakeholders by providing further
transparency about, or an alternate means of assessing, our
financial condition, operating results, prospective regulatory
capital requirements or capital adequacy.
These measures are not in accordance with, or a substitute for,
U.S. GAAP and may be different from or inconsistent with non-
GAAP financial measures used by other companies. Whenever
we refer to a non-GAAP financial measure, we will also
generally define it or present the most directly comparable
financial measure calculated and presented in accordance with
U.S. GAAP, along with a reconciliation of the differences
between the U.S. GAAP financial measure and the non-GAAP
financial measure.
The principal non-GAAP financial measures presented in this
document are set forth in the following tables.
Reconciliations from U.S. GAAP to Non-GAAP Consolidated
Financial Measures
Three Months Ended
March 31,
$ in millions, except per share data 2020 2019
Net income applicable to Morgan Stanley $ 1,698 $ 2,429
Impact of adjustments (31) (101)
Adjusted net income applicable to Morgan
Stanley—non-GAAP1 $ 1,667 $ 2,328
Earnings per diluted common share $ 1.01 $ 1.39
Impact of adjustments (0.02) (0.06)
Adjusted earnings per diluted common
share—non-GAAP1 $ 0.99 $ 1.33
Effective income tax rate 17.1% 16.5%
Impact of adjustments 1.4% 3.4%
Adjusted effective income tax rate—
non-GAAP1 18.5% 19.9%
Average Monthly Balance
Three Months Ended March 31,
$ in millions 2020 2019
Tangible equity
Morgan Stanley shareholders' equity $ 83,244 $ 80,115
Less: Goodwill and net intangible assets (9,200) (8,806)
Tangible Morgan Stanley shareholders'
equity—Non-GAAP $ 74,044 $ 71,309
Common shareholders' equity $ 74,724 $ 71,595
Less: Goodwill and net intangible assets (9,200) (8,806)
Tangible common shareholders' equity—
Non-GAAP $ 65,524 $ 62,789
Three Months Ended
March 31,
$ in billions 2020 2019
Average common equity
Unadjusted—GAAP $ 74.7 $ 71.6
Adjusted1—Non-GAAP 74.7 71.5
ROE2
Unadjusted—GAAP 8.5% 13.1%
Adjusted—Non-GAAP1, 3 8.3% 12.5%
Average tangible common equity—Non-GAAP
Unadjusted $ 65.5 $ 62.8
Adjusted1 65.5 62.7
ROTCE2—Non-GAAP
Unadjusted 9.7% 14.9%
Adjusted1, 3 9.5% 14.2%
-- 9 of 93 --
Table of Contents
Management’s Discussion and Analysis
7 March 2020 Form 10-Q
Non-GAAP Financial Measures by Business Segment
Three Months Ended
March 31,
$ in billions 2020 2019
Average common equity4, 5
Institutional Securities $ 42.8 $ 40.4
Wealth Management 18.2 18.2
Investment Management 2.6 2.5
Average tangible common equity4, 5
Institutional Securities $ 42.3 $ 39.9
Wealth Management 10.4 10.2
Investment Management 1.7 1.5
ROE6
Institutional Securities 6.3% 12.9%
Wealth Management 18.5% 19.8%
Investment Management 11.7% 21.9%
ROTCE6
Institutional Securities 6.4% 13.0%
Wealth Management 32.3% 35.6%
Investment Management 18.1% 35.3%
1. Adjusted amounts exclude net discrete tax provisions (benefits) that are intermittent
and include those that are recurring. Provisions (benefits) related to conversion of
employee share-based awards are expected to occur every year and, as such, are
considered recurring discrete tax items. For further information on the net discrete tax
provisions (benefits), see “Supplemental Financial Information—Income Tax Matters”
herein.
2. ROE and ROTCE represent annualized earnings applicable to Morgan Stanley
common shareholders as a percentage of average common equity and average
tangible common equity, respectively. When excluding intermittent net discrete tax
provisions (benefits), both the numerator and average denominator are adjusted.
3. The calculations used in determining our “ROE and ROTCE Targets” referred to in
the following section are the Adjusted ROE and Adjusted ROTCE amounts shown in
this table.
4. Average common equity and average tangible common equity for each business
segment is determined using our Required Capital framework (see "Liquidity and
Capital Resources—Regulatory Requirements—Attribution of Average Common
Equity According to the Required Capital Framework” herein).
5. The sums of the segments' Average common equity and Average tangible common
equity do not equal the Consolidated measures due to Parent equity.
6. The calculation of ROE and ROTCE by segment uses annualized net income
applicable to Morgan Stanley by segment less preferred dividends allocated to each
segment as a percentage of average common equity and average tangible common
equity, respectively, allocated to each segment.
Return on Tangible Common Equity Target
In January 2020, we established an ROTCE Target of 13% to
15% to be achieved over the next two years.
Our ROTCE Target is a forward-looking statement that was
based on a normal market environment and may be materially
affected by many factors, including, among other things:
macroeconomic and market conditions; legislative and
regulatory developments; industry trading and investment
banking volumes; equity market levels; interest rate
environment; outsized legal expenses or penalties; the ability to
maintain a reduced level of expenses; and capital levels.
With the COVID–19 pandemic, and the current global economic
crisis that includes negative impacts from many of the
aforementioned factors, it is uncertain that the ROTCE Target
will be met within the originally stated time frame. See
“Coronavirus Disease (COVID–19) Pandemic” herein and
“Risk Factors” for further information on market and economic
conditions and their effects on our financial results.
For further information on non-GAAP measures (ROTCE
excluding intermittent net discrete tax items), see “Selected
Non-GAAP Financial Information” herein. For information on
the impact of intermittent net discrete tax items, see
“Supplemental Financial Information—Income Tax Matters”
herein.
Business Segments
Substantially all of our operating revenues and operating
expenses are directly attributable to our business segments.
Certain revenues and expenses have been allocated to each
business segment, generally in proportion to its respective net
revenues, non-interest expenses or other relevant measures.
For an overview of the components of our business segments,
net revenues, compensation expense and income taxes, see
“Management’s Discussion and Analysis of Financial Condition
and Results of Operations—Business Segments” in the 2019
Form 10-K.
-- 10 of 93 --
Table of Contents
Management’s Discussion and Analysis
March 2020 Form 10-Q 8
Institutional Securities
Income Statement Information
Three Months Ended
March 31,
$ in millions 2020 2019 % Change
Revenues
Investment banking $ 1,144 $ 1,151 (1)%
Trading 3,416 3,130 9 %
Investments (25) 81 (131)%
Commissions and fees 874 621 41 %
Asset management 113 107 6 %
Other (1,079) 222 N/M
Total non-interest revenues 4,443 5,312 (16)%
Interest income 2,423 3,056 (21)%
Interest expense 1,961 3,172 (38)%
Net interest 462 (116) N/M
Net revenues 4,905 5,196 (6)%
Compensation and benefits 1,814 1,819 — %
Non-compensation expenses 2,141 1,782 20 %
Total non-interest expenses 3,955 3,601 10 %
Income before provision for
income taxes 950 1,595 (40)%
Provision for income taxes 151 190 (21)%
Net income 799 1,405 (43)%
Net income applicable to
noncontrolling interests 42 34 24 %
Net income applicable to
Morgan Stanley $ 757 $ 1,371 (45)%
Results in the Institutional Securities business segment reflect
constructive markets in January and February 2020 and the
significant effects of COVID-19 on markets in March. In
particular, in March:
• Uncertainty, driven by market volatility and the overall
environment, resulted in lower activity in Advisory and
Equity underwriting.
• Market volumes and volatility were significantly higher than
in the prior year quarter resulting in increased client activity
across the Sales and Trading businesses and widened bid-offer
spreads. Valuations were negatively impacted, and client
balances declined significantly in the Equity Financing
business.
• Credit deteriorated rapidly, the results of which are reflected
in losses on held-for-sale loans and lending commitments
recorded in Other revenues, partially offset by positive hedge
results in Other Sales and Trading, aggregating to $610
million for the current quarter; provisions for loan losses
recorded in Other revenues, and lending commitments shown
in Non-compensation expenses, aggregating to $388 million
for the current quarter; Trading losses in certain Credit
products within Fixed Income; and losses on certain
counterparties’ failure to meet margin requirements in Equity
sales and trading.
These effects, in the context of the full quarter’s results, are
further discussed herein.
Investment Banking
Investment Banking Revenues
Three Months Ended
March 31,
$ in millions 2020 2019 % Change
Advisory $ 362 $ 406 (11)%
Underwriting:
Equity 336 339 (1)%
Fixed income 446 406 10 %
Total Underwriting 782 745 5 %
Total Investment banking $ 1,144 $ 1,151 (1)%
Investment Banking Volumes
Three Months Ended
March 31,
$ in billions 2020 2019
Completed mergers and acquisitions1 $ 109 $ 195
Equity and equity-related offerings2, 3 13 14
Fixed income offerings2, 4 82 58
Source: Refinitiv data as of April 1, 2020. Transaction volumes may not be
indicative of net revenues in a given period. In addition, transaction volumes
for prior periods may vary from amounts previously reported due to the
subsequent withdrawal, change in value or change in timing of certain
transactions.
1. Includes transactions of $100 million or more. Based on full credit to each
of the advisors in a transaction.
2. Based on full credit for single book managers and equal credit for joint
book managers.
3. Includes Rule 144A issuances and registered public offerings of common
stock, convertible securities and rights offerings.
4. Includes Rule 144A and publicly registered issuances, non-convertible
preferred stock, mortgage-backed and asset-backed securities, and
taxable municipal debt. Excludes leveraged loans and self-led issuances.
Investment banking revenues of $1,144 million in the current
quarter were relatively unchanged from the prior year quarter,
reflecting lower results in our advisory business offset by higher
results in our fixed income underwriting business.
• Advisory revenues decreased in the current quarter primarily
as a result of lower volumes of completed M&A activity,
particularly large transactions.
• Equity underwriting revenues were relatively unchanged
compared with subdued results in the prior year quarter as
lower revenues in secondary block share trades were offset
by higher revenues in initial public offerings and follow-on
offerings.
-- 11 of 93 --
Table of Contents
Management’s Discussion and Analysis
9 March 2020 Form 10-Q
• Fixed income underwriting revenues increased in the current
quarter primarily due to higher overall volumes compared to
the prior year quarter, with higher revenues in investment
grade bond and non-investment grade loan issuances, partially
offset by lower revenues from investment grade loan
issuances.
See “Investment Banking Volumes” herein.
Sales and Trading Net Revenues
By Income Statement Line Item
Three Months Ended
March 31,
$ in millions 2020 2019 % Change
Trading $ 3,416 $ 3,130 9%
Commissions and fees 874 621 41%
Asset management 113 107 6%
Net interest 462 (116) N/M
Total $ 4,865 $ 3,742 30%
By Business
Three Months Ended
March 31,
$ in millions 2020 2019 % Change
Equity $ 2,422 $ 2,015 20%
Fixed Income 2,203 1,710 29%
Other 240 17 N/M
Total $ 4,865 $ 3,742 30%
Sales and Trading Revenues—Equity and Fixed Income
Three Months Ended
March 31, 2020
Net
$ in millions Trading Fees1 Interest2 Total
Financing $ 1,034 $ 101 $ (37) $ 1,098
Execution services 579 783 (38) 1,324
Total Equity $ 1,613 $ 884 $ (75) $ 2,422
Total Fixed Income $ 1,773 $ 102 $ 328 $ 2,203
Three Months Ended
March 31, 2019
Net
$ in millions Trading Fees1 Interest2 Total
Financing $ 1,115 $ 98 $ (258) $ 955
Execution services 551 553 (44) 1,060
Total Equity $ 1,666 $ 651 $ (302) $ 2,015
Total Fixed Income $ 1,727 $ 78 $ (95) $ 1,710
1. Includes Commissions and fees and Asset management revenues.
2. Includes funding costs, which are allocated to the businesses based on
funding usage.
Equity
Equity sales and trading net revenues of $2,422 million in the
current quarter increased 20% from the prior year quarter,
reflecting higher results in both our financing and execution
services businesses.
• Financing increased from the prior year quarter, primarily due
to higher average client balances, partially offset by the impact
of reduced dividend expectations on the valuation of certain
hedges. Net interest increased reflecting a reduction in
funding costs.
• Execution services increased from the prior year quarter,
reflecting an increase in market volumes in cash equities
resulting in higher Commissions and fees, and higher client
trading activity in derivatives products, which was partially
offset by the impact of losses on certain counterparties’ failure
to meet margin requirements and the impact of reduced
dividend expectations on derivative valuations.
Fixed Income
Fixed Income sales and trading net revenues of $2,203 million
in the current quarter were 29% higher than the prior year
quarter, primarily driven by higher results in global macro
products, partially offset by lower results in credit products.
• Global macro products Trading revenues increased primarily
due to higher client activity in both foreign exchange and rates
products, and the widening of bid-offer spreads from higher
market volatility. Higher average balances and lower funding
costs contributed to an increase in Net interest revenues.
• Credit products Trading revenues decreased primarily due to
the widening of credit spreads which resulted in losses in
securitized products and municipal securities, partially offset
by increased revenues from client activity in corporate credit
products from higher volumes and widening bid-offer
spreads. Net interest revenues increased, primarily driven by
higher spreads on Agency products and higher average
balances in secured lending facilities.
• Trading revenues from Commodities products and Other
decreased as a result of lower client structuring activity within
derivatives counterparty credit risk management, partially
offset by improved inventory management in commodities
due to higher market volatility in energy and metals. Net
interest revenues increased, reflecting lower funding costs.
Other
• Other sales and trading revenues of $240 million in the current
quarter increased from the prior year quarter reflecting gains
on hedges associated with loans and lending commitments
compared with losses in the prior year quarter, partially offset
by losses related to investments associated with certain
employee deferred cash-based compensation plans.
-- 12 of 93 --
Table of Contents
Management’s Discussion and Analysis
March 2020 Form 10-Q 10
Investments, Other Revenues, Non-interest Expenses, and
Income Tax Items
Investments
• Net investment losses of $25 million in the current quarter
compared to gains in the prior year quarter, were primarily
driven by losses in the current quarter on an energy-related
investment and lower revenues from fund-related
distributions.
Other Revenues
• Other net losses of $1,079 million in the current quarter were
primarily as a result of mark-to-market losses on loans and
lending commitments held for sale due to the widening of
credit spreads, compared with gains in the prior year quarter,
as well as an increase in the provision for credit losses on
loans held for investment.
Non-interest Expenses
Non-interest expenses of $3,955 million in the current quarter
increased from the prior year quarter, primarily reflecting a 20%
increase in Non-compensation expenses.
• Compensation and benefits expenses remained relatively
unchanged in the current quarter as the benefit from a decrease
in the fair value of investments to which certain deferred
compensation plans are referenced was offset by an increase
in discretionary incentive compensation reflecting baseline
annual compensation estimates, exclusive of the benefit
noted.
• Non-compensation expenses increased in the current quarter
primarily due to higher volume-related expenses as well as
an increase in the provision for credit losses for lending
commitments held for investment.
Income Tax Items
Intermittent net discrete tax benefits of $101 million were
recognized in Provision for income taxes in the prior year
quarter. For further information, see “Supplemental Financial
Information—Income Tax Matters” herein.
-- 13 of 93 --
Table of Contents
Management’s Discussion and Analysis
11 March 2020 Form 10-Q
Wealth Management
Income Statement Information
Three Months Ended
March 31,
$ in millions 2020 2019 % Change
Revenues
Investment banking $ 158 $ 109 45 %
Trading (347) 302 N/M
Investments — 1 (100)%
Commissions and fees 588 406 45 %
Asset management 2,680 2,361 14 %
Other 62 80 (23)%
Total non-interest revenues 3,141 3,259 (4)%
Interest income 1,193 1,413 (16)%
Interest expense 297 283 5 %
Net interest 896 1,130 (21)%
Net revenues 4,037 4,389 (8)%
Compensation and benefits 2,212 2,462 (10)%
Non-compensation expenses 770 739 4 %
Total non-interest expenses 2,982 3,201 (7)%
Income before provision for
income taxes $ 1,055 $ 1,188 (11)%
Provision for income taxes 191 264 (28)%
Net income applicable to
Morgan Stanley $ 864 $ 924 (6)%
Results in the Wealth Management business segment reflect the
significant effects of COVID-19 on the economy and markets
in March 2020. In particular, in March:
• The decline in global asset prices contributed to losses on
investments associated with certain employee deferred cash-
based compensation plans of $426 million in the current
quarter.
• Already elevated market volumes and volatility compared to
the prior year quarter increased further, resulting in increased
commissions from client activity.
These effects, in the context of the full quarter’s results, are
further discussed herein.
Financial Information and Statistical Data
At
March 31,
2020
At
December 31,
2019 $ in billions, except employee data
Client assets $ 2,397 $ 2,700
Fee-based client assets1 $ 1,134 $ 1,267
Fee-based client assets as a
percentage of total client assets 47% 47%
Client liabilities2 $ 92 $ 90
Investment securities portfolio $ 75.5 $ 67.2
Loans and lending commitments $ 95.9 $ 93.2
Wealth Management
representatives 15,432 15,468
Three Months Ended
March 31,
2020 2019
Per representative:
Annualized revenues ($ in thousands)3 $ 1,045 $ 1,118
Client assets ($ in millions)4 $ 155 $ 158
Fee-based asset flows ($ in billions)5 $ 18.4 $ 14.8
1. Fee-based client assets represent the amount of assets in client accounts
where the fee for services is calculated based on those assets.
2. Client liabilities include securities-based and tailored lending, residential
real estate loans and margin lending.
3. Revenues per representative equal Wealth Management’s annualized net
revenues divided by the average number of representatives.
4. Client assets per representative equal total period-end client assets divided
by period-end number of representatives.
5. For a description of the Inflows and Outflows included within Fee-based
asset flows, see “Management’s Discussion and Analysis of Financial
Condition and Results of Operations—Business Segments—Wealth
Management—Fee-Based Client Assets” in the 2019 Form 10-K. Excludes
institutional cash management-related activity.
Transactional Revenues
Three Months Ended
March 31,
$ in millions 2020 2019 % Change
Investment banking $ 158 $ 109 45 %
Trading (347) 302 N/M
Commissions and fees 588 406 45 %
Total $ 399 $ 817 (51)%
Transactional revenues as a %
of Net revenues 10% 19%
-- 14 of 93 --
Table of Contents
Management’s Discussion and Analysis
March 2020 Form 10-Q 12
Net Revenues
Transactional Revenues
Transactional revenues of $399 million in the current quarter
decreased 51% from the prior year quarter as negative Trading
revenues were partially offset by higher Commissions and fees
and Investment banking revenues.
• Investment banking revenues increased in the current quarter
primarily due to higher revenues from structured products and
closed-end fund issuances.
• Trading revenues decreased in the current quarter principally
due to losses related to investments associated with certain
employee deferred cash-based compensation plans,
compared with gains in the prior year quarter.
• Commissions and fees increased in the current quarter
primarily due to increased client activity in equities.
Asset Management
Asset management revenues of $2,680 million in the current
quarter increased 14% from the prior year quarter primarily due
to higher fee-based assets levels at the beginning of the monthly
billing cycles in 2020 due to market appreciation and positive
net flows, partially offset by lower average fee rates.
See “Fee-Based Client Assets—Rollforwards” herein.
Other
Other revenues of $62 million in the current quarter decreased
23% from the prior year quarter primarily due to an increase in
the provision for credit losses.
Net Interest
Net interest of $896 million in the current quarter decreased 21%
from the prior year quarter primarily due to lower interest rates
on Loans and the investment portfolio, changes in our funding
mix, and higher prepayment amortization expense related to
mortgage-backed securities. These decreases were partially
offset by the impact of lower rates paid on brokerage sweep
deposits and higher Loan balances.
Non-interest Expenses
Non-interest expenses of $2,982 million in the current quarter
decreased 7% from the prior year quarter primarily as a result
of lower Compensation and benefits expenses, partially offset
by higher Non-compensation expenses.
• Compensation and benefits expenses decreased in the current
quarter, primarily due to decreases in the fair value of
investments to which certain deferred compensation plans are
referenced, partially offset by an increase in the formulaic
payout to Wealth Management representatives driven by the
mix of revenues.
• Non-compensation expenses increased in the current quarter
primarily due to incremental expenses related to Solium
Capital, Inc., which was acquired in the second quarter of
2019.
Fee-Based Client Assets
Rollforwards
$ in billions
At
December 31,
2019 Inflows Outflows Market
Impact
At
March 31,
2020
Separately
managed1 $ 322 $ 12 $ (7) $ 2 $ 329
Unified managed 313 16 (13) (53) 263
Advisor 155 10 (9) (25) 131
Portfolio manager 435 27 (18) (65) 379
Subtotal $ 1,225 $ 65 $ (47) $ (141) $ 1,102
Cash management 42 4 (14) — 32
Total fee-based
client assets $ 1,267 $ 69 $ (61) $ (141) $ 1,134
$ in billions
At
December 31,
2018 Inflows Outflows Market
Impact
At
March 31,
2019
Separately
managed1 $ 279 $ 14 $ (5) $ (12) $ 276
Unified managed 257 13 (11) 24 283
Advisor 137 8 (9) 11 147
Portfolio manager 353 19 (14) 33 391
Subtotal $ 1,026 $ 54 $ (39) $ 56 $ 1,097
Cash management 20 4 (5) — 19
Total fee-based
client assets $ 1,046 $ 58 $ (44) $ 56 $ 1,116
Average Fee Rates
Three Months Ended
March 31,
Fee rate in bps 2020 2019
Separately managed 14 14
Unified managed 99 101
Advisor 85 88
Portfolio manager 94 96
Subtotal 72 74
Cash management 5 6
Total fee-based client assets 71 73
1. Includes non-custody account values reflecting prior quarter-end balances
due to a lag in the reporting of asset values by third-party custodians.
For a description of fee-based client assets and rollforward items
in the previous tables, see “Management’s Discussion and
Analysis of Financial Condition and Results of Operations—
Business Segments—Wealth Management—Fee-Based Client
Assets” in the 2019 Form 10-K.
-- 15 of 93 --
Table of Contents
Management’s Discussion and Analysis
13 March 2020 Form 10-Q
Investment Management
Income Statement Information
Three Months Ended
March 31,
$ in millions 2020 2019 % Change
Revenues
Trading $ (37) $ (3) N/M
Investments 63 191 (67)%
Asset management 665 617 8 %
Other 7 3 133 %
Total non-interest revenues 698 808 (14)%
Interest income 8 4 100 %
Interest expense 14 8 75 %
Net interest (6) (4) (50)%
Net revenues 692 804 (14)%
Compensation and benefits 257 370 (31)%
Non-compensation expenses 292 260 12 %
Total non-interest expenses 549 630 (13)%
Income before provision for
income taxes 143 174 (18)%
Provision for income taxes 25 33 (24)%
Net income 118 141 (16)%
Net income applicable to
noncontrolling interests 40 5 N/M
Net income applicable to
Morgan Stanley $ 78 $ 136 (43)%
Results in the Investment Management business segment reflect
the significant effects of COVID-19 on the economy and
markets in March 2020. In particular, in March:
• The decline in global asset prices led to losses of $326 million
in the current quarter related to the reversal of accrued carried
interest, and losses on investments in certain of our funds, net
of economic hedges, and net losses in Trading revenues.
These effects, in the context of the full quarter’s results, are
further discussed herein.
Net Revenues
Investments
Investments revenues of $63 million in the current quarter
decreased 67% from the prior year quarter primarily as a result
of the reversal of accrued carried interest and investment losses
in certain private equity, real estate, and infrastructure funds and
losses on seed investments in certain funds. Partially offsetting
these decreases were higher carried interest and investment
gains in an Asia private equity fund, principally driven by gains
from an underlying investment, which is subject to certain sales
restrictions.
Asset Management
Asset management revenues of $665 million in the current
quarter increased 8% from the prior year quarter primarily as a
result of higher average AUM.
See “Assets Under Management or Supervision” herein.
Non-interest Expenses
Non-interest expenses of $549 million in the current quarter
decreased 13% from the prior year quarter primarily as a result
of lower compensation and benefits expenses, partially offset
by higher non-compensation expenses.
• Compensation and benefits expenses decreased in the current
quarter primarily due to lower compensation associated with
carried interest and a decrease in the fair value of investments
to which certain deferred compensation plans are referenced.
• Non-compensation expenses in the current quarter increased
from the prior year quarter primarily as a result of higher fee
sharing paid to intermediaries driven by higher average AUM.
-- 16 of 93 --
Table of Contents
Management’s Discussion and Analysis
March 2020 Form 10-Q 14
Assets Under Management or Supervision
Rollforwards
$ in billions
At
December 31,
2019 Inflows Outflows Market
Impact Other
At
March 31,
2020
Equity $ 138 $ 14 $ (12) $ (18) $ (1) $ 121
Fixed income 79 10 (9) (4) (1) 75
Alternative/
Other 139 8 (4) (7) 5 141
Long-term AUM
subtotal 356 32 (25) (29) 3 337
Liquidity 196 446 (395) 1 (1) 247
Total AUM $ 552 $ 478 $ (420) $ (28) $ 2 $ 584
Shares of
minority stake
assets 6 6
$ in billions
At
December 31,
2018 Inflows Outflows Market
Impact Other
At
March 31,
2019
Equity $ 103 $ 9 $ (8) $ 16 $ — $ 120
Fixed income 68 6 (7) 1 — 68
Alternative/
Other 128 5 (4) 5 (1) 133
Long-term AUM
subtotal 299 20 (19) 22 (1) 321
Liquidity 164 343 (348) 1 (1) 159
Total AUM $ 463 $ 363 $ (367) $ 23 $ (2) $ 480
Shares of
minority stake
assets 7 6
Average AUM
Three Months Ended
March 31,
$ in billions 2020 2019
Equity $ 133 $ 113
Fixed income 79 68
Alternative/Other 139 131
Long-term AUM subtotal 351 312
Liquidity 206 163
Total AUM $ 557 $ 475
Shares of minority stake assets 6 6
Average Fee Rates
Three Months Ended
March 31,
Fee rate in bps 2020 2019
Equity 77 76
Fixed income 31 32
Alternative/Other 60 68
Long-term AUM 60 63
Liquidity 17 17
Total AUM 44 47
For a description of the asset classes and rollforward items in
the previous tables, see “Management’s Discussion and
Analysis of Financial Condition and Results of Operations—
Business Segments—Investment Management—Assets Under
Management or Supervision” in the 2019 Form 10-K.
-- 17 of 93 --
Table of Contents
Management’s Discussion and Analysis
15 March 2020 Form 10-Q
Supplemental Financial Information
Income Tax Matters
Effective Tax Rate from Continuing Operations
Three Months Ended
March 31,
$ in millions 2020 2019
U.S. GAAP 17.1% 16.5%
Adjusted effective income tax rate—
non-GAAP1 18.5% 19.9%
Net discrete tax provisions/(benefits)
Recurring2 $ (99) $ (107)
Intermittent3 $ (31) $ (101)
1. The adjusted effective income tax rate is a non-GAAP measure that
excludes net discrete tax provisions (benefits) that are intermittent and
includes those that are recurring. For further information on non-GAAP
measures, see “Selected Non-GAAP Financial Information” herein.
2. Provisions (benefits) related to conversion of employee share-based
awards are expected to occur every year and, as such, are considered
recurring discrete tax items.
3. Includes all tax provisions (benefits) that have been determined to be
discrete, other than Recurring items as defined above.
The current quarter includes intermittent net discrete tax benefits
associated with the remeasurement of prior years’ tax liabilities.
The prior year quarter includes intermittent net discrete tax
benefits primarily associated with remeasurement of reserves
and related interest as a result of new information pertaining to
the resolution of multi-jurisdiction tax examinations. See Note
18 to the financial statements for further information.
U.S. Bank Subsidiaries
Our U.S. bank subsidiaries, Morgan Stanley Bank N.A.
(“MSBNA”) and Morgan Stanley Private Bank, National
Association (“MSPBNA”) (collectively, “U.S. Bank
Subsidiaries”) accept deposits; provide loans to a variety of
customers, from large corporate and institutional clients to high
net worth individuals; and invest in securities. Lending activity
recorded in the U.S. Bank subsidiaries from the Institutional
Securities business segment primarily includes loans and
lending commitments to corporate clients. Lending activity
recorded in the U.S. Bank subsidiaries from the Wealth
Management business segment primarily includes securities-
based lending, which allows clients to borrow money against
the value of qualifying securities, and residential real estate
loans.
For a further discussion of our credit risks, see “Quantitative
and Qualitative Disclosures about Risk—Credit Risk.” For a
further discussion about loans and lending commitments, see
Notes 9 and 13 to the financial statements.
U.S. Bank Subsidiaries’ Supplemental Financial Information1
$ in billions
At
March 31,
2020
At
December 31,
2019
Assets $ 265.4 $ 219.6
Investment securities portfolio:
Investment securities—AFS 49.0 42.4
Investment securities—HTM 28.7 26.1
Total investment securities $ 77.7 $ 68.5
Deposits2 $ 234.1 $ 189.3
Wealth Management Loans
Securities-based lending and
other3 $ 51.4 $ 49.9
Residential real estate 31.1 30.2
Total $ 82.5 $ 80.1
Institutional Securities Loans
Corporate4:
Corporate relationship and
event-driven lending $ 15.4 $ 5.6
Secured lending facilities 28.4 26.8
Securities-based lending and
other 5.1 5.4
Commercial and residential real
estate 10.3 12.0
Total $ 59.2 $ 49.8
1. Amounts exclude transactions between the bank subsidiaries, as well as
deposits from the Parent Company and affiliates.
2. For further information on deposits, see “Liquidity and Capital Resources
—Funding Management—Unsecured Financing” herein.
3. Other loans primarily include tailored lending.
4. For a further discussion of corporate loans in the Institutional Securities
business segment, see “Credit Risk—Institutional Securities Corporate
Loans” herein.
Other Matters
Planned Acquisition of E*TRADE
On February 20, 2020, we entered into a definitive agreement
under which we will acquire E*TRADE Financial Corporation
(“E*TRADE”) in an all-stock transaction. In the current quarter,
we filed our application with the Federal Reserve and in early
April the Hart-Scott-Rodino Antitrust waiting period expired.
The acquisition is subject to customary closing conditions,
including regulatory approvals and approval by E*TRADE
shareholders, and we continue to expect the acquisition to close
in the fourth quarter of 2020.
Accounting Development Updates
The Financial Accounting Standards Board has issued certain
accounting updates that apply to us. Accounting updates not
listed below were assessed and either determined to be not
applicable or are not expected to have a significant impact on
our financial statements.
-- 18 of 93 --
Table of Contents
Management’s Discussion and Analysis
March 2020 Form 10-Q 16
The following accounting update is currently being evaluated
to determine the potential impact of adoption:
• Reference Rate Reform. This accounting update provides
optional accounting relief to entities with contracts, hedge
accounting relationships or other transactions that reference
LIBOR or other interest rate benchmarks for which the
referenced rate is expected to be discontinued or replaced.
This optional relief generally allows for contract
modifications solely related to the replacement of the
reference rate to be accounted for as a continuation of the
existing contract instead of as an extinguishment of the
contract, and would therefore not trigger certain accounting
impacts that would otherwise be required. The relief also
allows entities to change certain critical terms of existing
hedge accounting relationships that are affected by reference
rate reform, and these changes would not require de-
designating the hedge accounting relationship. The optional
relief can be applied beginning January 1, 2020, and ending
December 31, 2022. We plan to apply the accounting relief
as relevant contract and hedge accounting relationship
modifications are made during the course of the reference rate
reform transition period.
Critical Accounting Policies
Our financial statements are prepared in accordance with U.S.
GAAP, which requires us to make estimates and assumptions
(see Note 1 to the financial statements). We believe that of our
significant accounting policies (see Note 2 to the financial
statements in the 2019 Form 10-K and Note 2 to the financial
statements), the fair value, goodwill and intangible assets, legal
and regulatory contingencies and income taxes policies involve
a higher degree of judgment and complexity. For a further
discussion about our critical accounting policies, see
“Management’s Discussion and Analysis of Financial Condition
and Results of Operations—Critical Accounting Policies” in the
2019 Form 10-K.
Liquidity and Capital Resources
Senior management, with oversight by the Asset/Liability
Management Committee and the Board of Directors (“Board”),
establishes and maintains our liquidity and capital policies.
Through various risk and control committees, senior
management reviews business performance relative to these
policies, monitors the availability of alternative sources of
financing, and oversees the liquidity, interest rate and currency
sensitivity of our asset and liability position. Our Treasury
department, Firm Risk Committee, Asset/Liability
Management Committee, and other committees and control
groups assist in evaluating, monitoring and controlling the
impact that our business activities have on our balance sheet,
liquidity and capital structure. Liquidity and capital matters are
reported regularly to the Board and the Risk Committee of the
Board.
Balance Sheet
We monitor and evaluate the composition and size of our balance
sheet on a regular basis. Our balance sheet management process
includes quarterly planning, business-specific thresholds,
monitoring of business-specific usage versus key performance
metrics and new business impact assessments.
We establish balance sheet thresholds at the consolidated and
business segment levels. We monitor balance sheet utilization
and review variances resulting from business activity and
market fluctuations. On a regular basis, we review current
performance versus established thresholds and assess the need
to re-allocate our balance sheet based on business unit needs.
We also monitor key metrics, including asset and liability size
and capital usage.
Total Assets by Business Segment
At March 31, 2020
$ in millions IS WM IM Total
Assets
Cash and cash equivalents $ 101,615 $ 29,803 $ 91 $ 131,509
Trading assets at fair value 266,781 389 3,746 270,916
Investment securities 40,662 75,495 — 116,157
Securities purchased under
agreements to resell 88,008 16,792 — 104,800
Securities borrowed 71,826 474 — 72,300
Customer and other
receivables 58,523 15,216 685 74,424
Loans1 66,171 82,516 10 148,697
Other assets2 13,903 13,139 1,950 28,992
Total assets $ 707,489 $ 233,824 $ 6,482 $ 947,795
At December 31, 2019
$ in millions IS WM IM Total
Assets
Cash and cash equivalents $ 67,657 $ 14,247 $ 267 $ 82,171
Trading assets at fair value 293,477 47 3,586 297,110
Investment securities 38,524 67,201 — 105,725
Securities purchased under
agreements to resell 80,744 7,480 — 88,224
Securities borrowed 106,199 350 — 106,549
Customer and other
receivables 39,743 15,190 713 55,646
Loans1 50,557 80,075 5 130,637
Other assets2 14,300 13,092 1,975 29,367
Total assets $ 691,201 $ 197,682 $ 6,546 $ 895,429
IS—Institutional Securities
WM—Wealth Management
IM—Investment Management
1. Amounts include loans held for investment, net of allowance, and loans held for sale
but exclude loans at fair value, which are included in Trading assets in the balance
sheets (see Note 9 to the financial statements).
2. Other assets primarily includes Goodwill and Intangible assets, premises, equipment
and software, ROU assets related to leases, other investments, and deferred tax
assets.
A substantial portion of total assets consists of liquid marketable
securities and short-term receivables arising principally from
sales and trading activities in the Institutional Securities
-- 19 of 93 --
Table of Contents
Management’s Discussion and Analysis
17 March 2020 Form 10-Q
business segment. Total assets increased to $948 billion at March
31, 2020 from $895 billion at December 31, 2019.
Within Wealth Management, assets increased in the investment
portfolio comprising Cash and cash equivalents, Investment
securities and Securities purchased under agreements to resell,
as a result of significantly higher deposits in this segment, and
loans continued to grow.
Institutional Securities’ assets were also higher reflecting
increases within Cash and cash equivalents, primarily due to
higher initial margin related to derivatives; Customer and other
receivables, resulting from higher volumes of unsettled
transactions in line with market conditions; and loan growth in
March in support of client needs. Additionally, within
Institutional Securities, Trading assets and Securities borrowed
decreased, predominantly driven by corporate equities as the
markets declined. The decrease in Trading assets includes a
partial offset related to increased derivative exposures related
to market volatility.
Liquidity Risk Management Framework
The core components of our Liquidity Risk Management
Framework are the Required Liquidity Framework, Liquidity
Stress Tests and Liquidity Resources, which support our target
liquidity profile. For a further discussion about the Firm’s
Required Liquidity Framework and Liquidity Stress Tests, see
“Management’s Discussion and Analysis of Financial Condition
and Results of Operations—Liquidity and Capital Resources—
Liquidity Risk Management Framework” in the 2019 Form 10-
K.
At March 31, 2020 and December 31, 2019, we maintained
sufficient liquidity to meet current and contingent funding
obligations as modeled in our Liquidity Stress Tests.
Liquidity Resources
We maintain sufficient liquidity resources, which are comprised
of HQLA and cash deposits with banks (“Liquidity Resources”)
to cover daily funding needs and to meet strategic liquidity
targets sized by the Required Liquidity Framework and
Liquidity Stress Tests. The total amount of Liquidity Resources
is actively managed by us considering the following
components: unsecured debt maturity profile; balance sheet size
and composition; funding needs in a stressed environment,
inclusive of contingent cash outflows; legal entity, regional and
segment liquidity requirements; regulatory requirements; and
collateral requirements.
The amount of Liquidity Resources we hold is based on our risk
tolerance and is subject to change depending on market and
Firm-specific events. The Liquidity Resources are primarily
held within the Parent Company and its major operating
subsidiaries. The Total HQLA values in the tables immediately
following are different from Eligible HQLA which, in
accordance with the LCR rule, also takes into account certain
regulatory weightings and other operational considerations.
Liquidity Resources by Type of Investment1
$ in millions
At
March 31,
2020
At
December 31,
2019
Cash deposits with central banks $ 60,719 $ 35,025
Unencumbered HQLA Securities2:
U.S. government obligations 95,619 88,754
U.S. agency and agency mortgage-backed
securities 58,342 50,732
Non-U.S. sovereign obligations3 30,255 29,909
Other investment grade securities 700 1,591
Total HQLA2 $ 245,635 $ 206,011
Cash deposits with banks (non-HQLA) 9,499 9,857
Total Liquidity Resources $ 255,134 $ 215,868
1. In the first quarter of 2020, we changed our internal measure of liquidity from the
Global Liquidity Reserve to Liquidity Resources, which is more closely aligned with
the regulatory definition of HQLA. Prior periods have been recast to conform to the
current presentation.
2. HQLA is presented prior to applying weightings and includes all HQLA held in
subsidiaries.
3. Primarily composed of unencumbered U.K., French, Japanese, and German
government obligations.
Liquidity Resources by Bank and Non-Bank Legal Entities1
$ in millions
At
March 31,
2020
At
December 31,
2019
Average Daily Balance
Three Months Ended
March 31, 2020
Bank legal entities
Domestic $ 112,126 $ 75,894 $ 83,117
Foreign 5,265 4,049 4,419
Total Bank legal
entities 117,391 79,943 87,536
Non-Bank legal entities
Domestic:
Parent Company 53,548 53,128 49,284
Non-Parent
Company 33,665 28,905 36,295
Total Domestic 87,213 82,033 85,579
Foreign 50,530 53,892 54,333
Total Non-Bank legal
entities 137,743 135,925 139,912
Total Liquidity
Resources $ 255,134 $ 215,868 $ 227,448
1. In the first quarter of 2020, we changed our internal measure of liquidity from the
Global Liquidity Reserve to Liquidity Resources, which is more closely aligned with
the regulatory definition of HQLA. Prior periods have been recast to conform to the
current presentation.
Liquidity Resources may fluctuate from period to period based
on the overall size and composition of our balance sheet, the
maturity profile of our unsecured debt and estimates of funding
needs in a stressed environment, among other factors. During
the current quarter, cash deposits at central banks have increased,
largely driven by an increase in deposits received from
customers.
-- 20 of 93 --
Table of Contents
Management’s Discussion and Analysis
March 2020 Form 10-Q 18
Regulatory Liquidity Framework
Liquidity Coverage Ratio
We and our U.S. Bank Subsidiaries are subject to LCR
requirements, including a requirement to calculate each entity’s
LCR on each business day. The requirements are designed to
ensure that banking organizations have sufficient Eligible
HQLA to cover net cash outflows arising from significant stress
over 30 calendar days, thus promoting the short-term resilience
of the liquidity risk profile of banking organizations. The LCR
calculation applies weightings (or asset haircuts) to HQLA and
excludes certain HQLA held in subsidiaries.
As of March 31, 2020, we and our U.S. Bank Subsidiaries are
compliant with the minimum required LCR of 100%. For further
information on regulatory developments that have impacted our
LCR, see “Liquidity and Capital Resources—Regulatory
Requirements—Regulatory Developments” herein.
Liquidity Coverage Ratio
Average Daily Balance
Three Months Ended
$ in millions
March 31,
2020 December 31,
2019
Eligible HQLA1
Cash deposits with central banks $ 32,778 $ 29,597
Securities2 140,336 148,221
Total Eligible HQLA1 $ 173,114 $ 177,818
LCR 127% 134%
1. Under the LCR rule, Eligible HQLA is calculated using weightings and excluding certain
HQLA held in subsidiaries.
2. Primarily includes U.S. Treasuries, U.S. agency mortgage-backed securities,
sovereign bonds and investment grade corporate bonds.
The reduction in the LCR was driven by lower average Eligible
HQLA amounts, which included the removal from Eligible
HQLA of certain securities used to secure intraday credit,
following a recent regulatory rule clarification.
Net Stable Funding Ratio
The NSFR requires banking organizations to maintain
sufficiently stable sources of funding over a one-year horizon.
In 2016, the U.S. banking agencies issued a proposal to
implement the NSFR in the U.S.; however, a final rule has not
yet been issued. For an additional discussion of the NSFR, see
“Management’s Discussion and Analysis of Financial Condition
and Results of Operations—Liquidity and Capital Resources—
Regulatory Liquidity Framework—Net Stable Funding Ratio”
in the 2019 Form 10-K.
Funding Management
We manage our funding in a manner that reduces the risk of
disruption to our operations. We pursue a strategy of
diversification of secured and unsecured funding sources (by
product, investor and region) and attempt to ensure that the tenor
of our liabilities equals or exceeds the expected holding period
of the assets being financed.
We fund our balance sheet on a global basis through diverse
sources. These sources include our equity capital, borrowings,
securities sold under agreements to repurchase, securities
lending, deposits, letters of credit and lines of credit. We have
active financing programs for both standard and structured
products targeting global investors and currencies.
Secured Financing
For a discussion of our secured financing activities, see
“Management’s Discussion and Analysis of Financial Condition
and Results of Operations—Liquidity and Capital Resources—
Funding Management—Secured Financing” in the 2019 Form
10-K.
Collateralized Financing Transactions
$ in millions
At
March 31,
2020
At
December 31,
2019
Securities purchased under agreements
to resell and Securities borrowed $ 177,100 $ 194,773
Securities sold under agreements to
repurchase and Securities loaned $ 57,447 $ 62,706
Securities received as collateral1 $ 4,711 $ 13,022
Average Daily Balance
Three Months Ended
$ in millions
March 31,
2020 December 31,
2019
Securities purchased under agreements
to resell and Securities borrowed $ 177,971 $ 210,257
Securities sold under agreements to
repurchase and Securities loaned $ 61,143 $ 64,870
1. Included within Trading assets—Corporate equities in the balance sheets.
See “Total Assets by Business Segment” herein for more details
on the assets shown in the previous table, Note 2 to the financial
statements in the 2019 Form 10-K and Note 8 to the financial
statements for more details on collateralized financing
transactions.
In addition to the collateralized financing transactions shown in
the previous table, we engage in financing transactions
collateralized by customer-owned securities, which are
segregated in accordance with regulatory requirements.
Receivables under these financing transactions, primarily
margin loans, are included in Customer and other receivables
in the balance sheets, and payables under these financing
transactions, primarily to prime brokerage customers, are
included in Customer and other payables in the balance sheets.
Our risk exposure on these transactions is mitigated by collateral
maintenance policies. We also hold related liquidity reserves.
Unsecured Financing
For a discussion of our unsecured financing activities, see
“Management’s Discussion and Analysis of Financial Condition
-- 21 of 93 --
Table of Contents
Management’s Discussion and Analysis
19 March 2020 Form 10-Q
and Results of Operations—Liquidity and Capital Resources—
Funding Management—Unsecured Financing” in the 2019
Form 10-K.
Deposits
$ in millions
At
March 31,
2020
At
December 31,
2019
Savings and demand deposits:
Brokerage sweep deposits1 $ 151,618 $ 121,077
Savings and other 36,886 28,388
Total Savings and demand deposits 188,504 149,465
Time deposits 46,735 40,891
Total $ 235,239 $ 190,356
1. Amounts represent balances swept from client brokerage accounts.
Deposits are primarily sourced from our Wealth Management
clients and are considered to have stable, low-cost funding
characteristics. Total deposits at March 31, 2020 significantly
increased compared with December 31, 2019, primarily driven
by higher brokerage sweep and savings deposits as customers
sought relative safety away from volatile markets in March. In
addition, total deposits increased as a result of higher time
deposits. See Management’s Discussion and Analysis of
Financial Condition and Results of Operations—Executive
Summary—Coronavirus Disease (COVID-19) Pandemic
herein for further information on market and economic
conditions.
Borrowings by Remaining Maturity at March 31, 20201
$ in millions
Parent
Company Subsidiaries Total
Original maturities of one year or
less $ 8 $ 2,203 $ 2,211
Original maturities greater than one year
2020 $ 8,264 $ 2,692 $ 10,956
2021 19,575 4,099 23,674
2022 16,116 3,045 19,161
2023 15,155 2,938 18,093
2024 15,678 4,809 20,487
Thereafter 79,688 20,586 100,274
Total $ 154,476 $ 38,169 $ 192,645
Total Borrowings $ 154,484 $ 40,372 $ 194,856
Maturities over next 12 months2 $ 17,153
1. Original maturity in the table is generally based on contractual final maturity. For
borrowings with put options, remaining maturity represents the earliest put date.
2. Includes only borrowings with original maturities greater than one year.
Borrowings of $195 billion as of March 31, 2020 were relatively
unchanged when compared with $193 billion at December 31,
2019.
We believe that accessing debt investors through multiple
distribution channels helps provide consistent access to the
unsecured markets. In addition, the issuance of borrowings with
original maturities greater than one year allows us to reduce
reliance on short-term credit sensitive instruments. Borrowings
with original maturities greater than one year are generally
managed to achieve staggered maturities, thereby mitigating
refinancing risk, and to maximize investor diversification
through sales to global institutional and retail clients across
regions, currencies and product types.
The availability and cost of financing to us can vary depending
on market conditions, the volume of certain trading and lending
activities, our credit ratings and the overall availability of credit.
We also engage in, and may continue to engage in, repurchases
of our borrowings in the ordinary course of business.
For further information on Borrowings, see Note 12 to the
financial statements.
Credit Ratings
We rely on external sources to finance a significant portion of
our daily operations. The cost and availability of financing
generally are impacted by our credit ratings, among other things.
In addition, our credit ratings can have an impact on certain
trading revenues, particularly in those businesses where longer-
term counterparty performance is a key consideration, such as
certain OTC derivative transactions. When determining credit
ratings, rating agencies consider both company-specific and
industry-wide factors. These include regulatory or legislative
changes, the macroeconomic environment and perceived levels
of support, among other things. See also “Risk Factors—
Liquidity Risk” in the 2019 Form 10-K.
Parent Company and U.S. Bank Subsidiaries' Issuer Ratings
at April 30, 2020
Parent Company
Short-Term
Debt Long-Term
Debt Rating
Outlook
DBRS, Inc. R-1 (middle) A (high) Stable
Fitch Ratings, Inc. F1 A Negative
Moody’s Investors Service,
Inc. P-2 A3 Ratings
Under Review
Rating and Investment
Information, Inc. a-1 A Stable
S&P Global Ratings A-2 BBB+ Stable
MSBNA
Short-Term
Debt Long-Term
Debt Rating
Outlook
Fitch Ratings, Inc. F1 A+ Negative
Moody’s Investors Service,
Inc. P-1 A1 Ratings
Under Review
S&P Global Ratings A-1 A+ Stable
MSPBNA
Short-Term
Debt Long-Term
Debt Rating
Outlook
Moody’s Investors Service,
Inc. P-1 A1 Ratings
Under Review
S&P Global Ratings A-1 A+ Stable
On February 21, 2020, Moody’s Investors Service, Inc. placed
the Parent Company and U.S. Bank Subsidiaries on review for
-- 22 of 93 --
Table of Contents
Management’s Discussion and Analysis
March 2020 Form 10-Q 20
possible upgrade, changing their outlooks from Positive to
Ratings Under Review.
On April 23, 2020, Fitch Ratings, Inc. placed the Parent
Company and MSBNA ratings on Negative outlook, a change
from Stable, related to their expectation of significant operating
environment headwinds due to the disruption to economic
activity and financial markets from the COVID-19 pandemic.
Incremental Collateral or Terminating Payments
In connection with certain OTC derivatives and certain other
agreements where we are a liquidity provider to certain
financing vehicles associated with the Institutional Securities
business segment, we may be required to provide additional
collateral, immediately settle any outstanding liability balances
with certain counterparties or pledge additional collateral to
certain clearing organizations in the event of a future credit
rating downgrade irrespective of whether we are in a net asset
or net liability position. See Note 6 to the financial statements
for additional information on OTC derivatives that contain such
contingent features.
While certain aspects of a credit rating downgrade are
quantifiable pursuant to contractual provisions, the impact it
would have on our business and results of operations in future
periods is inherently uncertain and would depend on a number
of interrelated factors, including, among other things, the
magnitude of the downgrade, the rating relative to peers, the
rating assigned by the relevant agency pre-downgrade,
individual client behavior and future mitigating actions we
might take. The liquidity impact of additional collateral
requirements is included in our Liquidity Stress Tests.
Capital Management
We view capital as an important source of financial strength and
actively manage our consolidated capital position based upon,
among other things, business opportunities, risks, capital
availability and rates of return together with internal capital
policies, regulatory requirements and rating agency guidelines.
In the future, we may expand or contract our capital base to
address the changing needs of our businesses.
Common Stock Repurchases
Three Months Ended
March 31,
in millions, except for per share data 2020 2019
Number of shares 29 28
Average price per share $ 46.01 $ 42.19
Total $ 1,347 $ 1,180
On March 15, 2020, the Financial Services Forum announced
that its eight U.S. Bank members, including us, had voluntarily
suspended their share repurchase programs. See “Executive
Summary—Coronavirus Disease (COVID-19) Pandemic”
herein for information on the current and possible future effects
of the COVID-19 pandemic on our results.
For further information on our common stock repurchases, see
Note 16 to the financial statements.
For a description of our capital plan, see “Liquidity and Capital
Resources—Regulatory Requirements—Capital Plans and
Stress Tests.”
Common Stock Dividend Announcement
Announcement date April 16, 2020
Amount per share $0.35
Date to be paid May 15, 2020
Shareholders of record as of April 30, 2020
Preferred Stock Dividend Announcement
Announcement date March 16, 2020
Date paid April 15, 2020
Shareholders of record as of March 31, 2020
For additional information on common and preferred stock, see
Note 16 to the financial statements.
Off-Balance Sheet Arrangements and Contractual
Obligations
Off-Balance Sheet Arrangements
We enter into various off-balance sheet arrangements, including
through unconsolidated SPEs and lending-related financial
instruments (e.g., guarantees and commitments), primarily in
connection with the Institutional Securities and Investment
Management business segments.
We utilize SPEs primarily in connection with securitization
activities. For information on our securitization activities, see
Note 14 to the financial statements.
For information on our commitments, obligations under certain
guarantee arrangements and indemnities, see Note 13 to the
financial statements. For a further discussion of our lending
commitments, see “Quantitative and Qualitative Disclosures
about Risk—Credit Risk—Loans and Lending Commitments.”
Contractual Obligations
For a discussion about our contractual obligations, see
“Management’s Discussion and Analysis of Financial Condition
and Results of Operations—Liquidity and Capital Resources—
Contractual Obligations” in the 2019 Form 10-K.
-- 23 of 93 --
Table of Contents
Management’s Discussion and Analysis
21 March 2020 Form 10-Q
Regulatory Requirements
Regulatory Capital Framework
We are an FHC under the Bank Holding Company Act of 1956,
as amended (“BHC Act”), and are subject to the regulation and
oversight of the Federal Reserve. The Federal Reserve
establishes capital requirements for us, including “well-
capitalized” standards, and evaluates our compliance with such
capital requirements. Regulatory capital requirements
established by the Federal Reserve are largely based on the Basel
III capital standards established by the Basel Committee and
also implement certain provisions of the Dodd-Frank Wall Street
Reform and Consumer Protection Act (“Dodd-Frank Act”). The
OCC establishes similar capital requirements and standards for
our U.S. Bank Subsidiaries. For us to remain an FHC, we must
remain well-capitalized in accordance with standards
established by the Federal Reserve and our U.S. Bank
Subsidiaries must remain well-capitalized in accordance with
standards established by the OCC. For additional information
on regulatory capital requirements for our U.S. Bank
Subsidiaries, see Note 15 to the financial statements.
Regulatory Capital Requirements
We are required to maintain minimum risk-based and leverage-
based capital, and TLAC ratios. For more information, see
“Management’s Discussion and Analysis of Financial Condition
and Results of Operations—Liquidity and Capital Resources—
Regulatory Capital Requirements” in the 2019 Form 10-K. For
additional information on TLAC, see “Total Loss-Absorbing
Capacity, Long-Term Debt and Clean Holding Company
Requirements” herein.
Risk-Based Regulatory Capital. Minimum risk-based capital
ratio requirements apply to Common Equity Tier 1 capital, Tier
1 capital and Total capital (which includes Tier 2 capital). Capital
standards require certain adjustments to, and deductions from,
capital for purposes of determining these ratios.
In addition to the minimum risk-based capital ratio
requirements, we are subject to the following Common Equity
Tier 1 buffers:
• A greater than 2.5% capital conservation buffer;
• The G-SIB capital surcharge, currently at 3%; and
• Up to a 2.5% CCyB, currently set by U.S. banking agencies
at zero.
For a further discussion of the G-SIB capital surcharge, see
“Management’s Discussion and Analysis of Financial Condition
and Results of Operations—Liquidity and Capital Resources—
Regulatory Requirements—G-SIB Capital Surcharge” in the
2019 Form 10-K.
Our risk-based capital ratios for purposes of determining
regulatory compliance are the lower of the capital ratios
computed under (i) the standardized approaches for calculating
credit risk and market risk RWA (“Standardized Approach”) or
(ii) the applicable advanced approaches for calculating credit
risk, market risk and operational risk RWA (“Advanced
Approach”). The credit risk RWA calculations between the two
approaches differ in that the Standardized Approach requires
calculation of RWA using prescribed risk weights, whereas the
Advanced Approach utilizes models to calculate exposure
amounts and risk weights. At March 31, 2020 and December 31,
2019, our ratios for determining regulatory compliance are
based on the Advanced Approach and the Standardized
Approach rules, respectively.
Leverage-Based Regulatory Capital. Minimum leverage-based
capital requirements include a Tier 1 leverage ratio and an SLR.
We are required to maintain an SLR of 5%, inclusive of an
enhanced SLR capital buffer of at least 2%.
As of March 31, 2020, our risk-based and leverage-based capital
amounts and ratios, as well as RWA, adjusted average assets and
supplementary leverage exposure are calculated excluding the
effect of the adoption of CECL based on our election to defer
this effect over a five-year transition period. For further
information, see “Liquidity and Capital Resources—Regulatory
Requirements—Regulatory Developments” herein.
-- 24 of 93 --
Table of Contents
Management’s Discussion and Analysis
March 2020 Form 10-Q 22
Regulatory Capital Ratios
At March 31, 2020
$ in millions
Required
Ratio1 Standardized Advanced
Risk-based capital
Common Equity Tier 1 capital $ 65,195 $ 65,195
Tier 1 capital 73,896 73,896
Total capital 84,121 83,847
Total RWA 415,002 427,782
Common Equity Tier 1 capital
ratio 10.0% 15.7% 15.2%
Tier 1 capital ratio 11.5% 17.8% 17.3%
Total capital ratio 13.5% 20.3% 19.6%
$ in millions
Required
Ratio1
At
March 31,
2020
Leverage-based capital
Adjusted average assets2 $ 910,499
Tier 1 leverage ratio 4.0% 8.1%
Supplementary leverage exposure3 $ 1,185,734
SLR 5.0% 6.2%
At December 31, 2019
$ in millions
Required
Ratio1 Standardized Advanced
Risk-based capital
Common Equity Tier 1 capital $ 64,751 $ 64,751
Tier 1 capital 73,443 73,443
Total capital 82,708 82,423
Total RWA 394,177 382,496
Common Equity Tier 1 capital
ratio 10.0% 16.4% 16.9%
Tier 1 capital ratio 11.5% 18.6% 19.2%
Total capital ratio 13.5% 21.0% 21.5%
$ in millions
Required
Ratio1
At
December 31,
2019
Leverage-based capital
Adjusted average assets2 $ 889,195
Tier 1 leverage ratio 4.0% 8.3%
Supplementary leverage exposure3 $ 1,155,177
SLR 5.0% 6.4%
1. Required ratios are inclusive of any buffers applicable as of the date presented. Failure
to maintain the buffers would result in restrictions on our ability to make capital
distributions, including the payment of dividends and the repurchase of stock, and to
pay discretionary bonuses to executive officers.
2. Adjusted average assets represents the denominator of the Tier 1 leverage ratio and
is composed of the average daily balance of consolidated on-balance sheet assets
for the quarters ending on the respective balance sheet dates, reduced by disallowed
goodwill, intangible assets, investments in covered funds, defined benefit pension
plan assets, after-tax gain on sale from assets sold into securitizations, investments
in our own capital instruments, certain deferred tax assets and other capital deductions.
3. Supplementary leverage exposure is the sum of Adjusted average assets used in the
Tier 1 leverage ratio and other adjustments, primarily: (i) for derivatives, potential future
exposure and the effective notional principal amount of sold credit protection offset
by qualifying purchased credit protection; (ii) the counterparty credit risk for repo-style
transactions; and (iii) the credit equivalent amount for off-balance sheet exposures.
Regulatory Capital
$ in millions
At
March 31,
2020
At
December 31,
2019 Change
Common Equity Tier 1 capital
Common stock and surplus $ 3,727 $ 5,228 $ (1,501)
Retained earnings 71,718 70,589 1,129
AOCI 2,095 (2,788) 4,883
Regulatory adjustments and deductions:
Net goodwill (7,058) (7,081) 23
Net intangible assets (1,924) (2,012) 88
Other adjustments and
deductions1 (3,363) 815 (4,178)
Total Common Equity Tier 1
capital $ 65,195 $ 64,751 $ 444
Additional Tier 1 capital
Preferred stock $ 8,520 $ 8,520 $ —
Noncontrolling interests 536 607 (71)
Additional Tier 1 capital $ 9,056 $ 9,127 $ (71)
Deduction for investments in
covered funds (355) (435) 80
Total Tier 1 capital $ 73,896 $ 73,443 $ 453
Standardized Tier 2 capital
Subordinated debt $ 9,090 $ 8,538 $ 552
Noncontrolling interests 126 143 (17)
Eligible allowance for credit losses 1,013 590 423
Other adjustments and deductions (4) (6) 2
Total Standardized Tier 2 capital $ 10,225 $ 9,265 $ 960
Total Standardized capital $ 84,121 $ 82,708 $ 1,413
Advanced Tier 2 capital
Subordinated debt $ 9,090 $ 8,538 $ 552
Noncontrolling interests 126 143 (17)
Eligible credit reserves 739 305 434
Other adjustments and deductions (4) (6) 2
Total Advanced Tier 2 capital $ 9,951 $ 8,980 $ 971
Total Advanced capital $ 83,847 $ 82,423 $ 1,424
1. Other adjustments and deductions used in the calculation of Common Equity Tier 1
capital primarily includes net after-tax DVA, the credit spread premium over risk-free
rate for derivative liabilities, defined benefit pension plan assets, after-tax gain on sale
from assets sold into securitizations, investments in our own capital instruments and
certain deferred tax assets.
-- 25 of 93 --
Table of Contents
Management’s Discussion and Analysis
23 March 2020 Form 10-Q
RWA Rollforward
Three Months Ended
March 31, 2020
$ in millions Standardized Advanced
Credit risk RWA
Balance at December 31, 2019 $ 342,684 $ 228,927
Change related to the following items:
Derivatives 12,902 31,104
Securities financing transactions (13,755) 837
Securitizations (768) (600)
Investment securities 1,626 2,559
Commitments, guarantees and loans 11,162 3,652
Cash 919 591
Equity investments 953 1,003
Other credit risk1 4,652 4,925
Total change in credit risk RWA $ 17,691 $ 44,071
Balance at March 31, 2020 $ 360,375 $ 272,998
Market risk RWA
Balance at December 31, 2019 $ 51,493 $ 51,597
Change related to the following items:
Regulatory VaR 1,971 1,971
Regulatory stressed VaR 287 287
Incremental risk charge 1,737 1,737
Comprehensive risk measure 216 112
Specific risk:
Non-securitization 2,034 2,034
Securitization (3,111) (3,111)
Total change in market risk RWA $ 3,134 $ 3,030
Balance at March 31, 2020 $ 54,627 $ 54,627
Operational risk RWA
Balance at December 31, 2019 N/A $ 101,972
Change in operational risk RWA N/A (1,815)
Balance at March 31, 2020 N/A $ 100,157
Total RWA $ 415,002 $ 427,782
Regulatory VaR—VaR for regulatory capital requirements
1. Amounts reflect assets not in a defined category, non-material portfolios of exposures
and unsettled transactions, as applicable.
Credit risk RWA increased in the current quarter under both the
Standardized and Advanced Approaches primarily from an
increase in: i) Derivatives exposure, driven by market volatility;
ii) Commitments, guarantees and loans, driven by an increase
in commitments funded during the current quarter in the
Institutional Securities business segment; and iii) Other credit
risk, driven by an increase in unsettled transactions. Under the
Advanced Approach, the increased exposure in Derivatives and
widening credit spreads led to an increase in RWA related to
CVA. Partially offsetting the increase in Standardized RWA was
a decrease in Securities financing transactions.
Market risk RWA increased in the current quarter under the
Standardized Approach and Advanced Approach primarily due
to increases in Non-securitization specific risk charges and the
Incremental risk charge, both driven by increased exposures in
credit products, and an increase in Regulatory VaR mainly as a
result of a higher market volatility, partially offset by a decrease
in Securitization specific risk charges due to reduced exposures
to mortgage-backed securities.
The decrease in operational risk RWA under the Advanced
Approach in the current quarter reflects a decline in the severity
of execution-related losses.
Total Loss-Absorbing Capacity, Long-Term Debt and
Clean Holding Company Requirements
The Federal Reserve has established external TLAC, long-term
debt (“LTD”) and clean holding company requirements for top-
tier BHCs of U.S. G-SIBs (“covered BHCs”), including the
Parent Company. These requirements are designed to ensure that
covered BHCs will have enough loss-absorbing resources at the
point of failure to be recapitalized through the conversion of
eligible LTD to equity or otherwise by imposing losses on
eligible LTD or other forms of TLAC where an SPOE resolution
strategy is used. The External TLAC amount and ratios as of
March 31, 2020 are calculated excluding the effect of the
adoption of CECL based on our election to defer this effect over
a five-year transition period. Our External TLAC ratios that were
calculated including the full effect of the adoption of CECL also
exceeded each respective required ratio as of March 31, 2020.
Required and Actual TLAC and Eligible LTD Ratios
Actual
Amount/Ratio
$ in millions
Regulatory
Minimum Required
Ratio1
At
March 31,
2020
At
December 31,
2019
External TLAC2 $ 201,486 $ 196,888
External TLAC as a % of
RWA 18.0% 21.5% 47.1% 49.9%
External TLAC as a % of
leverage exposure 7.5% 9.5% 17.0% 17.0%
Eligible LTD3 $ 118,778 $ 113,624
Eligible LTD as a % of
RWA 9.0% 9.0% 27.8% 28.8%
Eligible LTD as a % of
leverage exposure 4.5% 4.5% 10.0% 9.8%
1. Required ratios are inclusive of applicable buffers.The final rule imposes TLAC buffer
requirements on top of both the risk-based and leverage exposure-based external
TLAC minimum requirements. The risk-based TLAC buffer is equal to the sum of 2.5%,
the covered BHC's Method 1 G-SIB surcharge and the CCyB, if any, as a percentage
of total RWA. The leverage exposure-based TLAC buffer is equal to 2% of the covered
BHC's total leverage exposure. Failure to maintain the buffers would result in
restrictions on our ability to make capital distributions, including the payment of
dividends and the repurchase of stock, and to pay discretionary bonuses to executive
officers.
2. External TLAC consists of Common Equity Tier 1 capital and Additional Tier 1 capital
(each excluding any noncontrolling minority interests), as well as eligible LTD.
3. Consists of TLAC-eligible LTD reduced by 50% for amounts of unpaid principal due
to be paid in more than one year but less than two years from each respective balance
sheet date.
We are in compliance with all relevant TLAC requirements as
of March 31, 2020 and December 31, 2019. For a further
discussion of TLAC and related requirements, see
“Management’s Discussion and Analysis of Financial Condition
and Results of Operations—Liquidity and Capital Resources—
Regulatory Requirements—Regulatory Capital Requirements
-- 26 of 93 --
Table of Contents
Management’s Discussion and Analysis
March 2020 Form 10-Q 24
—Total Loss-Absorbing Capacity, Long-Term Debt and Clean
Holding Company Requirements” in the 2019 Form 10-K.
Capital Plans and Stress Tests
Pursuant to the Dodd-Frank Act, the Federal Reserve has
adopted capital planning and stress test requirements for large
BHCs, including us, which form part of the Federal Reserve’s
annual CCAR framework.
We submitted our 2020 Capital Plan (“Capital Plan”) and
company-run stress test results to the Federal Reserve on April
6, 2020. We expect that the Federal Reserve will provide its
response to our 2020 Capital Plan and publish summary results
of the CCAR and Dodd-Frank Act supervisory stress tests of
each large BHC, including us, no later than June 30, 2020. We
are required to disclose a summary of the results of our company-
run stress tests within 15 days of the date that the Federal Reserve
discloses the results of the supervisory stress tests. We may be
required to resubmit our Capital Plan under certain
circumstances, including in the event of a material change in
our risk profile, financial condition or corporate structure. See
“Risk Factors” in the 2019 Form 10-K.
For a further discussion of our capital plans and stress tests, see
“Management’s Discussion and Analysis of Financial Condition
and Results of Operations—Liquidity and Capital Resources—
Regulatory Requirements—Capital Plans and Stress Tests” in
the 2019 Form 10-K.
Attribution of Average Common Equity According to the
Required Capital Framework
Our required capital (“Required Capital”) estimation is based
on the Required Capital framework, an internal capital adequacy
measure. Common equity attribution to the business segments
is based on capital usage calculated under the Required Capital
framework, as well as each business segment’s relative
contribution to our total Required Capital.
The Required Capital framework is a risk-based and leverage
use-of-capital measure, which is compared with our regulatory
capital to ensure that we maintain an amount of going concern
capital after absorbing potential losses from stress events, where
applicable, at a point in time. The amount of capital allocated
to the business segments is generally set at the beginning of each
year and remains fixed throughout the year until the next annual
reset unless a significant business change occurs (e.g.,
acquisition or disposition). We define the difference between
our total average common equity and the sum of the average
common equity amounts allocated to our business segments as
Parent common equity. We generally hold Parent common
equity for prospective regulatory requirements, organic growth,
acquisitions and other capital needs.
The Required Capital framework is expected to evolve over time
in response to changes in the business and regulatory
environment, for example, to incorporate changes in stress
testing or enhancements to modeling techniques. We will
continue to evaluate the framework with respect to the impact
of future regulatory requirements, as appropriate.
Average Common Equity Attribution1
Three Months Ended
March 31,
$ in billions 2020 2019
Institutional Securities $ 42.8 $ 40.4
Wealth Management 18.2 18.2
Investment Management 2.6 2.5
Parent 11.1 10.5
Total $ 74.7 $ 71.6
1. The attribution of average common equity to the business segments is a non-GAAP
financial measure. See “Selected Non-GAAP Financial Information” herein.
Resolution and Recovery Planning
Pursuant to the Dodd-Frank Act, we are required to periodically
submit to the Federal Reserve and the FDIC a resolution plan
that describes our strategy for a rapid and orderly resolution
under the U.S. Bankruptcy Code in the event of our material
financial distress or failure. Our next resolution plan submission
is expected to be a targeted resolution plan in July 2021.
As described in our 2019 resolution plan, which was submitted
on June 28, 2019, our preferred resolution strategy is an SPOE
strategy. In line with our SPOE strategy, the Parent Company
has transferred, and has agreed to transfer on an ongoing basis,
certain assets to its wholly owned, direct subsidiary Morgan
Stanley Holdings LLC (the “Funding IHC”). In addition, the
Parent Company has entered into an amended and restated
support agreement with its material entities (including the
Funding IHC) and certain other subsidiaries. In the event of a
resolution scenario, the Parent Company would be obligated to
contribute all of its Contributable Assets to our material entities
and/or the Funding IHC. The Funding IHC would be obligated
to provide capital and liquidity, as applicable, to our material
entities. The combined implication of the SPOE resolution
strategy and the requirement to maintain certain levels of TLAC
is that losses in resolution would be imposed on the holders of
eligible long-term debt and other forms of eligible TLAC issued
by the Parent Company before any losses are imposed on the
holders of the debt securities of our operating subsidiaries or
before putting U.S. taxpayers at risk.
For more information about resolution and recovery planning
requirements and our activities in these areas, including the
implications of such activities in a resolution scenario, see
“Business—Supervision and Regulation—Financial Holding
Company—Resolution and Recovery Planning,” “Risk Factors
—Legal, Regulatory and Compliance Risk” and
“Management’s Discussion and Analysis of Financial Condition
and Results of Operations—Liquidity and Capital Resources—
Regulatory Requirements—Resolution and Recovery
Planning” in the 2019 Form 10-K.
-- 27 of 93 --
Table of Contents
Management’s Discussion and Analysis
25 March 2020 Form 10-Q
Regulatory Developments
Stress Capital Buffer Final Rule
The Federal Reserve has adopted a final rule to integrate its
annual capital planning and stress testing requirements with
existing applicable regulatory capital requirements. The final
rule, which applies to certain BHCs, including us, introduces a
stress capital buffer (“SCB”) and related changes to the capital
planning and stress testing processes.
The SCB applies only with respect to Standardized Approach
risk-based capital requirements and replaces the existing
Common Equity Tier 1 capital conservation buffer, which is
2.5%. The SCB is the greater of (i) the maximum decline in our
Common Equity Tier 1 capital ratio under the severely adverse
scenario over the supervisory stress test measurement period
plus the sum of the four quarters of planned common stock
dividends divided by the projected RWAs from the quarter in
which the Firm’s projected Common Equity Tier 1 capital ratio
reaches its minimum in the supervisory stress test and (ii) 2.5%.
Risk-based regulatory capital requirements under the
Standardized Approach will include the SCB, as summarized
above, as well as our Common Equity Tier 1 GSIB capital
surcharge and any applicable Common Equity Tier 1 CCyB.
The final rule makes related changes to capital planning and
stress testing processes for BHCs subject to the SCB. In
particular, the supervisory stress test will assume that BHCs
generally maintain a constant level of assets and RWAs
throughout the projection period. In addition, the supervisory
stress test will no longer assume that BHCs make all planned
capital distributions, although the SCB will incorporate the
dollar amount of four quarters of planned common stock
dividends, as summarized above.
The final rule does not change regulatory capital requirements
under the Advanced Approach, the Tier 1 leverage ratio or the
SLR.
The Firm’s initial SCB will be based on the results of the 2020
CCAR supervisory stress test which the Federal Reserve is
expected to publish by June 30, 2020. The SCB will take effect
on October 1, 2020 and will remain in effect until September
30, 2021, and will be updated annually thereafter based on the
results of the annual CCAR supervisory stress test, with a revised
SCB taking effect on October 1 each year.
Upon receipt of the SCB, we will evaluate whether to update
our Required Capital framework to take into account any
changes in our risk-based capital requirements that result from
the SCB.
The SCB final rule also includes a transitional arrangement for
the third quarter of 2020. Between July 1, 2020 and September
30, 2020, the Firm will be authorized to make capital
distributions that do not exceed the four-quarter average of
capital distributions for which the Federal Reserve indicated its
non-objection in the 2019 capital plan cycle, unless otherwise
determined by the Federal Reserve.
Revisions to Definition of Eligible Retained Income
The U.S. banking agencies have adopted an interim final rule
amending the definition of eligible retained income in their
respective capital rules. As amended, eligible retained income
is defined by the Federal Reserve as the greater of (i) net income
for the four preceding calendar quarters, net of any distributions
and associated tax effects not already reflected in net income,
and (ii) the average of net income over the preceding four
quarters. This definition applies with respect to any payout
restrictions applicable in the event of a breach of any regulatory
capital buffers, including any applicable CCyB, G-SIB capital
surcharge, capital conservation buffer, the enhanced SLR and,
once effective, SCB, which replaces the capital conservation
buffer under the Standardized Approach. The interim final rule
became effective March 20, 2020.
Separately, the Federal Reserve has adopted an interim final rule
amending the definition of eligible retained income under its
TLAC rule to be consistent with the revised definition of eligible
retained income in the regulatory capital framework, as
summarized above. The interim final rule became effective
March 26, 2020.
Regulatory Capital and Stress Testing Developments Related
to Implementation of CECL
The U.S. banking agencies have adopted an interim final rule
altering, for purposes of the regulatory capital and TLAC
requirements, the required adoption time period for CECL.
Under the interim final rule, banking organizations that
implement the new accounting standard before the end of 2020
may elect to follow the three-year transition available under a
prior rule or a new five-year transition. This five-year transition
involves a two-year delay in recognizing the effects on
regulatory capital of the new accounting standard, followed by
a three-year transition period during which the electing
organization phases out the aggregate capital effects of the two-
year delay. The interim final rule became effective March 27,
2020. We have elected to implement the five-year transition for
recognizing the potentially adverse effects of the adoption of
CECL.
In addition, pursuant to the The Coronavirus Aid, Relief, and
Economic Security Act (the “CARES Act”), banking
organizations are not required to comply with CECL, for
purposes of U.S. GAAP accounting, until the earlier of the end
of the COVID-19 national emergency declared by the President
of the United States on March 15, 2020 under the National
Emergencies Act or December 31, 2020. We have not elected
to delay our compliance with CECL for purposes of U.S. GAAP
accounting.
-- 28 of 93 --
Table of Contents
Management’s Discussion and Analysis
March 2020 Form 10-Q 26
Regulatory Developments in Response to COVID-19
In the United States, the Federal Reserve, the other U.S. state
and federal financial regulatory agencies and Congress have
taken actions to mitigate disruptions to economic activity and
financial stability resulting from COVID-19.
Federal Reserve Actions
The Federal Reserve has established, or has taken steps to
establish, a range of facilities and programs to support the U.S.
economy and U.S. marketplace participants in response to
economic disruptions associated with COVID-19. Through
these facilities and programs, the Federal Reserve has taken
steps to directly or indirectly purchase assets or debt instruments
from, or make loans to, U.S. companies, financial institutions,
municipalities and other market participants.
In addition, the Federal Reserve has taken a range of other
actions to support the flow of credit to households and
businesses. For example, on March 15, 2020, the Federal
Reserve reduced the target range for the federal funds rate to 0
to 0.25% and announced that it would increase its holdings of
U.S. Treasury securities and agency mortgage-backed securities
and begin purchasing agency commercial mortgage-backed
securities. The Federal Reserve has also encouraged depository
institutions to borrow from the discount window and has
lowered the primary credit rate for such borrowings by 150 basis
points to 0.25% while extending the term of such loans up to 90
days. In addition, effective March 26, 2020, reserve
requirements have been reduced to zero.
Acting in concert with the other U.S. banking agencies, the
Federal Reserve has also issued statements encouraging banking
organizations to use their capital and liquidity buffers as they
lend to households and businesses affected by COVID-19. To
facilitate banking organizations' use of their capital buffers, the
Federal Reserve has revised the definition of eligible retained
income applicable in the capital and TLAC frameworks.
Additionally, the Federal Reserve has adopted an interim final
rule that temporarily excludes U.S. Treasury securities and
deposits at Federal Reserve Banks from the calculation of our
supplementary leverage exposure used in the SLR. For a further
discussion about the revised definition of eligible retained
income and changes to the SLR calculation, see “Revisions to
Definition of Eligible Retained Income” and “Supplementary
Leverage Ratio Interim Final Rule,” respectively, herein.
Further, the Federal Reserve along with the other U.S. banking
agencies, issued guidance stating that granting certain
concessions to borrowers that are current on existing loans,
either individually or as part of a program for creditworthy
borrowers who are experiencing short-term financial or
operational problems as a result of the coronavirus pandemic,
generally would not be considered TDRs under applicable U.S.
GAAP. This guidance also clarifies that efforts to work with
borrowers of one-to-four family residential mortgages impacted
by the COVID-19 pandemic and meeting certain criteria will
not result in such loans being deemed restructured or modified
for purposes of U.S. Basel III, and will therefore not be subject
to higher regulatory capital requirements.
As of March 31, 2020, we have participated in the PDCF, which
provides liquidity to primary dealers through a secured lending
facility, and, following the Federal Reserve's statement
encouraging banks to use its discount window, we have accessed
the discount window. While we continue to assess, we may
participate in other of these facilities and programs, including
on behalf of clients.
Non-U.S. Central Bank Actions
In addition to actions taken by the Federal Reserve, many non-
U.S. central banks have announced similar facilities and
programs in response to the economic and market disruptions
associated with COVID-19. Firm subsidiaries operating in non-
U.S. markets may participate, or perform customer facilitation
roles, in such non-U.S. facilities or programs.
The CARES Act
The CARES Act was signed into law on March 27, 2020.
Pursuant to the CARES Act, the U.S. Treasury has the authority
to provide loans, guarantees and other investments in support
of eligible businesses, states and municipalities affected by the
economic effects of COVID-19. Some of these funds may also
be used to support the several Federal Reserve programs and
facilities described in “Federal Reserve Actions” previously or
additional programs or facilities that are established by the
Federal Reserve under its Section 13(3) authority and meet
certain criteria. Among other provisions, the CARES Act also
includes funding for the Small Business Administration to
expand lending, relief from certain U.S. GAAP requirements to
allow COVID-19-related loan modifications to not be
categorized as TDRs and a range of incentives to encourage
deferment, forbearance or modification of consumer credit and
mortgage contracts.
The CARES Act also includes several measures that will
temporarily adjust existing laws or regulations. These include
providing the FDIC with additional authority to guarantee the
deposits of solvent insured depository institutions held in non-
interest-bearing business transaction accounts to a maximum
amount specified by the FDIC, reinstating the FDIC’s
Temporary Liquidity Guarantee Authority to guarantee debt
obligations of solvent insured depository institutions or
depository institution holding companies, temporarily allowing
the U.S. Treasury to fully guarantee money market mutual funds
and granting additional authority to the OCC to provide certain
exemptions to the lending limits imposed on national banks.
-- 29 of 93 --
Table of Contents
Management’s Discussion and Analysis
27 March 2020 Form 10-Q
Supplementary Leverage Ratio Interim Final Rule
In response to the COVID-19 pandemic, the Federal Reserve
has adopted an interim final rule that excludes, on a temporary
basis, U.S. Treasury securities and deposits at Federal Reserve
Banks from our SLR exposure measure from April 1, 2020 to
March 31, 2021. This interim final rule does not amend our U.S.
Bank Subsidiaries’ SLR requirements.
Other Matters
U.K. Withdrawal from the E.U.
On January 31, 2020, the U.K. withdrew from the E.U. under
the terms of a withdrawal agreement between the U.K. and the
E.U. The withdrawal agreement provides for a transition period
to the end of December 2020, during which time the U.K. will
continue to apply E.U. law as if it were a member state, and U.K.
firms’ rights to provide financial services in E.U. member states
will continue. Access to the E.U. market after the transition
period remains subject to negotiation.
We have prepared the structure of our European operations for
a range of potential outcomes, including for the possibility that
U.K. financial firms’ access to E.U. markets after the transition
period is limited, and we expect to be able to continue to serve
our clients and customers under each of these potential
outcomes.
For more information on the U.K.’s withdrawal from the E.U.,
our related preparations and the potential impact on our
operations, see “Risk Factors— International Risk” in the 2019
Form 10-K. For further information regarding our exposure to
the U.K., see also “Quantitative and Qualitative Disclosures
about Risk—Country and Other Risks."
Planned Replacement of London Interbank Offered Rate
and Replacement or Reform of Other Interest Rates
Central banks around the world, including the Federal Reserve,
have commissioned committees and working groups of market
participants and official sector representatives to replace LIBOR
and replace or reform other interest rate benchmarks
(collectively, the “IBORs”). Accordingly, we have established
and are undertaking a Firmwide IBOR transition plan to promote
the transition to alternative reference rates, which takes into
account the considerable uncertainty regarding the availability
of LIBOR beyond 2021.
For a further discussion of the expected replacement of the
IBORs and/or reform of interest rate benchmarks, and the related
risks and our transition plan, see “Management’s Discussion and
Analysis of Financial Condition and Results of Operations—
Liquidity and Capital Resources—Regulatory Requirements—
Other Matters” and “Risk Factors—Risk Management,”
respectively, in the 2019 Form 10-K.
-- 30 of 93 --
Table of Contents
March 2020 Form 10-Q 28
Quantitative and Qualitative Disclosures about Risk
Management believes effective risk management is vital to the
success of our business activities. For a discussion of our
Enterprise Risk Management framework and risk management
functions, see “Quantitative and Qualitative Disclosures about
Risk—Risk Management” in the 2019 Form 10-K.
Market Risk
Market risk refers to the risk that a change in the level of one or
more market prices, rates, indices, volatilities, correlations or
other market factors, such as market liquidity, will result in
losses for a position or portfolio. Generally, we incur market
risk as a result of trading, investing and client facilitation
activities, principally within the Institutional Securities business
segment where the substantial majority of our VaR for market
risk exposures is generated. In addition, we incur non-trading
market risk, principally within the Wealth Management and
Investment Management business segments. The Wealth
Management business segment primarily incurs non-trading
market risk from lending and deposit-taking activities. The
Investment Management business segment primarily incurs
non-trading market risk from capital investments in alternative
and other funds. For a further discussion of market risk, see
“Quantitative and Qualitative Disclosures about Risk—Market
Risk” in the 2019 Form 10-K.
Trading Risks
We are exposed to a wide range of risks related to interest rates,
equity prices, foreign exchange rates and commodity prices, and
the associated implied volatilities and spreads, related to the
global markets in which we conduct our trading activities.
The statistical technique known as VaR is one of the tools we
use to measure, monitor and review the market risk exposures
of our trading portfolios.
For information regarding our primary risk exposures and
market risk management, VaR methodology, assumptions and
limitations, see “Quantitative and Qualitative Disclosures about
Risk—Market Risk—Trading Risks” in the 2019 Form 10-K.
95%/One-Day Management VaR for the Trading Portfolio
Three Months Ended
March 31, 2020
$ in millions
Period
End Average High2 Low2
Interest rate and credit spread $ 62 $ 32 $ 62 $ 24
Equity price 22 15 23 12
Foreign exchange rate 11 8 14 5
Commodity price 12 13 19 10
Less: Diversification benefit1 (65) (33) N/A N/A
Primary Risk Categories $ 42 $ 35 $ 52 $ 28
Credit Portfolio 25 15 25 12
Less: Diversification benefit1 (12) (10) N/A N/A
Total Management VaR $ 55 $ 40 $ 58 $ 32
Three Months Ended
December 31, 2019
$ in millions
Period
End Average High2 Low2
Interest rate and credit spread $ 26 $ 28 $ 31 $ 24
Equity price 11 14 18 11
Foreign exchange rate 10 9 13 6
Commodity price 10 17 22 10
Less: Diversification benefit1 (27) (33) N/A N/A
Primary Risk Categories $ 30 $ 35 $ 40 $ 30
Credit Portfolio 15 15 17 13
Less: Diversification benefit1 (10) (11) N/A N/A
Total Management VaR $ 35 $ 39 $ 43 $ 33
1. Diversification benefit equals the difference between the total Management VaR
and the sum of the component VaRs. This benefit arises because the simulated
one-day losses for each of the components occur on different days; similar
diversification benefits also are taken into account within each component.
2. The high and low VaR values for the total Management VaR and each of the
component VaRs might have occurred on different days during the quarter, and
therefore, the diversification benefit is not an applicable measure.
While Average total Management VaR and average
Management VaR for the Primary Risk Categories were
relatively unchanged from the three months ended December
31, 2019, the period-end balance increased. The increase in
period-end VaR resulted primarily from the interest rate and
credit spread and equity price risk categories, which were
predominantly driven by increased market volatility related to
COVID-19, and reflected increased exposures in the Fixed
Income and Equity businesses related to client facilitation
activity and market movements in March 2020. These increases
were partially offset by an increased diversification benefit. For
information on the impact of COVID-19 on market and
economic conditions and their effect on our financial results,
refer to “Management’s Discussion and Analysis of Financial
Condition and Results of Operations—Executive Summary—
Coronavirus Disease (COVID-19) Pandemic” herein.
-- 31 of 93 --
Table of Contents
Risk Disclosures
29 March 2020 Form 10-Q
Distribution of VaR Statistics and Net Revenues
We evaluate the reasonableness of our VaR model by comparing
the potential declines in portfolio values generated by the model
with corresponding actual trading results for the Firm, as well
as individual business units. For days where losses exceed the
VaR statistic, we examine the drivers of trading losses to
evaluate the VaR model’s accuracy relative to realized trading
results. There were two days with trading losses in the current
quarter, one of which exceeded the 95%/one-day Total
Management VaR.
Daily 95%/One-Day Total Management VaR for the Current
Quarter
($ in millions)
Daily Net Trading Revenues for the Current Quarter
($ in millions)
The previous histogram shows the distribution of daily net
trading revenues for the current quarter. Daily net trading
revenues include profits and losses from Interest rate and credit
spread, Equity price, Foreign exchange rate, Commodity price,
and Credit Portfolio positions and intraday trading activities for
our trading businesses. Certain items such as fees, commissions
and net interest income are excluded from daily net trading
revenues and the VaR model. Revenues required for Regulatory
VaR backtesting further exclude intraday trading.
Non-Trading Risks
We believe that sensitivity analysis is an appropriate
representation of our non-trading risks. The following
sensitivity analyses cover substantially all of the non-trading
risk in our portfolio.
Credit Spread Risk Sensitivity1
$ in millions
At
March 31,
2020
At
December 31,
2019
Derivatives $ 6 $ 6
Funding liabilities2 39 42
1. Amounts represent the potential gain for each 1 bps widening of our credit spread.
2. Relates to Borrowings carried at fair value.
U.S. Bank Subsidiaries’ Net Interest Income Sensitivity Analysis
$ in millions
At
March 31,
2020
At
December 31,
2019
Basis point change
+100 $ 850 $ 151
-100 (495) (642)
The previous table presents an analysis of selected instantaneous
upward and downward parallel interest rate shocks (subject to
a floor of zero percent in the downward scenario) on net interest
income over the next 12 months for our U.S. Bank Subsidiaries.
These shocks are applied to our 12-month forecast for our U.S.
Bank Subsidiaries, which incorporates market expectations of
interest rates and our forecasted business activity.
We do not manage to any single rate scenario but rather manage
net interest income in our U.S. Bank Subsidiaries to optimize
across a range of possible outcomes, including non-parallel rate
change scenarios. The sensitivity analysis assumes that we take
no action in response to these scenarios, assumes there are no
changes in other macroeconomic variables normally correlated
with changes in interest rates, and includes subjective
assumptions regarding customer and market re-pricing behavior
and other factors. The change in sensitivity to interest rates
between March 31, 2020 and December 31, 2019 is primarily
driven by lower market rates. Given the current rate
environment, the correlation between market rate increases and
deposit cost increases is low, and therefore provides an
incremental benefit in the +100bps scenario.
-- 32 of 93 --
Table of Contents
Risk Disclosures
March 2020 Form 10-Q 30
Investments Sensitivity, Including Related Carried Interest
Loss from 10% Decline
$ in millions
At
March 31,
2020
At
December 31,
2019
Investments related to Investment
Management activities $ 327 $ 367
Other investments:
MUMSS 173 169
Other Firm investments 197 195
MUMSS—Mitsubishi UFJ Morgan Stanley Securities Co., Ltd.
We have exposure to public and private companies through
direct investments, as well as through funds that invest in these
assets. These investments are predominantly equity positions
with long investment horizons, a portion of which is for business
facilitation purposes. The market risk related to these
investments is measured by estimating the potential reduction
in net income associated with a 10% decline in investment values
and related impact on performance-based fees, as applicable.
The change in investments sensitivity related to Investment
Management activities between March 31, 2020 and
December 31, 2019 is primarily driven by lower valuations in
private equity funds, related to the decline of global asset prices
due to the effect of COVID-19 on economies and markets around
the world. For information on the impact of COVID-19 on
market and economic conditions and their effect on our financial
results, refer to “Management’s Discussion and Analysis of
Financial Condition and Results of Operations—Executive
Summary—Coronavirus Disease (COVID-19) Pandemic”
herein.
Equity Market Sensitivity
In the Wealth Management and Investment Management
business segments, certain fee-based revenue streams are driven
by the value of clients’ equity holdings. The overall level of
revenues for these streams also depends on multiple additional
factors that include, but are not limited to, the level and duration
of the equity market increase or decline, price volatility, the
geographic and industry mix of client assets, the rate and
magnitude of client investments and redemptions, and the
impact of such market increase or decline and price volatility
on client behavior. Therefore, overall revenues do not correlate
completely with changes in the equity markets. For information
on the impact of COVID-19 on market and economic conditions
and their effect on our financial results, refer to “Management’s
Discussion and Analysis of Financial Condition and Results of
Operations—Executive Summary—Coronavirus Disease
(COVID-19) Pandemic” herein.
Credit Risk
Credit risk refers to the risk of loss arising when a borrower,
counterparty or issuer does not meet its financial obligations to
us. We are primarily exposed to credit risk from institutions and
individuals through our Institutional Securities and Wealth
Management business segments. For a further discussion of our
credit risks, see “Quantitative and Qualitative Disclosures about
Risk—Credit Risk” in the 2019 Form 10-K.
The credit environment deteriorated rapidly towards the end of
the current quarter, driven by the effect of COVID-19 on
economic and market conditions. Within Institutional Securities
the effects were notable, with mark-to-market losses on held-
for-sale loans and lending commitments and increased
allowances for credit losses related to held-for-investment loans
and lending commitments, as discussed in Management’s
Discussion and Analysis. The uncertain environment also
caused an increase in client requests to draw down on lending
commitments and market volatility led to increased
counterparty credit exposures, both of which are further
discussed herein.
In addition, we have begun to have discussions with and receive
requests from certain clients for forbearance, or deferral of their
loan payments to us, driven or exacerbated by the economic
environment and following in part from the U.S. government’s
enactment of the CARES Act. These requests and discussions
primarily relate to commercial and residential real estate loans.
Certain clients have also requested modifications of covenant
terms.
The forbearance process is different based on loan and borrower
type, among other factors. In general, qualifying requests for
forbearance related to single family residential real estate loans
are immediately granted, whereas commercial real estate loan
forbearance requires negotiation and approval. Receiving or
granting forbearance or modification requests does not
necessarily mean that we will incur credit losses. As of April 30,
2020, the principal amount of loans for which forbearance
requests are currently active related to near-term payments on
commercial real estate loans and residential real estate loans
approximated $2 billion and $800 million, respectively.
These trends could continue in future periods given the present
uncertain global economic and market conditions. See
“Executive Summary—Coronavirus Disease (COVID-19)
Pandemic,” and “Risk Factors” herein for further information.
See also "Forward Looking Statements" in the 2019 10-K.
-- 33 of 93 --
Table of Contents
Risk Disclosures
31 March 2020 Form 10-Q
Loans and Lending Commitments
At March 31, 2020
$ in millions IS WM IM1 Total
Loans held for investment, before
allowance $ 49,358 $ 82,589 $ 5 $ 131,952
Allowance for credit losses (530) (87) — (617)
Loans held for investment, net
of allowance $ 48,828 $ 82,502 $ 5 $ 131,335
Loans held for sale 17,343 14 5 17,362
Loans held at fair value 9,573 — 489 10,062
Total loans $ 75,744 $ 82,516 $ 499 $ 158,759
Lending commitments2 92,911 13,366 — 106,277
Total loans and lending
commitments2 $ 168,655 $ 95,882 $ 499 $ 265,036
Total loans, before allowance $ 76,274 $ 82,603 $ 499 $ 159,376
At December 31, 2019
$ in millions IS WM IM1 Total
Loans held for investment, before
allowance $ 38,290 $ 80,114 $ 5 $ 118,409
Allowance for credit losses (297) (52) — (349)
Loans held for investment, net
of allowance $ 37,993 $ 80,062 $ 5 $ 118,060
Loans held for sale 12,564 13 — 12,577
Loans held at fair value 11,075 — 251 11,326
Total loans $ 61,632 $ 80,075 $ 256 $ 141,963
Lending commitments2 106,886 13,161 21 120,068
Total loans and lending
commitments2 $ 168,518 $ 93,236 $ 277 $ 262,031
Total loans, before allowance $ 61,929 $ 80,127 $ 256 $ 142,312
1. Investment Management business segment loans are related to certain of our activities
as an investment advisor and manager. At March 31, 2020 and December 31, 2019,
loans held at fair value are predominantly the result of the consolidation of CLO
vehicles, managed by Investment Management, composed primarily of senior secured
corporate loans.
2. Lending commitments represent the notional amount of legally binding obligations to
provide funding to clients for lending transactions. Since commitments associated with
these business activities may expire unused or may not be utilized to full capacity,
they do not necessarily reflect the actual future cash funding requirements.
We provide loans and lending commitments to a variety of
customers, from large corporate and institutional clients to high
net worth individuals. In addition, we purchase loans in the
secondary market. Loans and lending commitments are either
held for investment, held for sale or carried at fair value. For
more information on these loan classifications, see Note 2 to the
financial statements in the 2019 Form 10-K.
Total loans and lending commitments increased by
approximately $3 billion since December 31, 2019, primarily
due to growth in tailored lending and Residential real estate loans
within the Wealth Management business segment. In addition,
within the Institutional Securities business segment, there was
an increase in Corporate relationship and event-driven lending
commitments funded during the current quarter.
See Notes 4, 9 and 13 to the financial statements for further
information.
Allowance for Credit Losses Rollforward—Loans and
Lending Commitments
$ in millions
December 31, 20191 $ 590
Effect of CECL adoption (41)
Gross charge-offs (32)
Provision 407
Other (3)
March 31, 2020 $ 921
Allowance for credit losses—Loans $ 617
Allowance for credit losses—Lending commitments 304
1. At December 31, 2019, the total allowance for credit losses for Loans and Lending
commitments was $349 million and $241 million, respectively.
Credit exposure arising from our loans and lending
commitments is measured in accordance with our internal risk
management standards. Risk factors considered in determining
the aggregate allowance for loan and commitment losses include
the borrower’s financial strength, industry, facility structure,
loan-to-value ratio, debt service ratio, collateral and covenants.
Qualitative and environmental factors such as economic and
business conditions, nature and volume of the portfolio and
lending terms, and volume and severity of past due loans may
also be considered.
The aggregate allowance for loans and lending commitments
increased in the current quarter, principally reflecting a
provision for credit losses within the Institutional Securities
business segment resulting from the economic impact of
COVID-19. This provision was primarily the result of higher
actual and expected future downgrades, an increase in funded
balances, principally in Corporate relationship and event-driven
loans, as well as revisions to our forecasts in light of current and
expected future market and macroeconomic conditions. See
Note 2 to the financial statements for a discussion of the Firm’s
allowance for credit loss methodology under CECL.
Status of Loans Held for Investment
At March 31, 2020 At December 31, 2019
IS WM IS WM
Current 99.5% 99.9% 99.0% 99.9%
Nonaccrual1 0.5% 0.1% 1.0% 0.1%
1. These loans are on nonaccrual status because the loans were past due for a period
of 90 days or more or payment of principal or interest was in doubt.
-- 34 of 93 --
Table of Contents
Risk Disclosures
March 2020 Form 10-Q 32
Institutional Securities Loans and Lending Commitments1
At March 31, 2020
Contractual Years to Maturity
$ in millions Less than 1 1-3 3-5 Over 5 Total
Loans
AA $ 59 $ 47 $ 14 $ 5 $ 125
A 931 1,456 554 589 3,530
BBB 3,619 5,872 6,867 574 16,932
BB 12,401 11,430 10,186 1,251 35,268
Other NIG 5,865 5,503 4,313 2,242 17,923
Unrated2 101 92 286 1,487 1,966
Total loans 22,976 24,400 22,220 6,148 75,744
Lending commitments
AAA — 50 — — 50
AA 2,831 818 2,562 30 6,241
A 3,994 7,477 9,150 279 20,900
BBB 8,407 12,732 15,460 731 37,330
BB 3,635 3,986 7,219 1,067 15,907
Other NIG 2,064 2,754 6,604 1,056 12,478
Unrated2 3 — — 2 5
Total lending
commitments 20,934 27,817 40,995 3,165 92,911
Total exposure $ 43,910 $ 52,217 $ 63,215 $ 9,313 $ 168,655
At December 31, 2019
Contractual Years to Maturity
$ in millions Less than 1 1-3 3-5 Over 5 Total
Loans
AA $ 7 $ 50 $ — $ 5 $ 62
A 955 923 516 277 2,671
BBB 2,297 5,589 3,592 949 12,427
BB 9,031 11,189 9,452 1,449 31,121
Other NIG 4,020 5,635 2,595 1,143 13,393
Unrated2 117 82 131 1,628 1,958
Total loans 16,427 23,468 16,286 5,451 61,632
Lending commitments
AAA — 50 — — 50
AA 2,838 908 2,509 — 6,255
A 6,461 7,287 9,371 298 23,417
BBB 7,548 13,780 20,560 753 42,641
BB 2,464 5,610 8,333 1,526 17,933
Other NIG 2,193 4,741 7,062 2,471 16,467
Unrated2 — 9 107 7 123
Total lending
commitments 21,504 32,385 47,942 5,055 106,886
Total exposure $ 37,931 $ 55,853 $ 64,228 $10,506 $ 168,518
NIG–Non-investment grade
1. Counterparty credit ratings are internally determined by CRM.
2. Unrated loans and lending commitments are primarily trading positions that are
measured at fair value and risk-managed as a component of market risk. For a further
discussion of our market risk, see “Market Risk” herein.
As a result of the economic impacts of COVID-19, there was
an increase in lending commitments funded during the current
quarter in the Institutional Securities business segment. The
increase was primarily driven by clients with non-investment
grade and BBB internal credit ratings, who sought liquidity in
a period where, given the economic backdrop, capital markets
alternatives to drawing on lines of credit were less available.
Institutional Securities Loans and Lending Commitments by
Industry
$ in millions
At
March 31,
2020
At
December 31,
2019
Industry
Financials $ 40,142 $ 40,992
Real estate 27,190 28,348
Industrials 16,100 13,136
Healthcare 13,582 14,113
Communications services 10,839 12,165
Utilities 10,231 9,905
Information technology 10,019 9,201
Consumer discretionary 9,993 9,589
Energy 9,856 9,461
Consumer staples 9,415 9,724
Materials 5,469 5,577
Insurance 3,961 3,755
Other 1,858 2,552
Total $ 168,655 $ 168,518
The decline in economic activity, driven by the effects of
COVID-19, and recent decline in oil prices, have currently
impacted borrowers in many industries. The future
developments of COVID-19 and its related effect on the
economic environment are uncertain and may continue to
impact certain sectors and industries, in which we have, or may
in the future have, exposure in the form of loans or lending
commitments. In addition, refer to “Risk Factors” herein.
The Institutional Securities business segment lending activities
include Corporate relationship and event-driven lending,
Secured lending facilities, Commercial real estate lending and
Securities-based lending and other.
Corporate relationship and event-driven loans and lending
commitments typically consist of revolving lines of credit, term
loans and bridge loans; may have varying terms; may be senior
or subordinated; may be secured or unsecured; are generally
contingent upon representations, warranties and contractual
conditions applicable to the borrower; and may be syndicated,
traded or hedged. For additional information on event-driven
loans, see “Institutional Securities Event-Driven Loans and
Lending Commitments” herein.
Secured lending facilities include loans provided to clients,
which are primarily secured by loans on underlying real estate
or other assets. The underlying loans are associated with various
types of collateral, including residential real estate, commercial
real estate, corporate and financial assets. These facilities
generally provide for overcollateralization. Credit risk with
respect to these loans and lending commitments arises from the
failure of a borrower to perform according to the terms of the
loan agreement and/or a decline in the underlying collateral
-- 35 of 93 --
Table of Contents
Risk Disclosures
33 March 2020 Form 10-Q
value. The Firm monitors collateral levels against the
requirements of lending agreements.
Commercial real estate loans are primarily senior, secured by
underlying real estate and typically in term loan form.
Securities-based lending and other includes financing extended
to sales and trading customers and corporate loans purchased in
the secondary market.
Institutional Securities Loans1
$ in millions
At
March 31,
2020
At
December 31,
2019
Corporate relationship and
event-driven lending $ 27,058 $ 11,638
Secured lending facilities 30,493 29,654
Commercial & residential real estate 11,604 13,198
Securities-based lending and other 7,119 7,439
Total Institutional Securities loans $ 76,274 $ 61,929
1. Amounts include loans held for investment, before the allowance for credit losses,
loans held for sale and loans at fair value.
Institutional Securities Event-Driven Loans and Lending
Commitments1
At March 31, 2020
Contractual Years to Maturity
$ in millions Less than 1 1-3 3-5 Over 5 Total
Loans $ 3,284 $ 1,205 $ 1,527 $ 1,132 $ 7,148
Lending commitments 7,312 2,317 1,921 1,507 13,057
Total loans and lending
commitments $ 10,596 $ 3,522 $ 3,448 $ 2,639 $20,205
At December 31, 2019
Contractual Years to Maturity
$ in millions Less than 1 1-3 3-5 Over 5 Total
Loans $ 1,194 $ 1,024 $ 839 $ 390 $ 3,447
Lending commitments 7,921 5,012 2,285 3,090 18,308
Total loans and lending
commitments $ 9,115 $ 6,036 $ 3,124 $ 3,480 $21,755
1. Amounts include loans and lending commitments held for investment, before the
allowance for credit losses, and held for sale.
Event-driven loans and lending commitments are associated
with a particular event or transaction, such as to support client
merger, acquisition, recapitalization or project finance
activities. Balances may fluctuate as such lending is related to
transactions that vary in timing and size from period to period.
In the current quarter, credit spreads in the market for these loans
and commitments widened significantly, resulting in a
substantial slowdown in the volume of sales and syndications,
which is a trend that could continue in the future given the current
uncertain economic and market conditions. See “Executive
Summary—Coronavirus Disease (COVID-19) Pandemic” and
“Risk Factors” herein, and Forward Looking Statements in the
2019 Form 10-K.
Institutional Securities Loans and Lending Commitments Held
for Investment
At March 31, 2020 At December 31, 2019
$ in millions Loans Lending
Commitments Loans Lending
Commitments
Corporate
relationship and
event-driven
lending $ 15,457 $ 55,365 $ 5,426 $ 61,716
Secured lending
facilities 25,805 5,987 24,502 6,105
Commercial &
residential real
estate1 7,430 730 7,859 425
Securities-based
lending and
other2 666 461 503 832
Total, before
allowance for
credit losses $ 49,358 $ 62,543 $ 38,290 $ 69,078
Allowance for
credit losses (530) (298) (297) (236)
1. Amounts principally comprise Commercial real estate loans and lending commitments.
2. Amounts principally comprise Other loans and lending commitments.
Institutional Securities Allowance for Credit Losses
Rollforward—Loans
$ in millions
Corporate
relationship
and event-
driven
lending
Secured
lending
facilities
Commercial
& residential
real estate
Securities-
based
lending and
other Total
December 31, 2019 $ 115 $ 101 $ 75 $ 6 $ 297
Effect of CECL
adoption (2) (42) 34 3 (7)
Gross charge-offs (32) — — — (32)
Provision 177 29 66 1 273
Other — — (1) — (1)
March 31, 2020 $ 258 $ 88 $ 174 $ 10 $ 530
Institutional Securities Allowance for Credit Losses
Rollforward—Lending Commitments
$ in millions
Corporate
relationship
and event-
driven
lending
Secured
lending
facilities
Commercial
& residential
real estate
Securities-
based
lending and
other Total
December 31, 2019 $ 201 $ 27 $ 7 $ 1 $ 236
Effect of CECL
adoption (41) (11) 1 — (51)
Provision 91 16 5 3 115
Other (2) — — — (2)
March 31, 2020 $ 249 $ 32 $ 13 $ 4 $ 298
-- 36 of 93 --
Table of Contents
Risk Disclosures
March 2020 Form 10-Q 34
Institutional Securities HFI Loans—Ratios of Allowance for
Credit Losses to Balance Before Allowance
At
March 31,
2020
At
December 31,
2019
Corporate relationship and event-driven
lending 1.7% 2.1%
Secured lending facilities 0.3% 0.4%
Commercial & residential real estate 2.3% 1.0%
Securities-based lending and other 1.5% 1.2%
Total Institutional Securities loans 1.1% 0.8%
Wealth Management Loans and Lending Commitments
At March 31, 2020
Contractual Years to Maturity
$ in millions Less than 1 1-3 3-5 Over 5 Total
Securities-based lending
and other loans $ 43,158 $ 4,709 $ 2,141 $ 1,441 $51,449
Residential real estate
loans 14 7 — 31,046 31,067
Total loans $ 43,172 $ 4,716 $ 2,141 $32,487 $82,516
Lending commitments 10,397 2,382 326 261 13,366
Total loans and lending
commitments $ 53,569 $ 7,098 $ 2,467 $32,748 $95,882
At December 31, 2019
Contractual Years to Maturity
$ in millions Less than 1 1-3 3-5 Over 5 Total
Securities-based lending
and other loans $ 41,863 $ 3,972 $ 2,783 $ 1,284 $49,902
Residential real estate
loans 13 11 — 30,149 30,173
Total loans $ 41,876 $ 3,983 $ 2,783 $31,433 $80,075
Lending commitments 10,219 2,564 71 307 13,161
Total loans and lending
commitments $ 52,095 $ 6,547 $ 2,854 $31,740 $93,236
The principal Wealth Management business segment lending
activities include securities-based lending and residential real
estate loans.
Securities-based lending allows clients to borrow money against
the value of qualifying securities, generally for any purpose
other than purchasing, trading or carrying securities, or
refinancing margin debt. For more information about our
securities-based lending and residential real estate loans, see
“Quantitative and Qualitative Disclosures about Risk—Credit
Risk” in the 2019 Form 10-K.
For the current quarter, Loans and Lending commitments
associated with the Wealth Management business segment
increased primarily due to growth in tailored lending and
Residential real estate loans.
Wealth Management Allowance for Credit Losses Rollforward
—Loans and Lending Commitments
$ in millions
December 31, 20191 $ 57
Effect of CECL adoption 17
Provision 19
March 31, 2020 $ 93
Allowance for credit losses—Loans $ 87
Allowance for credit losses—Lending commitments 6
1. At December 31, 2019, the total Allowance for credit losses for Loans and Lending
commitments was $52 million and $5 million, respectively.
At March 31, 2020, approximately 75% of Wealth Management
residential real estate loans were to borrowers with
"Exceptional" or "Very Good" FICO scores (i.e., exceeding
740). Additionally, Wealth Management's securities-based
lending portfolio remains well-collateralized and subject to
daily client margining, which includes requiring customers to
deposit additional collateral, or reduce debt positions, when
necessary.
Customer and Other Receivables
Margin Loans
At March 31, 2020
$ in millions IS WM Total
Customer receivables representing margin
loans $ 16,635 $ 9,546 $ 26,181
At December 31, 2019
$ in millions IS WM Total
Customer receivables representing margin
loans $ 22,216 $ 9,700 $ 31,916
The Institutional Securities and Wealth Management business
segments provide margin lending arrangements, which allow
customers to borrow against the value of qualifying securities,
primarily for the purpose of purchasing additional securities, as
well as to collateralize short positions. Margin lending activities
generally have lower credit risk due to the value of collateral
held and their short-term nature. Amounts may fluctuate from
period to period as overall client balances change as a result of
market levels, client positioning and leverage.
Employee Loans
$ in millions
At
March 31,
2020
At
December 31,
2019
Currently employed by the Firm $ 2,867 N/A
No longer employed by the Firm 150 N/A
Balance $ 3,017 $ 2,980
Allowance for credit losses1 (180) (61)
Balance, net $ 2,837 $ 2,919
Remaining repayment term, weighted
average in years 5.0 4.8
1. The change in Allowance for credit losses includes a $124 million increase due to the
adoption of CECL on January 1, 2020.
-- 37 of 93 --
Table of Contents
Risk Disclosures
35 March 2020 Form 10-Q
Employee loans are granted in conjunction with a program
established primarily to recruit certain Wealth Management
representatives and are full recourse and generally require
periodic repayments. The allowance for credit losses as of March
31, 2020 was calculated under CECL, while the allowance for
credit losses at December 31, 2019 was calculated under the
prior incurred loss model. The related provision is recorded in
Compensation and benefits expense in the income statements.
See Note 2 for a description of the CECL allowance
methodology, including credit quality indicators, for employee
loans. For additional information on employee loans, see Note
9.
Derivatives
Fair Value of OTC Derivative Assets
Counterparty Credit Rating1
$ in millions AAA AA A BBB NIG Total
At March 31, 2020
<1 year $ 2,046 $ 26,829 $ 55,668 $ 38,756 $ 19,369 $ 142,668
1-3 years 536 6,458 22,788 18,243 13,104 61,129
3-5 years 521 5,952 14,442 10,521 4,718 36,154
Over 5 years 4,257 32,785 93,165 68,387 17,506 216,100
Total, gross $ 7,360 $ 72,024 $ 186,063 $ 135,907 $ 54,697 $ 456,051
Counterparty netting (3,472) (55,991) (150,333) (104,343) (30,638) (344,777)
Cash and securities
collateral (3,336) (12,216) (29,345) (23,461) (16,979) (85,337)
Total, net $ 552 $ 3,817 $ 6,385 $ 8,103 $ 7,080 $ 25,937
Counterparty Credit Rating1
$ in millions AAA AA A BBB NIG Total
At December 31, 2019
<1 year $ 371 $ 9,195 $ 31,789 $ 22,757 $ 6,328 $ 70,440
1-3 years 378 5,150 17,707 11,495 9,016 43,746
3-5 years 502 4,448 9,903 6,881 3,421 25,155
Over 5 years 3,689 24,675 70,765 40,542 14,587 154,258
Total, gross $ 4,940 $ 43,468 $ 130,164 $ 81,675 $ 33,352 $ 293,599
Counterparty netting (2,172) (33,521) (103,452) (62,345) (19,514) (221,004)
Cash and securities
collateral (2,641) (8,134) (22,319) (14,570) (10,475) (58,139)
Total, net $ 127 $ 1,813 $ 4,393 $ 4,760 $ 3,363 $ 14,456
$ in millions
At
March 31,
2020
At
December 31,
2019
Industry
Financials $ 8,343 $ 3,448
Utilities 5,226 4,275
Industrials 2,877 914
Healthcare 1,558 991
Regional governments 1,089 791
Not-for-profit organizations 936 657
Sovereign governments 900 403
Energy 891 524
Materials 826 325
Consumer staples 725 129
Information technology 686 659
Communications services 684 381
Consumer discretionary 463 370
Insurance 391 214
Real estate 215 315
Other 127 60
Total $ 25,937 $ 14,456
1. Counterparty credit ratings are determined internally by CRM.
We are exposed to credit risk as a dealer in OTC derivatives.
Credit risk with respect to derivative instruments arises from the
possibility that a counterparty may fail to perform according to
the terms of the contract. In the current quarter, our exposure to
credit risk arising from OTC derivatives has increased, primarily
as a function of the effect of market factors and volatility on the
valuation of our positions. For more information on derivatives,
see “Quantitative and Qualitative Disclosures about Risk—
Credit Risk—Derivatives” in the 2019 Form 10-K and Note 6
to the financial statements.
Country Risk
Country risk exposure is the risk that events in, or that affect, a
foreign country (any country other than the U.S.) might
adversely affect us. We actively manage country risk exposure
through a comprehensive risk management framework that
combines credit and market fundamentals and allows us to
effectively identify, monitor and limit country risk. For a further
discussion of our country risk exposure see, “Quantitative and
Qualitative Disclosures about Risk—Country and Other Risks”
in the 2019 Form 10-K.
Our sovereign exposures consist of financial contracts and
obligations entered into with sovereign and local governments.
Our non-sovereign exposures consist of financial contracts and
obligations entered into primarily with corporations and
financial institutions. Index credit derivatives are included in
the following country risk exposure table. Each reference entity
within an index is allocated to that reference entity’s country of
risk. Index exposures are allocated to the underlying reference
entities in proportion to the notional weighting of each reference
entity in the index, adjusted for any fair value receivable or
-- 38 of 93 --
Table of Contents
Risk Disclosures
March 2020 Form 10-Q 36
payable for that reference entity. Where credit risk crosses
multiple jurisdictions, for example, a CDS purchased from an
issuer in a specific country that references bonds issued by an
entity in a different country, the fair value of the CDS is reflected
in the Net Counterparty Exposure row based on the country of
the CDS issuer. Further, the notional amount of the CDS adjusted
for the fair value of the receivable or payable is reflected in the
Net Inventory row based on the country of the underlying
reference entity.
Top 10 Non-U.S. Country Exposures at March 31, 2020
United Kingdom
$ in millions Sovereigns Non-sovereigns Total
Net inventory1 $ (238) $ 1,327 $ 1,089
Net counterparty exposure2 88 13,314 13,402
Loans — 2,822 2,822
Lending commitments — 6,547 6,547
Exposure before hedges (150) 24,010 23,860
Hedges3 (311) (1,266) (1,577)
Net exposure $ (461) $ 22,744 $ 22,283
Germany
$ in millions Sovereigns Non-sovereigns Total
Net inventory1 $ 1,080 $ 281 $ 1,361
Net counterparty exposure2 127 5,539 5,666
Loans — 1,649 1,649
Lending commitments — 3,492 3,492
Exposure before hedges 1,207 10,961 12,168
Hedges3 (285) (874) (1,159)
Net exposure $ 922 $ 10,087 $ 11,009
Japan
$ in millions Sovereigns Non-sovereigns Total
Net inventory1 $ 1,501 $ 431 $ 1,932
Net counterparty exposure2 78 4,559 4,637
Loans — 714 714
Lending commitments — 3 3
Exposure before hedges 1,579 5,707 7,286
Hedges3 (92) (130) (222)
Net exposure $ 1,487 $ 5,577 $ 7,064
France
$ in millions Sovereigns Non-sovereigns Total
Net inventory1 $ (427) $ (476) $ (903)
Net counterparty exposure2 14 3,734 3,748
Loans — 935 935
Lending commitments — 2,919 2,919
Exposure before hedges (413) 7,112 6,699
Hedges3 (6) (712) (718)
Net exposure $ (419) $ 6,400 $ 5,981
Canada
$ in millions Sovereigns Non-sovereigns Total
Net inventory1 $ 587 $ 369 $ 956
Net counterparty exposure2 57 3,221 3,278
Loans — 629 629
Lending commitments — 985 985
Exposure before hedges 644 5,204 5,848
Hedges3 — (97) (97)
Net exposure $ 644 $ 5,107 $ 5,751
Spain
$ in millions Sovereigns Non-sovereigns Total
Net inventory1 $ 360 $ (139) $ 221
Net counterparty exposure2 3 383 386
Loans — 3,623 3,623
Lending commitments — 713 713
Exposure before hedges 363 4,580 4,943
Hedges3 — (132) (132)
Net exposure $ 363 $ 4,448 $ 4,811
China
$ in millions Sovereigns Non-sovereigns Total
Net inventory1 $ (432) $ 1,487 $ 1,055
Net counterparty exposure2 135 460 595
Loans — 1,965 1,965
Lending commitments — 770 770
Exposure before hedges (297) 4,682 4,385
Hedges3 (82) (82) (164)
Net exposure $ (379) $ 4,600 $ 4,221
Australia
$ in millions Sovereigns Non-sovereigns Total
Net inventory1 $ 1,464 $ 359 $ 1,823
Net counterparty exposure2 16 1,346 1,362
Loans — 355 355
Lending commitments — 647 647
Exposure before hedges 1,480 2,707 4,187
Hedges3 — (107) (107)
Net exposure $ 1,480 $ 2,600 $ 4,080
Brazil
$ in millions Sovereigns Non-sovereigns Total
Net inventory1 $ 2,384 $ 79 $ 2,463
Net counterparty exposure2 — 924 924
Loans — 237 237
Lending commitments — 64 64
Exposure before hedges 2,384 1,304 3,688
Hedges3 (12) (16) (28)
Net exposure $ 2,372 $ 1,288 $ 3,660
-- 39 of 93 --
Table of Contents
Risk Disclosures
37 March 2020 Form 10-Q
India
$ in millions Sovereigns Non-sovereigns Total
Net inventory1 $ 1,571 $ 680 $ 2,251
Net counterparty exposure2 — 612 612
Loans — 235 235
Exposure before hedges 1,571 1,527 3,098
Net exposure $ 1,571 $ 1,527 $ 3,098
1. Net inventory represents exposure to both long and short single-name and index
positions (i.e., bonds and equities at fair value and CDS based on a notional amount
assuming zero recovery adjusted for the fair value of any receivable or payable).
2. Net counterparty exposure (e.g., repurchase transactions, securities lending and OTC
derivatives) is net of the benefit of collateral received and also is net by counterparty
when legally enforceable master netting agreements are in place. For more
information, see “Additional Information—Top 10 Non-U.S. Country Exposures”
herein.
3. Amounts represent net CDS hedges (purchased and sold) on net counterparty
exposure and lending executed by trading desks responsible for hedging counterparty
and lending credit risk exposures. Amounts are based on the CDS notional amount
assuming zero recovery adjusted for any fair value receivable or payable. For further
description of the contractual terms for purchased credit protection and whether they
may limit the effectiveness of our hedges, see “Quantitative and Qualitative
Disclosures about Risk—Credit Risk—Derivatives” in the 2019 Form 10-K.
Additional Information—Top 10 Non-U.S. Country
Exposures
Collateral Held against Net Counterparty Exposure1
$ in millions
At
March 31,
2020
Counterparty credit exposure Collateral2
United Kingdom U.K., U.S. and Spain $ 14,985
Germany Italy and Germany 13,356
Other Japan, U.S. and Canada 27,025
1. The benefit of collateral received is reflected in the Top 10 Non-U.S. Country Exposures
at March 31, 2020.
2. Collateral primarily consists of cash and government obligations.
Country Risk Exposures Related to the U.K.
At March 31, 2020, our country risk exposures in the U.K.
included net exposures of $22,283 million (as shown in the Top
10 Non-U.S. Country Exposures table) and overnight deposits
of $5,163 million. The $22,744 million of exposures to non-
sovereigns were diversified across both names and sectors and
include $7,253 million to U.K.-focused counterparties that
generate more than one-third of their revenues in the U.K.,
$5,845 million to geographically diversified counterparties, and
$8,361 million to exchanges and clearinghouses.
Operational Risk
Operational risk refers to the risk of loss, or of damage to our
reputation, resulting from inadequate or failed processes or
systems, from human factors or from external events (e.g., fraud,
theft, legal and compliance risks, cyber attacks or damage to
physical assets). We may incur operational risk across the full
scope of our business activities, including revenue-generating
activities (e.g., sales and trading) and support and control groups
(e.g., information technology and trade processing). For a
further discussion about our operational risk, see “Quantitative
and Qualitative Disclosures about Risk—Operational Risk” in
the 2019 Form 10-K. In addition, for further information on
market and economic conditions and their effects on risk in
general, see "Management’s Discussion and Analysis of
Financial Condition and Results of Operations—Executive
Summary—Coronavirus Disease (COVID-19) Pandemic" and
“Risk Factors” herein.
Model Risk
Model risk refers to the potential for adverse consequences from
decisions based on incorrect or misused model outputs. Model
risk can lead to financial loss, poor business and strategic
decision making or damage to our reputation. The risk inherent
in a model is a function of the materiality, complexity and
uncertainty around inputs and assumptions. Model risk is
generated from the use of models impacting financial
statements, regulatory filings, capital adequacy assessments and
the formulation of strategy. For a further discussion about our
model risk, see “Quantitative and Qualitative Disclosures about
Risk—Model Risk” in the 2019 Form 10-K.
Liquidity Risk
Liquidity risk refers to the risk that we will be unable to finance
our operations due to a loss of access to the capital markets or
difficulty in liquidating our assets. Liquidity risk also
encompasses our ability (or perceived ability) to meet our
financial obligations without experiencing significant business
disruption or reputational damage that may threaten our viability
as a going concern. For a further discussion about our liquidity
risk, see “Quantitative and Qualitative Disclosures about Risk
—Liquidity Risk” in the 2019 Form 10-K and “Management’s
Discussion and Analysis of Financial Condition and Results of
Operations—Liquidity and Capital Resources” herein. In
addition, for further information on market and economic
conditions and their effects on risk in general, see
“Management’s Discussion and Analysis of Financial Condition
and Results of Operations—Executive Summary—Coronavirus
Disease (COVID-19) Pandemic” and “Risk Factors” herein.
Legal and Compliance Risk
Legal and compliance risk includes the risk of legal or regulatory
sanctions, material financial loss, including fines, penalties,
judgments, damages and/or settlements, or loss to reputation
that we may suffer as a result of failure to comply with laws,
regulations, rules, related self-regulatory organization standards
and codes of conduct applicable to our business activities. This
risk also includes contractual and commercial risk, such as the
risk that a counterparty’s performance obligations will be
unenforceable. It also includes compliance with AML, terrorist
financing, and anti-corruption rules and regulations. For a
further discussion about our legal and compliance risk, see
“Quantitative and Qualitative Disclosures about Risk—Legal
and Compliance Risk” in the 2019 Form 10-K.
-- 40 of 93 --
Table of Contents
March 2020 Form 10-Q 38
Report of Independent Registered Public Accounting Firm
To the Board of Directors and Shareholders of Morgan Stanley:
Results of Review of Interim Financial Information
We have reviewed the accompanying condensed consolidated
balance sheet of Morgan Stanley and subsidiaries (the “Firm”)
as of March 31, 2020, and the related condensed consolidated
income statements, comprehensive income statements, cash
flow statements and statements of changes in total equity for the
three-month periods ended March 31, 2020 and 2019, and the
related notes (collectively referred to as the “interim financial
information”). Based on our reviews, we are not aware of any
material modifications that should be made to the accompanying
interim financial information for it to be in conformity with
accounting principles generally accepted in the United States of
America.
We have previously audited, in accordance with the standards
of the Public Company Accounting Oversight Board (United
States) (PCAOB), the consolidated balance sheet of the Firm as
of December 31, 2019, and the related consolidated income
statement, comprehensive income statement, cash flow
statement and statement of changes in total equity for the year
then ended (not presented herein) included in the Firm’s Annual
Report on Form 10-K; and in our report dated February 27, 2020,
we expressed an unqualified opinion on those consolidated
financial statements. In our opinion, the information set forth in
the accompanying condensed consolidated balance sheet as of
December 31, 2019 is fairly stated, in all material respects, in
relation to the consolidated balance sheet from which it has been
derived.
Basis for Review Results
This interim financial information is the responsibility of the
Firm’s management. We are a public accounting firm registered
with the PCAOB and are required to be independent with respect
to the Firm in accordance with the U.S. federal securities laws
and the applicable rules and regulations of the Securities and
Exchange Commission and the PCAOB.
We conducted our reviews in accordance with the standards of
the PCAOB. A review of interim financial information consists
principally of applying analytical procedures and making
inquiries of persons responsible for financial and accounting
matters. It is substantially less in scope than an audit conducted
in accordance with the standards of the PCAOB, the objective
of which is the expression of an opinion regarding the financial
statements taken as a whole. Accordingly, we do not express
such an opinion.
/s/ Deloitte & Touche LLP
New York, New York
May 5, 2020
-- 41 of 93 --
Table of Contents
Consolidated Income Statements
(Unaudited)
See Notes to Consolidated Financial Statements 39 March 2020 Form 10-Q
Three Months Ended
March 31,
in millions, except per share data 2020 2019
Revenues
Investment banking $ 1,271 $ 1,242
Trading 3,056 3,441
Investments 38 273
Commissions and fees 1,360 966
Asset management 3,417 3,049
Other (1,011) 301
Total non-interest revenues 8,131 9,272
Interest income 3,503 4,290
Interest expense 2,147 3,276
Net interest 1,356 1,014
Net revenues 9,487 10,286
Non-interest expenses
Compensation and benefits 4,283 4,651
Brokerage, clearing and exchange fees 740 593
Information processing and communications 563 532
Professional services 449 514
Occupancy and equipment 365 347
Marketing and business development 132 141
Other 809 553
Total non-interest expenses 7,341 7,331
Income before provision for income taxes 2,146 2,955
Provision for income taxes 366 487
Net income $ 1,780 $ 2,468
Net income applicable to noncontrolling interests 82 39
Net income applicable to Morgan Stanley $ 1,698 $ 2,429
Preferred stock dividends 108 93
Earnings applicable to Morgan Stanley common shareholders $ 1,590 $ 2,336
Earnings per common share
Basic $ 1.02 $ 1.41
Diluted $ 1.01 $ 1.39
Average common shares outstanding
Basic 1,555 1,658
Diluted 1,573 1,677
-- 42 of 93 --
Table of Contents
Consolidated Comprehensive Income Statements
(Unaudited)
March 2020 Form 10-Q 40 See Notes to Consolidated Financial Statements
Three Months Ended
March 31,
$ in millions 2020 2019
Net income $ 1,780 $ 2,468
Other comprehensive income (loss), net of tax:
Foreign currency translation adjustments (132) (22)
Change in net unrealized gains (losses) on available-for-sale securities 1,325 429
Pension, postretirement and other 25 1
Change in net debt valuation adjustment 3,803 (620)
Total other comprehensive income (loss) $ 5,021 $ (212)
Comprehensive income $ 6,801 $ 2,256
Net income applicable to noncontrolling interests 82 39
Other comprehensive income (loss) applicable to noncontrolling interests 138 (31)
Comprehensive income applicable to Morgan Stanley $ 6,581 $ 2,248
-- 43 of 93 --
Table of Contents
Consolidated Balance Sheets
See Notes to Consolidated Financial Statements 41 March 2020 Form 10-Q
$ in millions, except share data
(Unaudited)
At
March 31,
2020
At
December 31,
2019
Assets
Cash and cash equivalents $ 131,509 $ 82,171
Trading assets at fair value ($103,637 and $128,386 were pledged to various parties) 270,916 297,110
Investment securities (includes $68,871 and $62,223 at fair value) 116,157 105,725
Securities purchased under agreements to resell (includes $5 and $4 at fair value) 104,800 88,224
Securities borrowed 72,300 106,549
Customer and other receivables 74,424 55,646
Loans:
Held for investment (net of allowance of $617 and $349) 131,335 118,060
Held for sale 17,362 12,577
Goodwill 7,125 7,143
Intangible assets (net of accumulated amortization of $3,281 and $3,204) 2,021 2,107
Other assets 19,846 20,117
Total assets $ 947,795 $ 895,429
Liabilities
Deposits (includes $4,052 and $2,099 at fair value) $ 235,239 $ 190,356
Trading liabilities at fair value 142,076 133,356
Securities sold under agreements to repurchase (includes $775 and $733 at fair value) 45,816 54,200
Securities loaned 11,631 8,506
Other secured financings (includes $6,897 and $7,809 at fair value) 13,058 14,698
Customer and other payables 198,074 197,834
Other liabilities and accrued expenses 19,817 21,155
Borrowings (includes $57,162 and $64,461 at fair value) 194,856 192,627
Total liabilities 860,567 812,732
Commitments and contingent liabilities (see Note 13)
Equity
Morgan Stanley shareholders’ equity:
Preferred stock 8,520 8,520
Common stock, $0.01 par value:
Shares authorized: 3,500,000,000; Shares issued: 2,038,893,979; Shares outstanding: 1,575,500,507 and
1,593,973,680 20 20
Additional paid-in capital 23,428 23,935
Retained earnings 71,518 70,589
Employee stock trusts 3,088 2,918
Accumulated other comprehensive income (loss) 2,095 (2,788)
Common stock held in treasury at cost, $0.01 par value (463,393,472 and 444,920,299 shares) (19,721) (18,727)
Common stock issued to employee stock trusts (3,088) (2,918)
Total Morgan Stanley shareholders’ equity 85,860 81,549
Noncontrolling interests 1,368 1,148
Total equity 87,228 82,697
Total liabilities and equity $ 947,795 $ 895,429
-- 44 of 93 --
Table of Contents
Consolidated Statements of Changes in Total Equity
(Unaudited)
See Notes to Consolidated Financial Statements 42 March 2020 Form 10-Q
Three Months Ended
March 31,
$ in millions 2020 2019
Preferred Stock
Beginning and ending balance $ 8,520 $ 8,520
Common Stock
Beginning and ending balance 20 20
Additional Paid-in Capital
Beginning balance 23,935 23,794
Share-based award activity (507) (618)
Other net increases — 2
Ending balance 23,428 23,178
Retained Earnings
Beginning balance 70,589 64,175
Cumulative adjustments for accounting changes1 (100) 63
Net income applicable to Morgan Stanley 1,698 2,429
Preferred stock dividends2 (108) (93)
Common stock dividends2 (561) (513)
Ending balance 71,518 66,061
Employee Stock Trusts
Beginning balance 2,918 2,836
Share-based award activity 170 164
Ending balance 3,088 3,000
Accumulated Other Comprehensive Income (Loss)
Beginning balance (2,788) (2,292)
Net change in Accumulated other comprehensive income (loss) 4,883 (181)
Ending balance 2,095 (2,473)
Common Stock Held In Treasury at Cost
Beginning balance (18,727) (13,971)
Share-based award activity 788 1,034
Repurchases of common stock and employee tax withholdings (1,782) (1,645)
Ending balance (19,721) (14,582)
Common Stock Issued to Employee Stock Trusts
Beginning balance (2,918) (2,836)
Share-based award activity (170) (164)
Ending balance (3,088) (3,000)
Non-Controlling Interests
Beginning balance 1,148 1,160
Net income applicable to non-controlling interests 82 39
Net change in Accumulated other comprehensive income (loss) 138 (31)
Ending balance 1,368 1,168
Total Equity $ 87,228 $ 81,892
1. See Notes 2 and 16 for further information regarding cumulative adjustments for accounting changes.
2. See Note 16 for information regarding dividends per share for each class of stock.
-- 45 of 93 --
Table of Contents
Consolidated Cash Flow Statements
(Unaudited)
See Notes to Consolidated Financial Statements 43 March 2020 Form 10-Q
Three Months Ended
March 31,
$ in millions 2020 2019
Cash flows from operating activities
Net income $ 1,780 $ 2,468
Adjustments to reconcile net income to net cash provided by (used for) operating activities:
Stock-based compensation expense 154 293
Depreciation and amortization 824 658
Provision for (Release of) credit losses on lending activities 407 36
Other operating adjustments 1,044 (92)
Changes in assets and liabilities:
Trading assets, net of Trading liabilities 35,079 23,977
Securities borrowed 34,249 (22,578)
Securities loaned 3,125 600
Customer and other receivables and other assets (23,619) 1,567
Customer and other payables and other liabilities (4,247) 9,971
Securities purchased under agreements to resell (16,576) 1,952
Securities sold under agreements to repurchase (8,384) (1,811)
Net cash provided by (used for) operating activities 23,836 17,041
Cash flows from investing activities
Proceeds from (payments for):
Other assets—Premises, equipment and software, net (354) (529)
Changes in loans, net (13,243) (1,329)
Investment securities:
Purchases (12,924) (15,895)
Proceeds from sales 3,128 7,875
Proceeds from paydowns and maturities 2,378 2,663
Other investing activities (93) (12)
Net cash provided by (used for) investing activities (21,108) (7,227)
Cash flows from financing activities
Net proceeds from (payments for):
Other secured financings 259 (1,575)
Deposits 44,694 (8,089)
Proceeds from issuance of Borrowings 20,601 8,091
Payments for:
Borrowings (14,967) (11,927)
Repurchases of common stock and employee tax withholdings (1,782) (1,645)
Cash dividends (688) (663)
Other financing activities (163) (56)
Net cash provided by (used for) financing activities 47,954 (15,864)
Effect of exchange rate changes on cash and cash equivalents (1,344) (464)
Net increase (decrease) in cash and cash equivalents 49,338 (6,514)
Cash and cash equivalents, at beginning of period 82,171 87,196
Cash and cash equivalents, at end of period $ 131,509 $ 80,682
Supplemental Disclosure of Cash Flow Information
Cash payments for:
Interest $ 2,123 $ 2,896
Income taxes, net of refunds 342 245
-- 46 of 93 --
Table of Contents
Notes to Consolidated Financial Statements
(Unaudited)
March 2020 Form 10-Q 44
1. Introduction and Basis of Presentation
The Firm
Morgan Stanley is a global financial services firm that maintains
significant market positions in each of its business segments—
Institutional Securities, Wealth Management and Investment
Management. Morgan Stanley, through its subsidiaries and
affiliates, provides a wide variety of products and services to a
large and diversified group of clients and customers, including
corporations, governments, financial institutions and
individuals. Unless the context otherwise requires, the terms
“Morgan Stanley” or the “Firm” mean Morgan Stanley (the
“Parent Company”) together with its consolidated subsidiaries.
See the “Glossary of Common Terms and Acronyms” for the
definition of certain terms and acronyms used throughout this
Form 10-Q.
A description of the clients and principal products and services
of each of the Firm’s business segments is as follows:
Institutional Securities provides investment banking, sales
and trading, lending and other services to corporations,
governments, financial institutions and high to ultra-high net
worth clients. Investment banking services consist of capital
raising and financial advisory services, including services
relating to the underwriting of debt, equity and other
securities, as well as advice on mergers and acquisitions,
restructurings, real estate and project finance. Sales and
trading services include sales, financing, prime brokerage and
market-making activities in equity and fixed income products,
including foreign exchange and commodities. Lending
activities include originating corporate loans and commercial
real estate loans, providing secured lending facilities, and
extending financing to sales and trading customers. Other
activities include Asia wealth management services,
investments and research.
Wealth Management provides a comprehensive array of
financial services and solutions to individual investors and
small to medium-sized businesses and institutions covering:
brokerage and investment advisory services; financial and
wealth planning services; stock plan administration services;
annuity and insurance products; securities-based lending,
residential real estate loans and other lending products;
banking; and retirement plan services.
Investment Management provides a broad range of investment
strategies and products that span geographies, asset classes,
and public and private markets to a diverse group of clients
across institutional and intermediary channels. Strategies and
products, which are offered through a variety of investment
vehicles, include equity, fixed income, liquidity and
alternative/other products. Institutional clients include
defined benefit/defined contribution plans, foundations,
endowments, government entities, sovereign wealth funds,
insurance companies, third-party fund sponsors and
corporations. Individual clients are generally served through
intermediaries, including affiliated and non-affiliated
distributors.
Basis of Financial Information
The financial statements are prepared in accordance with U.S.
GAAP, which requires the Firm to make estimates and
assumptions regarding the valuations of certain financial
instruments, the valuations of goodwill and intangible assets,
the outcome of legal and tax matters, deferred tax assets,
allowance for credit losses, and other matters that affect its
financial statements and related disclosures. The Firm believes
that the estimates utilized in the preparation of its financial
statements are prudent and reasonable. Actual results could
differ materially from these estimates.
Certain reclassifications have been made to prior periods to
conform to the current presentation. The Notes are an integral
part of the Firm's financial statements. The Firm has evaluated
subsequent events for adjustment to or disclosure in these
financial statements through the date of this report and has not
identified any recordable or disclosable events not otherwise
reported in these financial statements or the notes thereto.
The accompanying financial statements should be read in
conjunction with the Firm’s financial statements and notes
thereto included in the 2019 Form 10-K. Certain footnote
disclosures included in the 2019 Form 10-K have been
condensed or omitted from these financial statements as they
are not required for interim reporting under U.S. GAAP. The
financial statements reflect all adjustments of a normal,
recurring nature that are, in the opinion of management,
necessary for the fair presentation of the results for the interim
period. The results of operations for interim periods are not
necessarily indicative of results for the entire year.
Consolidation
The financial statements include the accounts of the Firm, its
wholly owned subsidiaries and other entities in which the Firm
has a controlling financial interest, including certain VIEs (see
Note 14). Intercompany balances and transactions have been
eliminated. For consolidated subsidiaries that are not wholly
owned, the third-party holdings of equity interests are referred
to as noncontrolling interests. The net income attributable to
noncontrolling interests for such subsidiaries is presented as Net
income applicable to noncontrolling interests in the income
statements. The portion of shareholders’ equity that is
attributable to noncontrolling interests for such subsidiaries is
presented as noncontrolling interests, a component of Total
equity, in the balance sheets.
For a discussion of the Firm’s significant regulated U.S. and
international subsidiaries and its involvement with VIEs, see
Note 1 to the financial statements in the 2019 Form 10-K.
-- 47 of 93 --
Table of Contents
Notes to Consolidated Financial Statements
(Unaudited)
45 March 2020 Form 10-Q
2. Significant Accounting Policies
For a detailed discussion about the Firm’s significant accounting
policies and for further information on accounting updates
adopted in the prior year, see Note 2 to the financial statements
in the 2019 Form 10-K.
During the three months ended March 31, 2020 (“current
quarter”), there were no significant revisions to the Firm’s
significant accounting policies, other than for the accounting
updates adopted.
Accounting Updates Adopted in 2020
See Note 16 for a summary of the Retained earnings impact of
this adoption.
Financial Instruments — Credit Losses
The Firm adopted the Financial Instruments - Credit Losses
accounting update on January 1, 2020.
This accounting update impacted the impairment model for
certain financial assets measured at amortized cost by requiring
a CECL methodology to estimate expected credit losses over
the entire life of the financial asset, recorded at inception or
purchase. CECL replaced the loss model currently applicable to
loans held for investment, HTM securities and other receivables
carried at amortized cost, such as employee loans.
The update also eliminated the concept of other-than-temporary
impairment for AFS securities and instead requires impairments
on AFS securities to be recognized in earnings through an
allowance when the fair value is less than amortized cost and a
credit loss exists, and through a permanent reduction of the
amortized cost basis when the securities are expected to be sold
before recovery of amortized cost.
For certain portfolios, we determined that there are de minimus
or zero expected credit losses; for example, for lending and
financing transactions, such as Securities borrowed, Securities
purchased under agreements to resell and certain other portfolios
where collateral arrangements are being followed. Also, we have
zero expected credit losses for certain financial assets based on
the credit quality of the borrower or issuer, such as U.S.
government and agency securities.
At transition on January 1, 2020, the adoption of this accounting
standard resulted in an increase in the allowance for credit losses
of $131 million with a corresponding reduction in Retained
earnings of $100 million, net of tax. The adoption impact was
primarily attributable to a $124 million increase in the allowance
for credit losses on employee loans.
The following discussion highlights changes to the Firm’s
accounting policies as a result of this adoption.
Instruments Measured at Amortized Cost and Certain Off-
Balance Sheet Credit Exposures
Allowance for Credit Losses (“ACL”)
The ACL for financial instruments measured at amortized cost
and certain off-balance sheet exposures (e.g., HFI loans and
lending commitments, HTM securities, customer and other
receivables and certain guarantees) represents an estimate of
expected credit losses over the entire life of the financial
instrument.
Factors considered by management when determining the ACL
include payment status, fair value of collateral, expected
payments of principal and interest, as well as internal or external
information relating to past events, current conditions and
reasonable and supportable forecasts. The Firm’s forecasts
include assumptions about certain macroeconomic variables
including, but not limited to, U.S. gross domestic product, equity
market indices, unemployment rates, as well as commercial real
estate and home price indices. At the conclusion of the Firm’s
reasonable and supportable forecast period of three years, there
is a gradual reversion back to historical averages.
The ACL is measured on a collective basis when similar risk
characteristics exist for multiple instruments considering all
available information relevant to assessing the collectability of
cash flows. Generally, the Firm applies a probability of default
(“PD”)/loss given default (“LGD”) model (“PD/LGD model”)
for instruments that are collectively assessed, under which the
ACL is calculated as the product of PD, LGD and exposure at
default (“EAD”). These parameters are forecast for each
collective group of loans using a scenario-based statistical
model and at the conclusion of the Firm’s reasonable and
supportable forecast period, the parameters gradually revert
back to historical averages.
If the instrument does not share similar risk characteristics with
other instruments, including when it is probable that the Firm
will be unable to collect the full payment of principal and interest
on the instrument when due, the ACL is measured on an
individual basis. The Firm typically applies a discounted cash
flow (“DCF”) method for instruments that are individually
assessed.
The Firm may also elect to use an approach that considers the
fair value of the collateral when measuring the ACL if the loan
is collateral dependent (i.e.,repayment of the loan is expected
to be provided substantially by the sale or operation of the
underlying collateral and the borrower is experiencing financial
difficulty).
Additionally, the Firm can elect to use an approach to measure
the ACL using the fair value of collateral where the borrower is
required to, and reasonably expected to, continually adjust and
replenish the amount of collateral securing the instrument to
reflect changes in the fair value of such collateral. The Firm has
-- 48 of 93 --
Table of Contents
Notes to Consolidated Financial Statements
(Unaudited)
March 2020 Form 10-Q 46
elected to use this approach for certain securities-based loans,
customer receivables representing margin loans, Securities
purchased under agreements to resell and Securities borrowed.
Credit quality indicators considered in developing the ACL
include:
• Corporate loans and Commercial real estate loans and
securities: Internal risk ratings developed by CRM which are
refreshed at least annually, and more frequently as necessary.
These ratings generally correspond to external ratings
published by S&P. The Firm also considers transaction
structure, including type of collateral, collateral terms, and
position of the obligation within the capital structure. In
addition, for Commercial real estate, the Firm considers
property type and location, net operating income, LTV ratios,
among others, as well as commercial real estate price and
credit spread indices and capitalization rates.
• Residential real estate loans: Loan origination Fair Isaac
Corporation (“FICO”) credit scores as determined by
independent credit agencies in the United States and loan-
to-value (“LTV”) ratios.
• Employee loans: Employment status, which includes those
currently employed by the Firm and for which the Firm can
deduct any unpaid amounts due to it through certain
compensation arrangements; and those no longer employed
by the Firm where such compensation arrangements are no
longer applicable.
Consumer loans primarily comprise securities-based loans and
therefore the Firm generally measures the ACL on such loans
based on the fair value of collateral.
Qualitative and environmental factors such as economic and
business conditions, the nature and volume of the portfolio, and
lending terms and the volume and severity of past due loans are
also considered in the ACL calculations.
Recognition. The Firm recognizes its ACL and provision for
credit losses in its balance sheets and income statements,
respectively, for on– and off–balance sheet instruments as
follows.
ACL Provision for
credit losses
Instruments measured at amortized
cost (e.g., HFI loans, HTM securities
and customer and other
receivables) Contra asset Other revenue
Employee loans Contra asset
Compensation
and benefits
expense
Off-balance sheet instruments (e.g.,
HFI lending commitments and
certain guarantees)
Other liabilities
and accrued
expenses Other expense
Troubled Debt Restructurings (“TDRs”)
The Firm may modify the terms of certain loans for economic
or legal reasons related to a borrower’s financial difficulties by
granting one or more concessions that the Firm would not
otherwise consider. Such modifications are accounted for and
reported as a TDR, except for certain modifications related to
the Coronavirus Disease (“COVID-19”) as noted in
“Modifications and Nonaccrual Status for Borrowers Impacted
by COVID-19” herein. A loan that has been modified in a TDR
is generally considered to be impaired and is evaluated
individually. TDRs are also generally classified as nonaccrual
and may be returned to accrual status only after the Firm expects
repayment of the remaining contractual principal and interest
and there is sustained repayment performance for a reasonable
period.
Nonaccrual
The Firm places financial instruments on nonaccrual status if
principal or interest is past due for a period of 90 days or more
or payment of principal or interest is in doubt unless the
obligation is well-secured and in the process of collection, or in
certain cases when related to the Coronavirus Disease
(“COVID-19”) as noted in “Modifications and Nonaccrual
Status for Borrowers Impacted by COVID-19” herein. For any
instrument placed on nonaccrual status, the Firm reverses any
unpaid interest accrued with an offsetting reduction to Interest
income. Principal and interest payments received on nonaccrual
instruments are applied to principal if there is doubt regarding
the ultimate collectability of principal. If collection of the
principal is not in doubt, interest income is realized on a cash
basis. If neither principal nor interest collection is in doubt and
the instruments are brought current, instruments are generally
placed on accrual status and interest income is recognized using
the effective interest method.
Modifications and Nonaccrual Status for Borrowers Impacted
by COVID-19
In the first quarter of 2020, the Firm elected to apply the guidance
issued by Congress in the Coronavirus Aid, Relief, and
Economic Security Act (“CARES Act”) as well as by the U.S.
banking agencies stating that certain concessions granted to
borrowers that are current on existing loans, either individually
or as part of a program for creditworthy borrowers who are
experiencing short-term financial or operational problems as a
result of the coronavirus pandemic, generally would not be
considered TDRs or nonaccrual.
ACL Write-offs
The Firm writes-off a financial instrument in the period that it
is deemed uncollectible and records a reduction in the ACL and
the balance of the financial instrument in the balance sheet.
However, for accrued interest receivable balances that are
separately recorded from the related financial instruments, the
Firm's nonaccrual policy requires that accrued interest
receivable be written off against Interest income when the
related financial instrument is placed in nonaccrual status.
Accordingly, the Firm elected not to measure an ACL for accrued
interest receivables.
-- 49 of 93 --
Table of Contents
Notes to Consolidated Financial Statements
(Unaudited)
47 March 2020 Form 10-Q
Available-for-Sale (“AFS”) Investment Securities
Unrealized Losses on AFS Securities
AFS securities are analyzed as part of the Firm's periodic
assessment of credit losses at the individual security level. When
considering if a credit loss exists, the Firm considers relevant
information as discussed in Note 2 of the 2019 Form 10-K. Upon
the adoption of Financial Instruments—Credit Losses, the Firm
no longer considers the length of time the fair value has been
less than the amortized cost basis in determining whether a credit
loss exists.
Recognition. The Firm recognizes its ACL and provision for
credit losses for AFS securities in its balance sheets and income
statements, respectively, as follows.
ACL Provision for credit
losses
AFS securities Contra asset Other revenue
The Firm recognizes the non-credit loss component of the
unrealized loss as an adjustment to the security’s asset balance
with an offsetting entry to AOCI in the balance sheets.
For AFS securities in an unrealized loss position as of the balance
sheet date that the Firm either has the intent to sell or that the
Firm is likely to be required to sell before recovery of its
amortized cost basis, any allowance for credit losses previously
established is written off and the amortized cost basis is written
down to the security’s fair value with any incremental unrealized
losses reported in Other revenues.
Nonaccrual & ACL Write-Offs on AFS Securities
AFS securities follow the same nonaccrual and write-off
guidance as discussed in “Instruments Measured at Amortized
Cost and Certain Off-Balance Sheet Credit Exposures” herein.
3. Cash and Cash Equivalents
Cash and cash equivalents consist of Cash and due from banks
and Interest bearing deposits with banks. Cash equivalents are
highly liquid investments with remaining maturities of three
months or less from the acquisition date that are readily
convertible to cash and are not held for trading purposes.
$ in millions
At
March 31,
2020
At
December 31,
2019
Cash and due from banks $ 11,570 $ 6,763
Interest bearing deposits with banks 119,939 75,408
Total Cash and cash equivalents $ 131,509 $ 82,171
Restricted cash $ 56,064 $ 32,512
Cash and cash equivalents also include Restricted cash such as
cash in banks subject to withdrawal restrictions, restricted
deposits held as compensating balances and cash segregated in
compliance with federal or other regulations, including the
minimum reserve requirement set by the Federal Reserve Bank
and other central banks.
4. Fair Values
Recurring Fair Value Measurements
Assets and Liabilities Measured at Fair Value on a Recurring
Basis
At March 31, 2020
$ in millions Level 1 Level 2 Level 3 Netting1 Total
Assets at fair value
Trading assets:
U.S. Treasury and
agency securities $ 42,231 $ 29,105 $ 99 $ — $ 71,435
Other sovereign
government obligations 29,493 5,017 17 — 34,527
State and municipal
securities — 2,226 1 — 2,227
MABS — 838 483 — 1,321
Loans and lending
commitments2 — 4,082 5,980 — 10,062
Corporate and other debt — 23,448 1,708 — 25,156
Corporate equities3 66,409 582 146 — 67,137
Derivative and other contracts:
Interest rate 14,025 253,646 1,367 — 269,038
Credit — 12,605 753 — 13,358
Foreign exchange 26 112,711 76 — 112,813
Equity 1,041 93,175 1,560 — 95,776
Commodity and other 1,070 17,813 3,384 — 22,267
Netting1 (12,720) (376,568) (1,301) (69,653) (460,242)
Total derivative and other
contracts 3,442 113,382 5,839 (69,653) 53,010
Investments4 562 204 725 — 1,491
Physical commodities — 960 — — 960
Total trading assets4 142,137 179,844 14,998 (69,653) 267,326
Investment securities—AFS 35,899 32,972 — — 68,871
Securities purchased under
agreements to resell — 5 — — 5
Total assets at fair value $ 178,036 $ 212,821 $ 14,998 $ (69,653) $ 336,202
-- 50 of 93 --
Table of Contents
Notes to Consolidated Financial Statements
(Unaudited)
March 2020 Form 10-Q 48
At March 31, 2020
$ in millions Level 1 Level 2 Level 3 Netting1 Total
Liabilities at fair value
Deposits $ — $ 3,935 $ 117 $ — $ 4,052
Trading liabilities:
U.S. Treasury and
agency securities 13,273 201 16 — 13,490
Other sovereign
government obligations 20,273 836 2 — 21,111
Corporate and other debt — 9,341 6 — 9,347
Corporate equities3 57,134 85 40 — 57,259
Derivative and other contracts:
Interest rate 14,655 242,840 494 — 257,989
Credit — 12,631 555 — 13,186
Foreign exchange 20 112,552 226 — 112,798
Equity 1,090 89,344 2,936 — 93,370
Commodity and other 1,438 15,280 1,535 — 18,253
Netting1 (12,720) (376,568) (1,301) (64,138) (454,727)
Total derivative and other
contracts 4,483 96,079 4,445 (64,138) 40,869
Total trading liabilities 95,163 106,542 4,509 (64,138) 142,076
Securities sold under
agreements to repurchase — 775 — — 775
Other secured financings — 6,508 389 — 6,897
Borrowings — 53,164 3,998 — 57,162
Total liabilities at fair
value $ 95,163 $ 170,924 $ 9,013 $ (64,138) $ 210,962
At December 31, 2019
$ in millions Level 1 Level 2 Level 3 Netting1 Total
Assets at fair value
Trading assets:
U.S. Treasury and
agency securities $ 36,866 $ 28,992 $ 22 $ — $ 65,880
Other sovereign
government obligations 23,402 4,347 5 — 27,754
State and municipal
securities — 2,790 1 — 2,791
MABS — 1,690 438 — 2,128
Loans and lending
commitments2 — 6,253 5,073 — 11,326
Corporate and other debt — 22,124 1,396 — 23,520
Corporate equities3 123,942 652 97 — 124,691
Derivative and other contracts:
Interest rate 1,265 182,977 1,239 — 185,481
Credit — 6,658 654 — 7,312
Foreign exchange 15 64,260 145 — 64,420
Equity 1,219 48,927 922 — 51,068
Commodity and other 1,079 7,255 2,924 — 11,258
Netting1 (2,794) (235,947) (993) (47,804) (287,538)
Total derivative and other
contracts 784 74,130 4,891 (47,804) 32,001
Investments4 481 252 858 — 1,591
Physical commodities — 1,907 — — 1,907
Total trading assets4 185,475 143,137 12,781 (47,804) 293,589
Investment securities—AFS 32,902 29,321 — — 62,223
Securities purchased under
agreements to resell — 4 — — 4
Total assets at fair value $ 218,377 $ 172,462 $ 12,781 $ (47,804) $ 355,816
At December 31, 2019
$ in millions Level 1 Level 2 Level 3 Netting1 Total
Liabilities at fair value
Deposits $ — $ 1,920 $ 179 $ — $ 2,099
Trading liabilities:
U.S. Treasury and
agency securities 11,191 34 — — 11,225
Other sovereign
government obligations 21,837 1,332 1 — 23,170
Corporate and other debt — 7,410 — — 7,410
Corporate equities3 63,002 79 36 — 63,117
Derivative and other contracts:
Interest rate 1,144 171,025 462 — 172,631
Credit — 7,391 530 — 7,921
Foreign exchange 6 67,473 176 — 67,655
Equity 1,200 49,062 2,606 — 52,868
Commodity and other 1,194 7,118 1,312 — 9,624
Netting1 (2,794) (235,947) (993) (42,531) (282,265)
Total derivative and other
contracts 750 66,122 4,093 (42,531) 28,434
Total trading liabilities 96,780 74,977 4,130 (42,531) 133,356
Securities sold under
agreements to repurchase — 733 — — 733
Other secured financings — 7,700 109 — 7,809
Borrowings — 60,373 4,088 — 64,461
Total liabilities at fair
value $ 96,780 $ 145,703 $ 8,506 $ (42,531) $ 208,458
MABS—Mortgage- and asset-backed securities
1. For positions with the same counterparty that cross over the levels of the fair value hierarchy,
both counterparty netting and cash collateral netting are included in the column titled “Netting.”
Positions classified within the same level that are with the same counterparty are netted within
that level. For further information on derivative instruments and hedging activities, see Note
6.
2. For a further breakdown by type, see the following Detail of Loans and Lending Commitments
at Fair Value table.
3. For trading purposes, the Firm holds or sells short equity securities issued by entities in
diverse industries and of varying sizes.
4. Amounts exclude certain investments that are measured based on NAV per share, which are
not classified in the fair value hierarchy. For additional disclosure about such investments,
see “Net Asset Value Measurements” herein.
Detail of Loans and Lending Commitments at Fair Value
$ in millions
At
March 31,
2020
At
December 31,
2019
Corporate $ 7,711 $ 8,036
Residential real estate 1,154 1,192
Commercial real estate 1,197 2,098
Total $ 10,062 $ 11,326
Unsettled Fair Value of Futures Contracts1
$ in millions
At
March 31,
2020
At
December 31,
2019
Customer and other receivables, net $ 935 $ 365
1. These contracts are primarily Level 1, actively traded, valued based on quoted prices from
the exchange and are excluded from the previous recurring fair value tables.
For a description of the valuation techniques applied to the
Firm’s major categories of assets and liabilities measured at fair
value on a recurring basis, see Note 3 to the financial statements
in the 2019 Form 10-K. During the current quarter, there were
no significant revisions made to the Firm’s valuation techniques.
-- 51 of 93 --
Table of Contents
Notes to Consolidated Financial Statements
(Unaudited)
49 March 2020 Form 10-Q
Rollforward of Level 3 Assets and Liabilities Measured at Fair
Value on a Recurring Basis
Three Months Ended
March 31,
$ in millions 2020 2019
U.S. Treasury and agency securities
Beginning balance $ 22 $ 54
Realized and unrealized gains (losses) 5 —
Purchases 85 —
Sales (21) (50)
Net transfers 8 3
Ending balance $ 99 $ 7
Unrealized gains (losses) $ 5 $ —
Other sovereign government obligations
Beginning balance $ 5 $ 17
Realized and unrealized gains (losses) 1 —
Purchases 10 2
Sales — (2)
Net transfers 1 (12)
Ending balance $ 17 $ 5
Unrealized gains (losses) $ 1 $ —
State and municipal securities
Beginning balance $ 1 $ 148
Realized and unrealized gains (losses) — 1
Purchases — 10
Sales — (44)
Net transfers — (103)
Ending balance $ 1 $ 12
Unrealized gains (losses) $ — $ 1
MABS
Beginning balance $ 438 $ 354
Realized and unrealized gains (losses) (89) (7)
Purchases 158 19
Sales (140) (83)
Settlements — (3)
Net transfers 116 21
Ending balance $ 483 $ 301
Unrealized gains (losses) $ (92) $ (14)
Loans and lending commitments
Beginning balance $ 5,073 $ 6,870
Realized and unrealized gains (losses) (102) —
Purchases and originations 1,952 1,255
Sales (529) (108)
Settlements (1,387) (820)
Net transfers1 973 (854)
Ending balance $ 5,980 $ 6,343
Unrealized gains (losses) $ (101) $ (7)
Three Months Ended
March 31,
$ in millions 2020 2019
Corporate and other debt
Beginning balance $ 1,396 $ 1,076
Realized and unrealized gains (losses) (92) 43
Purchases 585 204
Sales (177) (127)
Settlements — (3)
Net transfers (4) (132)
Ending balance $ 1,708 $ 1,061
Unrealized gains (losses) $ (90) $ 41
Corporate equities
Beginning balance $ 97 $ 95
Realized and unrealized gains (losses) (60) 6
Purchases 22 51
Sales (40) (9)
Net transfers 127 9
Ending balance $ 146 $ 152
Unrealized gains (losses) $ (54) $ 7
Investments
Beginning balance $ 858 $ 757
Realized and unrealized gains (losses) (63) 10
Purchases 15 10
Sales (8) (4)
Net transfers (77) 201
Ending balance $ 725 $ 974
Unrealized gains (losses) $ (64) $ 14
Net derivatives: Interest rate
Beginning balance $ 777 $ 618
Realized and unrealized gains (losses) 156 (48)
Purchases 61 24
Issuances (7) (19)
Settlements (42) (12)
Net transfers (72) (12)
Ending balance $ 873 $ 551
Unrealized gains (losses) $ 111 $ (43)
Net derivatives: Credit
Beginning balance $ 124 $ 40
Realized and unrealized gains (losses) 131 162
Purchases 26 26
Issuances (21) (442)
Settlements (24) (33)
Net transfers (38) (14)
Ending balance $ 198 $ (261)
Unrealized gains (losses) $ 123 $ 167
-- 52 of 93 --
Table of Contents
Notes to Consolidated Financial Statements
(Unaudited)
March 2020 Form 10-Q 50
Three Months Ended
March 31,
$ in millions 2020 2019
Net derivatives: Foreign exchange
Beginning balance $ (31) $ 75
Realized and unrealized gains (losses) (62) (113)
Purchases 3 1
Issuances (8) —
Settlements (8) 8
Net transfers (44) 34
Ending balance $ (150) $ 5
Unrealized gains (losses) $ (164) $ 3
Net derivatives: Equity
Beginning balance $ (1,684) $ (1,485)
Realized and unrealized gains (losses) 635 (191)
Purchases 97 34
Issuances (144) (193)
Settlements (167) 139
Net transfers (113) (64)
Ending balance $ (1,376) $ (1,760)
Unrealized gains (losses) $ 566 $ (203)
Net derivatives: Commodity and other
Beginning balance $ 1,612 $ 2,052
Realized and unrealized gains (losses) 75 43
Purchases 3 5
Issuances (3) (1)
Settlements 157 (81)
Net transfers 5 88
Ending balance $ 1,849 $ 2,106
Unrealized gains (losses) $ 22 $ (25)
Deposits
Beginning balance $ 179 $ 27
Realized and unrealized losses (gains) (6) 6
Issuances 12 24
Settlements (5) (1)
Net transfers (63) 43
Ending balance $ 117 $ 99
Unrealized losses (gains) $ (6) $ 6
Nonderivative trading liabilities
Beginning balance $ 37 $ 16
Realized and unrealized losses (gains) (43) (1)
Purchases (82) (6)
Sales 52 23
Net transfers 100 11
Ending balance $ 64 $ 43
Unrealized losses (gains) $ (43) $ (1)
Other secured financings
Beginning balance $ 109 $ 208
Realized and unrealized losses (gains) (12) 4
Issuances 2 —
Settlements (115) (7)
Net transfers 405 (52)
Ending balance $ 389 $ 153
Unrealized losses (gains) $ (12) $ 4
Three Months Ended
March 31,
$ in millions 2020 2019
Borrowings
Beginning balance $ 4,088 $ 3,806
Realized and unrealized losses (gains) (897) 287
Issuances 701 264
Settlements (234) (115)
Net transfers 340 (467)
Ending balance $ 3,998 $ 3,775
Unrealized losses (gains) $ (895) $ 276
Portion of Unrealized losses (gains) recorded
in OCI—Change in net DVA (398) 59
1. Net transfers in the current quarter include the transfer of $857 million of equity
margin loans from Level 2 to Level 3 as the unobservable input became significant.
Level 3 instruments may be hedged with instruments classified
in Level 1 and Level 2. The realized and unrealized gains (losses)
for assets and liabilities within the Level 3 category presented
in the previous tables do not reflect the related realized and
unrealized gains (losses) on hedging instruments that have been
classified by the Firm within the Level 1 and/or Level 2
categories.
The unrealized gains (losses) during the period for assets and
liabilities within the Level 3 category may include changes in
fair value during the period that were attributable to both
observable and unobservable inputs. Total realized and
unrealized gains (losses) are primarily included in Trading
revenues in the income statements.
Additionally, in the previous tables, consolidations of VIEs are
included in Purchases and deconsolidations of VIEs are included
in Settlements.
-- 53 of 93 --
Table of Contents
Notes to Consolidated Financial Statements
(Unaudited)
51 March 2020 Form 10-Q
Significant Unobservable Inputs Used in Recurring and
Nonrecurring Level 3 Fair Value Measurements
Valuation Techniques and Unobservable Inputs
Balance / Range (Average)1
$ in millions, except
inputs At March 31, 2020 At December 31, 2019
Assets Measured at Fair Value on a Recurring Basis
U.S. Treasury and
agency securities $ 99 $ 22
Comparable pricing:
Bond price 18 to 117 points (86 points) N/M
MABS $ 483 $ 438
Comparable pricing:
Bond price 0 to 87 points (43 points) 0 to 96 points (47 points)
Loans and lending
commitments $ 5,980 $ 5,073
Margin loan model:
Discount rate 1% to 10% (2%) 1% to 9% (2%)
Volatility skew 13% to 89% (58%) 15% to 80% (28%)
Credit Spread 12 to 109 bps (41 bps) 9 to 39 bps (19 bps)
Comparable pricing:
Loan price 71 to 100 points (92 points) 69 to 100 points (93 points)
Corporate and other
debt $ 1,708 $ 1,396
Comparable pricing:
Bond price 10 to 108 points (85 points) 11 to 108 points (84 points)
Discounted cash flow:
Recovery rate 51% to 62% (54% / 51%) 35%
Option model:
At the money
volatility 21% 21%
Corporate equities $ 146 $ 97
Comparable pricing:
Equity price 100% 100%
Investments $ 725 $ 858
Discounted cash flow:
WACC 11% to 16% (14%) 8% to 17% (15%)
Exit multiple 7 to 17 times (12 times) 7 to 16 times (11 times)
Market approach:
EBITDA multiple 7 to 22 times (9 times) 7 to 24 times (11 times)
Comparable pricing:
Equity price 50% to 100% (99%) 75% to 100% (99%)
Net derivative and other contracts:
Interest rate $ 873 $ 777
Option model:
IR volatility skew 2% to 183% (68% / 70%) 24% to 156% (63% / 59%)
IR curve
correlation 46% to 88% (71% / 73%) 47% to 90% (72% / 72%)
Bond volatility 6% to 35% (25% / 25%) 4% to 15% (13% / 14%)
Inflation volatility 24% to 63% (44% / 41%) 24% to 63% (44% / 41%)
IR curve 0% 1%
Balance / Range (Average)1
$ in millions, except
inputs At March 31, 2020 At December 31, 2019
Credit $ 198 $ 124
Credit default swap model:
Cash-synthetic
basis 6 points 6 points
Bond price 0 to 98 points (52 points) 0 to 104 points (45 points)
Credit spread 20 to 488 bps (114 bps) 9 to 469 bps (81 bps)
Funding spread 204 to 278 bps (267 bps) 47 to 117 bps (84 bps)
Correlation model:
Credit correlation 40% to 78% (50%) 29% to 62% (36%)
Foreign exchange2 $ (150) $ (31)
Option model:
IR - FX correlation 21% to 58% (38% / 38%) 32% to 56% (46% / 46%)
IR volatility skew 2% to 183% (68% / 70%) 24% to 156% (63% / 59%)
IR curve 10% 10% to 11% (10% / 10%)
Contingency
probability 95% 85% to 95% (94% / 95%)
Equity2 $ (1,376) $ (1,684)
Option model:
At the money
volatility 17% to 78% (45%) 9% to 90% (36%)
Volatility skew -4% to 0% (-1%) -2% to 0% (-1%)
Equity correlation 5% to 96% (76%) 5% to 98% (70%)
FX correlation -79% to 55% (-39%) -79% to 60% (-37%)
IR correlation -7% to 44% (19% / 18%) -11% to 44% (18% / 16%)
Commodity and
other $ 1,849 $ 1,612
Option model:
Forward power
price $1 to $137 ($26) per MWh $3 to $182 ($28) per MWh
Commodity
volatility 8% to 145% (18%) 7% to 183% (18%)
Cross-commodity
correlation 5% to 99% (93%) 43% to 99% (93%)
Liabilities Measured at Fair Value on a Recurring Basis
Deposits $ 117 $ 179
Option Model:
At the money
volatility 7% to 24% (7%) 16% to 37% (20%)
Other secured
financings $ 389 $ 109
Discounted cash flow:
Funding spread 106 to 161 bps (121 bps) 111 to 124 bps (117 bps)
Comparable pricing:
Loan price 30 to 101 points (86 points) N/M
Borrowings $ 3,998 $ 4,088
Option model:
At the money
volatility 5% to 55% (31%) 5% to 44% (21%)
Volatility skew -2% to 0% (0%) -2% to 0% (0%)
Equity correlation 39% to 98% (81%) 38% to 94% (78%)
Equity - FX
correlation -75% to 17% (-32%) -75% to 26% (-25%)
IR - FX Correlation -27% to 7% (-5% / -5%) -26% to 10% (-7% / -7%)
-- 54 of 93 --
Table of Contents
Notes to Consolidated Financial Statements
(Unaudited)
March 2020 Form 10-Q 52
Balance / Range (Average)1
$ in millions, except
inputs At March 31, 2020 At December 31, 2019
Nonrecurring Fair Value Measurement
Loans $ 3,901 $ 1,500
Corporate loan model:
Credit spread 44 to 600 bps (367 bps) 69 to 446 bps (225 bps)
Warehouse model:
Credit spread 159 to 743 bps (313 bps) 287 to 318 bps (297 bps)
Points—Percentage of par
IR—Interest rate
FX—Foreign exchange
1. A single amount is disclosed for range and average when there is no significant
difference between the minimum, maximum and average. Amounts represent
weighted averages except where simple averages and the median of the inputs are
more relevant.
2. Includes derivative contracts with multiple risks (i.e., hybrid products).
The previous tables provide information on the valuation
techniques, significant unobservable inputs, and the ranges and
averages for each major category of assets and liabilities
measured at fair value on a recurring and nonrecurring basis
with a significant Level 3 balance. The level of aggregation and
breadth of products cause the range of inputs to be wide and not
evenly distributed across the inventory of financial instruments.
Further, the range of unobservable inputs may differ across firms
in the financial services industry because of diversity in the types
of products included in each firm’s inventory. There are no
predictable relationships between multiple significant
unobservable inputs attributable to a given valuation technique.
For a description of the Firm’s significant unobservable inputs
and qualitative information about the effect of hypothetical
changes in the values of those inputs, see Note 3 to the financial
statements in the 2019 Form 10-K. During the current quarter,
there were no significant revisions made to the descriptions of
the Firm’s significant unobservable inputs.
Net Asset Value Measurements
Fund Interests
At March 31, 2020 At December 31, 2019
$ in millions
Carrying
Value Commitment Carrying
Value Commitment
Private equity $ 2,219 $ 557 $ 2,078 $ 450
Real estate 1,280 147 1,349 150
Hedge1 91 — 94 4
Total $ 3,590 $ 704 $ 3,521 $ 604
1. Investments in hedge funds may be subject to initial period lock-up or gate provisions,
which restrict an investor from withdrawing from the fund during a certain initial period
or restrict the redemption amount on any redemption date, respectively.
Amounts in the previous table represent the Firm’s carrying
value of general and limited partnership interests in fund
investments, as well as any related performance-based fees in
the form of carried interest. The carrying amounts are measured
based on the NAV of the fund taking into account the distribution
terms applicable to the interest held. This same measurement
applies whether the fund investments are accounted for under
the equity method or fair value.
For a description of the Firm’s investments in private equity
funds, real estate funds and hedge funds, which are measured
based on NAV, see Note 3 to the financial statements in the 2019
Form 10-K.
See Note 13 for information regarding general partner
guarantees, which include potential obligations to return
performance fee distributions previously received. See Note 19
for information regarding unrealized carried interest at risk of
reversal.
Nonredeemable Funds by Contractual Maturity
Carrying Value at March 31, 2020
$ in millions Private Equity Real Estate
Less than 5 years $ 1,409 $ 431
5-10 years 759 173
Over 10 years 51 676
Total $ 2,219 $ 1,280
Nonrecurring Fair Value Measurements
Carrying and Fair Values
At March 31, 2020
Fair Value
$ in millions Level 2 Level 31 Total
Assets
Loans $ 5,823 $ 3,901 $ 9,724
Liabilities
Other liabilities and accrued expenses—
Lending commitments $ 321 $ 247 $ 568
At December 31, 2019
Fair Value
$ in millions Level 2 Level 31 Total
Assets
Loans $ 1,543 $ 1,500 $ 3,043
Other assets—Other investments $ — $ 113 $ 113
Total $ 1,543 $ 1,613 $ 3,156
Liabilities
Other liabilities and accrued expenses—
Lending commitments $ 132 $ 69 $ 201
Total $ 132 $ 69 $ 201
1. For significant Level 3 balances, refer to “Significant Unobservable Inputs Used in
Recurring and Nonrecurring Level 3 Fair Value Measurements” section herein for
details of the significant unobservable inputs used for nonrecurring fair value
measurement.
-- 55 of 93 --
Table of Contents
Notes to Consolidated Financial Statements
(Unaudited)
53 March 2020 Form 10-Q
Gains (Losses) from Fair Value Remeasurements1
Three Months Ended
March 31,
$ in millions 2020 2019
Assets
Loans2 $ (713) $ 36
Other assets—Other investments3 — (5)
Other assets—Premises, equipment and
software4 (3) (2)
Total $ (716) $ 29
Liabilities
Other liabilities and accrued expenses—
Lending commitments2 $ (316) $ 67
Total $ (316) $ 67
1. Gains and losses for Loans and Other assets—Other investments are classified in
Other revenues. For other items, gains and losses are recorded in Other revenues if
the item is held for sale; otherwise, they are recorded in Other expenses.
2. Nonrecurring changes in the fair value of loans and lending commitments were
calculated as follows: for the held-for-investment category, based on the value of the
underlying collateral; and for the held-for-sale category, based on recently executed
transactions, market price quotations, valuation models that incorporate market
observable inputs where possible, such as comparable loan or debt prices and CDS
spread levels adjusted for any basis difference between cash and derivative
instruments, or default recovery analysis where such transactions and quotations are
unobservable.
3. Losses related to Other assets—Other investments were determined using techniques
that included discounted cash flow models, methodologies that incorporate multiples
of certain comparable companies and recently executed transactions.
4. Losses related to Other assets—Premises, equipment and software generally include
write-offs related to the disposal of certain assets.
Financial Instruments Not Measured at Fair Value
At March 31, 2020
Carrying
Value
Fair Value
$ in millions Level 1 Level 2 Level 3 Total
Financial assets
Cash and cash
equivalents $ 131,509 $ 131,509 $ — $ — $ 131,509
Investment
securities—HTM 47,286 32,207 17,149 777 50,133
Securities
purchased under
agreements to
resell 104,795 — 103,451 1,426 104,877
Securities borrowed 72,300 — 72,303 — 72,303
Customer and other
receivables1 69,923 — 67,086 2,852 69,938
Loans2 148,697 — 32,529 114,841 147,370
Other assets 461 — 461 — 461
Financial liabilities
Deposits $ 231,187 $ — $231,555 $ — $ 231,555
Securities
sold under
agreements to
repurchase 45,041 — 45,077 — 45,077
Securities loaned 11,631 — 11,633 — 11,633
Other
secured financings 6,161 — 6,167 — 6,167
Customer and other
payables1 195,211 — 195,211 — 195,211
Borrowings 137,694 — 135,148 10 135,158
Commitment
Amount
Lending
commitments3 $ 105,466 $ — $ 1,668 $ 1,089 $ 2,757
At December 31, 2019
Carrying
Value
Fair Value
$ in millions Level 1 Level 2 Level 3 Total
Financial assets
Cash and cash
equivalents $ 82,171 $ 82,171 $ — $ — $ 82,171
Investment securities—
HTM 43,502 30,661 12,683 789 44,133
Securities purchased
under agreements to
resell 88,220 — 86,794 1,442 88,236
Securities borrowed 106,549 — 106,551 — 106,551
Customer and other
receivables1 51,134 — 48,215 2,872 51,087
Loans2 130,637 — 22,293 108,059 130,352
Other assets 495 — 495 — 495
Financial liabilities
Deposits $ 188,257 $ — $ 188,639 $ — $ 188,639
Securities sold under
agreements to
repurchase 53,467 — 53,486 — 53,486
Securities loaned 8,506 — 8,506 — 8,506
Other secured financings 6,889 — 6,800 92 6,892
Customer and other
payables1 195,035 — 195,035 — 195,035
Borrowings 128,166 — 133,563 10 133,573
Commitment
Amount
Lending commitments3 $ 119,004 $ — $ 748 $ 338 $ 1,086
1. Accrued interest and dividend receivables and payables have been excluded.
Carrying value approximates fair value for these receivables and payables. As of March
31, 2020 and December 31, 2019, accrued interest receivable was $2.4 billion and
$1.7 billion, respectively.
2. Amounts include loans measured at fair value on a nonrecurring basis.
3. Represents Lending commitments accounted for as Held for Investment and Held for
Sale. For a further discussion on lending commitments, see Note 13.
The previous tables exclude certain financial instruments such
as equity method investments and all non-financial assets and
liabilities such as the value of the long-term relationships with
the Firm’s deposit customers.
-- 56 of 93 --
Table of Contents
Notes to Consolidated Financial Statements
(Unaudited)
March 2020 Form 10-Q 54
5. Fair Value Option
The Firm has elected the fair value option for certain eligible
instruments that are risk managed on a fair value basis to mitigate
income statement volatility caused by measurement basis
differences between the elected instruments and their associated
risk management transactions or to eliminate complexities of
applying certain accounting models.
Borrowings Measured at Fair Value on a Recurring Basis
$ in millions
At
March 31,
2020
At
December 31,
2019
Business Unit Responsible for Risk Management
Equity $ 25,089 $ 30,214
Interest rates 25,195 27,298
Commodities 4,681 4,501
Credit 1,179 1,246
Foreign exchange 1,018 1,202
Total $ 57,162 $ 64,461
Net Revenues from Borrowings under the Fair Value Option
Three Months Ended
March 31,
$ in millions 2020 2019
Trading revenues $ 3,447 $ (2,903)
Interest expense 83 93
Net revenues1 $ 3,364 $ (2,996)
1. Amounts do not reflect any gains or losses from related economic hedges.
Gains (losses) from changes in fair value are recorded in Trading
revenues and are mainly attributable to movements in the
reference price or index, interest rates or foreign exchange rates.
Gains (Losses) Due to Changes in Instrument-Specific Credit
Risk
Three Months Ended March 31,
2020 2019
$ in millions
Trading
Revenues OCI Trading
Revenues OCI
Borrowings $ (5) $ 4,948 $ (4) $ (816)
Loans and other debt1 (281) — 93 —
Lending commitments 2 — (1) —
Deposits — 72 — (4)
$ in millions
At
March 31,
2020
At
December 31,
2019
Cumulative pre-tax DVA gain (loss)
recognized in AOCI $ 3,022 $ (1,998)
1. Loans and other debt instrument-specific credit gains (losses) were determined by
excluding the non-credit components of gains and losses.
Difference Between Contractual Principal and Fair Value1
$ in millions
At
March 31,
2020
At
December 31,
2019
Loans and other debt2 $ 13,654 $ 13,037
Nonaccrual loans2 11,014 10,849
Borrowings3 798 (1,665)
1. Amounts indicate contractual principal greater than or (less than) fair value.
2. The majority of the difference between principal and fair value amounts for loans and
other debt relates to distressed debt positions purchased at amounts well below par.
3. Excludes borrowings where the repayment of the initial principal amount fluctuates
based on changes in a reference price or index.
The previous tables exclude non-recourse debt from
consolidated VIEs, liabilities related to transfers of financial
assets treated as collateralized financings, pledged commodities
and other liabilities that have specified assets attributable to
them.
Fair Value Loans on Nonaccrual Status
$ in millions
At
March 31,
2020
At
December 31,
2019
Nonaccrual loans $ 1,150 $ 1,100
Nonaccrual loans 90 or more days
past due $ 262 $ 330
-- 57 of 93 --
Table of Contents
Notes to Consolidated Financial Statements
(Unaudited)
55 March 2020 Form 10-Q
6. Derivative Instruments and Hedging Activities
Fair Values of Derivative Contracts
At March 31, 2020
Assets
$ in millions Bilateral
OTC Cleared
OTC Exchange-
Traded Total
Designated as accounting hedges
Interest rate $ 1,295 $ 7 $ — $ 1,302
Foreign exchange 152 83 — 235
Total 1,447 90 — 1,537
Not designated as accounting hedges
Interest rate 252,956 13,730 1,050 267,736
Credit 10,204 3,154 — 13,358
Foreign exchange 109,212 3,191 175 112,578
Equity 44,289 — 51,487 95,776
Commodity and other 17,778 — 4,489 22,267
Total 434,439 20,075 57,201 511,715
Total gross derivatives $ 435,886 $ 20,165 $ 57,201 $ 513,252
Amounts offset
Counterparty netting (328,104) (16,673) (54,079) (398,856)
Cash collateral netting (59,531) (1,855) — (61,386)
Total in Trading assets $ 48,251 $ 1,637 $ 3,122 $ 53,010
Amounts not offset1
Financial instruments collateral (23,868) — — (23,868)
Other cash collateral (83) — — (83)
Net amounts $ 24,300 $ 1,637 $ 3,122 $ 29,059
Net amounts for which master netting or collateral agreements are not in place
or may not be legally enforceable $ 3,984
Liabilities
$ in millions
Bilateral
OTC Cleared
OTC Exchange-
Traded Total
Designated as accounting hedges
Interest rate $ — $ — $ — $ —
Foreign exchange 54 2 — 56
Total 54 2 — 56
Not designated as accounting hedges
Interest rate 245,978 10,698 1,313 257,989
Credit 9,556 3,630 — 13,186
Foreign exchange 109,225 3,336 181 112,742
Equity 39,606 — 53,764 93,370
Commodity and other 13,661 — 4,592 18,253
Total 418,026 17,664 59,850 495,540
Total gross derivatives $ 418,080 $ 17,666 $ 59,850 $ 495,596
Amounts offset
Counterparty netting (328,104) (16,673) (54,079) (398,856)
Cash collateral netting (55,307) (564) — (55,871)
Total in Trading liabilities $ 34,669 $ 429 $ 5,771 $ 40,869
Amounts not offset1
Financial instruments collateral (8,357) — (3,825) (12,182)
Other cash collateral (34) (37) — (71)
Net amounts $ 26,278 $ 392 $ 1,946 $ 28,616
Net amounts for which master netting or collateral agreements are not in place
or may not be legally enforceable 5,601
At December 31, 2019
Assets
$ in millions Bilateral
OTC Cleared
OTC Exchange-
Traded Total
Designated as accounting hedges
Interest rate $ 673 $ — $ — $ 673
Foreign exchange 41 1 — 42
Total 714 1 — 715
Not designated as accounting hedges
Interest rate 179,450 4,839 519 184,808
Credit 4,895 2,417 — 7,312
Foreign exchange 62,957 1,399 22 64,378
Equity 27,621 — 23,447 51,068
Commodity and other 9,306 — 1,952 11,258
Total 284,229 8,655 25,940 318,824
Total gross derivatives $ 284,943 $ 8,656 $ 25,940 $ 319,539
Amounts offset
Counterparty netting (213,710) (7,294) (24,037) (245,041)
Cash collateral netting (41,222) (1,275) — (42,497)
Total in Trading assets $ 30,011 $ 87 $ 1,903 $ 32,001
Amounts not offset1
Financial instruments collateral (15,596) — — (15,596)
Other cash collateral (46) — — (46)
Net amounts $ 14,369 $ 87 $ 1,903 $ 16,359
Net amounts for which master netting or collateral agreements are not in place
or may not be legally enforceable $ 1,900
Liabilities
$ in millions
Bilateral
OTC Cleared
OTC Exchange-
Traded Total
Designated as accounting hedges
Interest rate $ 1 $ — $ — $ 1
Foreign exchange 121 38 — 159
Total 122 38 — 160
Not designated as accounting hedges
Interest rate 168,597 3,597 436 172,630
Credit 4,798 3,123 — 7,921
Foreign exchange 65,965 1,492 39 67,496
Equity 30,135 — 22,733 52,868
Commodity and other 7,713 — 1,911 9,624
Total 277,208 8,212 25,119 310,539
Total gross derivatives $ 277,330 $ 8,250 $ 25,119 $ 310,699
Amounts offset
Counterparty netting (213,710) (7,294) (24,037) (245,041)
Cash collateral netting (36,392) (832) — (37,224)
Total in Trading liabilities $ 27,228 $ 124 $ 1,082 $ 28,434
Amounts not offset1
Financial instruments collateral (7,747) — (287) (8,034)
Other cash collateral (14) — — (14)
Net amounts $ 19,467 $ 124 $ 795 $ 20,386
Net amounts for which master netting or collateral agreements are not in place
or may not be legally enforceable $ 3,680
1. Amounts relate to master netting agreements and collateral agreements that have been
determined by the Firm to be legally enforceable in the event of default but where certain
other criteria are not met in accordance with applicable offsetting accounting guidance.
See Note 4 for information related to the unsettled fair value of
futures contracts not designated as accounting hedges, which
are excluded from the previous tables.
-- 58 of 93 --
Table of Contents
Notes to Consolidated Financial Statements
(Unaudited)
March 2020 Form 10-Q 56
Notionals of Derivative Contracts
At March 31, 2020
Assets
$ in billions
Bilateral
OTC Cleared
OTC Exchange-
Traded Total
Designated as accounting hedges
Interest rate $ 10 $ 144 $ — $ 154
Foreign exchange 5 2 — 7
Total 15 146 — 161
Not designated as accounting hedges
Interest rate 4,261 8,028 615 12,904
Credit 173 111 — 284
Foreign exchange 3,054 104 10 3,168
Equity 426 — 453 879
Commodity and other 111 — 72 183
Total 8,025 8,243 1,150 17,418
Total gross derivatives $ 8,040 $ 8,389 $ 1,150 $ 17,579
Liabilities
$ in billions
Bilateral
OTC Cleared
OTC Exchange-
Traded Total
Designated as accounting hedges
Interest rate $ — $ 43 $ — $ 43
Foreign exchange 6 — — 6
Total 6 43 — 49
Not designated as accounting hedges
Interest rate 5,085 8,023 545 13,653
Credit 164 124 — 288
Foreign exchange 2,981 104 9 3,094
Equity 352 — 541 893
Commodity and other 89 — 69 158
Total 8,671 8,251 1,164 18,086
Total gross derivatives $ 8,677 $ 8,294 $ 1,164 $ 18,135
At December 31, 2019
Assets
$ in billions
Bilateral
OTC Cleared
OTC Exchange-
Traded Total
Designated as accounting hedges
Interest rate $ 14 $ 94 $ — $ 108
Foreign exchange 2 — — 2
Total 16 94 — 110
Not designated as accounting hedges
Interest rate 4,230 7,398 732 12,360
Credit 136 79 — 215
Foreign exchange 2,667 91 10 2,768
Equity 429 — 419 848
Commodity and other 99 — 61 160
Total 7,561 7,568 1,222 16,351
Total gross derivatives $ 7,577 $ 7,662 $ 1,222 $ 16,461
Liabilities
$ in billions
Bilateral
OTC Cleared
OTC Exchange-
Traded Total
Designated as accounting hedges
Interest rate $ — $ 71 $ — $ 71
Foreign exchange 9 2 — 11
Total 9 73 — 82
Not designated as accounting hedges
Interest rate 4,185 6,866 666 11,717
Credit 153 84 — 237
Foreign exchange 2,841 91 14 2,946
Equity 455 — 515 970
Commodity and other 85 — 61 146
Total 7,719 7,041 1,256 16,016
Total gross derivatives $ 7,728 $ 7,114 $ 1,256 $ 16,098
The Firm believes that the notional amounts of derivative
contracts generally overstate its exposure. In most
circumstances, notional amounts are used only as a reference
point from which to calculate amounts owed between the parties
to the contract. Furthermore, notional amounts do not reflect the
benefit of legally enforceable netting arrangements or risk
mitigating transactions.
For a discussion of the Firm's derivative instruments and
hedging activities, see Note 5 to the financial statements in the
2019 Form 10-K.
-- 59 of 93 --
Table of Contents
Notes to Consolidated Financial Statements
(Unaudited)
57 March 2020 Form 10-Q
Gains (Losses) on Accounting Hedges
Three Months Ended
March 31,
$ in millions 2020 2019
Fair value hedges—Recognized in Interest income
Interest rate contracts $ (64) $ (5)
Investment Securities—AFS 65 5
Fair value hedges—Recognized in Interest expense
Interest rate contracts $ 6,667 $ 1,577
Deposits1 (261) —
Borrowings (6,432) (1,621)
Net investment hedges—Foreign exchange contracts
Recognized in OCI $ 410 $ 64
Forward points excluded from hedge effectiveness
testing—Recognized in Interest income 33 35
Fair Value Hedges—Hedged Items
$ in millions
At
March 31,
2020
At
December 31,
2019
Investment Securities—AFS
Carrying amount2 currently or previously
hedged $ 1,969 $ 917
Basis adjustments included in carrying
amount3 $ 77 $ 14
Deposits1
Carrying amount currently or previously
hedged 18,335 5,435
Basis adjustments included in carrying
amount3 254 (7)
Borrowings
Carrying amount currently or previously
hedged $ 109,810 $ 102,456
Basis adjustments included in carrying
amount3 $ 9,007 $ 2,593
1. The Firm began designating interest rate swaps as fair value hedges of certain Deposits in
the fourth quarter of 2019.
2. Carrying amount represents amortized cost basis for AFS securities.
3. Hedge accounting basis adjustments are primarily related to outstanding hedges.
Net Derivative Liabilities and Collateral Posted
$ in millions
At
March 31,
2020
At
December 31,
2019
Net derivative liabilities with credit risk-
related contingent features $ 33,064 $ 21,620
Collateral posted 28,502 17,392
The previous table presents the aggregate fair value of certain
derivative contracts that contain credit risk-related contingent
features that are in a net liability position for which the Firm has
posted collateral in the normal course of business.
Incremental Collateral and Termination Payments upon
Potential Future Ratings Downgrade
$ in millions
At
March 31,
2020
One-notch downgrade $ 325
Two-notch downgrade 377
Bilateral downgrade agreements included in the amounts above1 $ 614
1. Amount represents arrangements between the Firm and other parties where upon the
downgrade of one party, the downgraded party must deliver collateral to the other party. These
bilateral downgrade arrangements are used by the Firm to manage the risk of counterparty
downgrades.
The additional collateral or termination payments that may be
called in the event of a future credit rating downgrade vary by
contract and can be based on ratings by either or both of Moody’s
Investors Service, Inc. (“Moody’s”) and S&P Global Ratings.
The previous table shows the future potential collateral amounts
and termination payments that could be called or required by
counterparties or exchange and clearing organizations in the
event of one-notch or two-notch downgrade scenarios based on
the relevant contractual downgrade triggers.
Maximum Potential Payout/Notional of Credit Protection
Sold1
Years to Maturity at March 31, 2020
$ in billions < 1 1-3 3-5 Over 5 Total
Single-name CDS
Investment grade $ 13 $ 17 $ 34 $ 13 $ 77
Non-investment grade 9 9 16 5 39
Total $ 22 $ 26 $ 50 $ 18 $ 116
Index and basket CDS
Investment grade $ 5 $ 8 $ 65 $ 34 $ 112
Non-investment grade 7 5 21 17 50
Total $ 12 $ 13 $ 86 $ 51 $ 162
Total CDS sold $ 34 $ 39 $ 136 $ 69 $ 278
Other credit contracts — — — — —
Total credit protection
sold $ 34 $ 39 $ 136 $ 69 $ 278
CDS protection sold with identical protection purchased $ 242
Years to Maturity at December 31, 2019
$ in billions < 1 1-3 3-5 Over 5 Total
Single-name CDS
Investment grade $ 16 $ 17 $ 33 $ 9 $ 75
Non-investment grade 9 9 16 1 35
Total $ 25 $ 26 $ 49 $ 10 $ 110
Index and basket CDS
Investment grade $ 4 $ 7 $ 46 $ 11 $ 68
Non-investment grade 7 4 17 10 38
Total $ 11 $ 11 $ 63 $ 21 $ 106
Total CDS sold $ 36 $ 37 $ 112 $ 31 $ 216
Other credit contracts — — — — —
Total credit protection
sold $ 36 $ 37 $ 112 $ 31 $ 216
CDS protection sold with identical protection purchased $ 187
-- 60 of 93 --
Table of Contents
Notes to Consolidated Financial Statements
(Unaudited)
March 2020 Form 10-Q 58
Fair Value Asset (Liability) of Credit Protection Sold1
$ in millions
At
March 31,
2020
At
December 31,
2019
Single-name CDS
Investment grade $ (963) $ 1,057
Non-investment grade (3,350) (540)
Total $ (4,313) $ 517
Index and basket CDS
Investment grade $ (693) $ 1,052
Non-investment grade (4,849) 134
Total $ (5,542) $ 1,186
Total CDS sold $ (9,855) $ 1,703
Other credit contracts (4) (17)
Total credit protection sold $ (9,859) $ 1,686
1. Investment grade/non-investment grade determination is based on the internal credit rating
of the reference obligation. Internal credit ratings serve as the Credit Risk Management
Department’s assessment of credit risk and the basis for a comprehensive credit limits
framework used to control credit risk. The Firm uses quantitative models and judgment to
estimate the various risk parameters related to each obligor.
Protection Purchased with CDS
Notional
$ in billions
At
March 31,
2020
At
December 31,
2019
Single name $ 123 $ 118
Index and basket 153 103
Tranched index and basket 18 15
Total $ 294 $ 236
Fair Value Asset (Liability)
$ in millions
At
March 31,
2020
At
December 31,
2019
Single name $ 4,152 $ (723)
Index and basket 5,176 (1,139)
Tranched index and basket 699 (450)
Total $ 10,027 $ (2,312)
The Firm enters into credit derivatives, principally CDS, under
which it receives or provides protection against the risk of
default on a set of debt obligations issued by a specified
reference entity or entities. A majority of the Firm’s
counterparties for these derivatives are banks, broker-dealers,
and insurance and other financial institutions.
The fair value amounts as shown in the previous tables are prior
to cash collateral or counterparty netting. For further
information on credit derivatives and other contracts, see Note
5 to the financial statements in the 2019 Form 10-K.
-- 61 of 93 --
Table of Contents
Notes to Consolidated Financial Statements
(Unaudited)
59 March 2020 Form 10-Q
7. Investment Securities
AFS and HTM Securities
At March 31, 2020
$ in millions
Amortized
Cost1
Gross
Unrealized
Gains
Gross
Unrealized
Losses Fair
Value
AFS securities
U.S. government and agency securities:
U.S. Treasury securities $ 34,600 $ 1,298 $ — $ 35,898
U.S. agency securities2 22,687 717 82 23,322
Total U.S. government and
agency securities 57,287 2,015 82 59,220
Corporate and other debt:
Agency CMBS 4,765 244 8 5,001
Corporate bonds 1,828 16 35 1,809
State and municipal
securities 1,453 48 48 1,453
FFELP student loan
ABS3 1,535 — 147 1,388
Total corporate and other
debt 9,581 308 238 9,651
Total AFS securities 66,868 2,323 320 68,871
HTM securities
U.S. government and agency securities:
U.S. Treasury securities 29,951 2,256 — 32,207
U.S. agency securities2 16,542 607 — 17,149
Total U.S. government and
agency securities 46,493 2,863 — 49,356
Corporate and other debt:
Non-agency CMBS 793 4 20 777
Total HTM securities 47,286 2,867 20 50,133
Total investment
securities $ 114,154 $ 5,190 $ 340 $ 119,004
At December 31, 2019
$ in millions
Amortized
Cost
Gross
Unrealized
Gains
Gross
Unrealized
Losses Fair
Value
AFS securities
U.S. government and agency securities:
U.S. Treasury securities $ 32,465 $ 224 $ 111 $ 32,578
U.S. agency securities2 20,725 249 100 20,874
Total U.S. government and
agency securities 53,190 473 211 53,452
Corporate and other debt:
Agency CMBS 4,810 55 57 4,808
Corporate bonds 1,891 17 1 1,907
State and municipal
securities 481 22 — 503
FFELP student loan
ABS3 1,580 1 28 1,553
Total corporate and other
debt 8,762 95 86 8,771
Total AFS securities 61,952 568 297 62,223
HTM securities
U.S. government and agency securities:
U.S. Treasury securities 30,145 568 52 30,661
U.S. agency securities2 12,589 151 57 12,683
Total U.S. government and
agency securities 42,734 719 109 43,344
Corporate and other debt:
Non-agency CMBS 768 22 1 789
Total HTM securities 43,502 741 110 44,133
Total investment
securities $ 105,454 $ 1,309 $ 407 $ 106,356
1. Amounts are net of any allowance for credit losses.
2. U.S. agency securities consist mainly of agency-issued debt, agency mortgage pass-
through pool securities and CMOs.
3. Underlying loans are backed by a guarantee, ultimately from the U.S. Department of
Education, of at least 95% of the principal balance and interest outstanding.
In the current quarter, the Firm transferred certain municipal
securities from Trading assets into AFS securities as a result of
a change in intent due to the severe deterioration in liquidity for
these instruments. At March 31, 2020, these securities had a fair
value of $441 million.
-- 62 of 93 --
Table of Contents
Notes to Consolidated Financial Statements
(Unaudited)
March 2020 Form 10-Q 60
Investment Securities in an Unrealized Loss Position
At March 31, 2020
Less than 12 Months 12 Months or Longer Total
$ in millions Fair Value
Gross
Unrealized
Losses Fair Value
Gross
Unrealized
Losses Fair Value
Gross
Unrealized
Losses
AFS securities
U.S. agency securities $ 931 $ 7 $ 3,892 $ 75 $ 4,823 $ 82
Corporate and other debt:
Agency CMBS 30 — 670 8 700 8
Corporate bonds 747 24 58 11 805 35
State and municipal securities 678 48 — — 678 48
FFELP student loan ABS 349 29 1,038 118 1,387 147
Total corporate and other debt 1,804 101 1,766 137 3,570 238
Total AFS securities $ 2,735 $ 108 $ 5,658 $ 212 $ 8,393 $ 320
At December 31, 2019
Less than 12 Months 12 Months or Longer Total
$ in millions Fair Value
Gross
Unrealized
Losses Fair Value
Gross
Unrealized
Losses Fair Value
Gross
Unrealized
Losses
AFS securities
U.S. government and agency securities:
U.S. Treasury securities $ 4,793 $ 28 $ 7,904 $ 83 $ 12,697 $ 111
U.S. agency securities 2,641 20 7,697 80 10,338 100
Total U.S. government and agency securities 7,434 48 15,601 163 23,035 211
Corporate and other debt:
Agency CMBS 2,294 26 681 31 2,975 57
Corporate bonds 194 1 44 — 238 1
FFELP student loan ABS 91 — 1,165 28 1,256 28
Total corporate and other debt 2,579 27 1,890 59 4,469 86
Total AFS securities 10,013 75 17,491 222 27,504 297
HTM securities
U.S. government and agency securities:
U.S. Treasury securities 6,042 52 651 — 6,693 52
U.S. agency securities 2,524 18 2,420 39 4,944 57
Total U.S. government and agency securities 8,566 70 3,071 39 11,637 109
Corporate and other debt:
Non-agency CMBS 167 1 65 — 232 1
Total HTM securities 8,733 71 3,136 39 11,869 110
Total investment securities $ 18,746 $ 146 $ 20,627 $ 261 $ 39,373 $ 407
For AFS securities, the Firm believes there are no securities in
an unrealized loss position that have credit losses after
performing the analysis described in Note 2. Additionally, the
Firm does not intend to sell the securities and is not likely to be
required to sell the securities prior to recovery of the amortized
cost basis. Furthermore, the securities have not experienced
credit losses as they are predominantly investment-grade and
the Firm expects to recover the amortized cost basis.
As of March 31, 2020, the HTM securities net carrying amount
reflects an amortized cost of $47,312 million less an allowance
for credit losses of $26 million related to Non-agency CMBS.
See Note 2 for a description of the ACL methodology used
beginning in 2020 following the Firm's adoption of CECL and
see Note 2 to the financial statements in the 2019 Form 10-K
for prior period credit loss considerations. There were no
securities in an unrealized loss position as of December 31, 2019
that had credit losses. As of March 31, 2020, and December 31,
2019, Non-Agency CMBS HTM securities were all on accrual
status and were predominantly investment-grade.
See Note 14 for additional information on securities issued by
VIEs, including U.S. agency mortgage-backed securities, non-
agency CMBS and FFELP student loan ABS.
-- 63 of 93 --
Table of Contents
Notes to Consolidated Financial Statements
(Unaudited)
61 March 2020 Form 10-Q
Investment Securities by Contractual Maturity
At March 31, 2020
$ in millions
Amortized
Cost1 Fair
Value
Annualized
Average
Yield
AFS securities
U.S. government and agency securities:
U.S. Treasury securities:
Due within 1 year $ 3,728 $ 3,770 2.0%
After 1 year through 5 years 27,748 28,791 1.7%
After 5 years through 10 years 3,124 3,337 1.6%
Total 34,600 35,898
U.S. agency securities:
Due within 1 year 235 236 0.8%
After 1 year through 5 years 78 78 1.4%
After 5 years through 10 years 1,293 1,322 1.8%
After 10 years 21,081 21,686 2.3%
Total 22,687 23,322
Total U.S. government and agency
securities 57,287 59,220 1.9%
Corporate and other debt:
Agency CMBS:
After 1 year through 5 years 599 605 1.8%
After 5 years through 10 years 3,273 3,488 2.5%
After 10 years 893 908 2.0%
Total 4,765 5,001
Corporate bonds:
Due within 1 year 44 44 2.3%
After 1 year through 5 years 1,439 1,439 2.6%
After 5 years through 10 years 345 326 2.9%
Total 1,828 1,809
State and municipal securities:
After 1 year through 5 years 2 2 3.4%
After 5 years through 10 years 139 142 3.1%
After 10 Years 1,312 1,309 2.8%
Total 1,453 1,453
FFELP student loan ABS:
After 1 year through 5 years 98 87 0.8%
After 5 years through 10 years 307 270 0.9%
After 10 years 1,130 1,031 1.2%
Total 1,535 1,388
Total corporate and other debt 9,581 9,651 2.3%
Total AFS securities 66,868 68,871 2.0%
At March 31, 2020
$ in millions
Amortized
Cost1 Fair
Value
Annualized
Average
Yield
HTM securities
U.S. government and agency securities:
U.S. Treasury securities:
Due within 1 year 3,282 3,332 2.6%
After 1 year through 5 years 17,769 18,733 2.0%
After 5 years through 10 years 7,818 8,777 2.2%
After 10 years 1,082 1,365 2.5%
Total 29,951 32,207
U.S. agency securities:
After 5 years through 10 years 50 51 1.8%
After 10 years 16,492 17,098 2.4%
Total 16,542 17,149
Total U.S. government and agency
securities 46,493 49,356 2.2%
Corporate and other debt:
Non-agency CMBS:
Due within 1 year 100 99 4.8%
After 1 year through 5 years 107 104 3.7%
After 5 years through 10 years 549 536 3.9%
After 10 years 37 38 4.4%
Total corporate and other debt 793 777 4.0%
Total HTM securities 47,286 50,133 2.3%
Total investment securities $ 114,154 $ 119,004 2.1%
1. Amounts are net of any allowance for credit losses.
Gross Realized Gains (Losses) on Sales of AFS Securities
Three Months Ended
March 31,
$ in millions 2020 2019
Gross realized gains $ 49 $ 19
Gross realized (losses) (8) (9)
Total1 $ 41 $ 10
1. Realized gains and losses are recognized in Other revenues in the income statements.
-- 64 of 93 --
Table of Contents
Notes to Consolidated Financial Statements
(Unaudited)
March 2020 Form 10-Q 62
8. Collateralized Transactions
Offsetting of Certain Collateralized Transactions
At March 31, 2020
$ in millions
Gross
Amounts Amounts
Offset
Net
Amounts
Presented Amounts
Not Offset1 Net
Amounts
Assets
Securities
purchased under
agreements to
resell $249,124 $ (144,324) $ 104,800 $ (98,800) $ 6,000
Securities
borrowed 76,276 (3,976) 72,300 (67,384) 4,916
Liabilities
Securities sold
under
agreements to
repurchase $189,937 $ (144,121) $ 45,816 $ (39,114) $ 6,702
Securities loaned 15,810 (4,179) 11,631 (11,241) 390
Net amounts for which master netting agreements are not in place or
may not be legally enforceable
Securities purchased under agreements to resell $ 5,403
Securities borrowed 1,010
Securities sold under agreements to repurchase 5,325
Securities loaned 134
At December 31, 2019
$ in millions
Gross
Amounts Amounts
Offset
Net
Amounts
Presented Amounts
Not Offset1 Net
Amounts
Assets
Securities
purchased under
agreements to
resell $247,545 $ (159,321) $ 88,224 $ (85,200) $ 3,024
Securities
borrowed 109,528 (2,979) 106,549 (101,850) 4,699
Liabilities
Securities sold
under
agreements to
repurchase $213,519 $ (159,319) $ 54,200 $ (44,549) $ 9,651
Securities loaned 11,487 (2,981) 8,506 (8,324) 182
Net amounts for which master netting agreements are not in place or
may not be legally enforceable
Securities purchased under agreements to resell $ 2,255
Securities borrowed 1,181
Securities sold under agreements to repurchase 8,033
Securities loaned 101
1. Amounts relate to master netting agreements that have been determined by the Firm
to be legally enforceable in the event of default but where certain other criteria are not
met in accordance with applicable offsetting accounting guidance.
For further discussion of the Firm’s collateralized transactions,
see Note 7 to the financial statements in the 2019 Form 10-K.
For information related to offsetting of derivatives, see Note 6.
Gross Secured Financing Balances by Remaining
Contractual Maturity
At March 31, 2020
$ in millions
Overnight
and Open Less than
30 Days 30-90
Days Over
90 Days Total
Securities sold under
agreements to
repurchase $ 65,591 $ 60,940 $25,746 $ 37,660 $189,937
Securities loaned 6,824 214 2,034 6,738 15,810
Total included in the
offsetting disclosure $ 72,415 $ 61,154 $27,780 $ 44,398 $205,747
Trading liabilities—
Obligation to return
securities received
as collateral 15,270 — — — 15,270
Total $ 87,685 $ 61,154 $27,780 $ 44,398 $221,017
At December 31, 2019
$ in millions
Overnight
and Open Less than
30 Days 30-90
Days Over
90 Days Total
Securities sold under
agreements to
repurchase $ 67,158 $ 81,300 $26,904 $ 38,157 $213,519
Securities loaned 2,378 3,286 516 5,307 11,487
Total included in the
offsetting disclosure $ 69,536 $ 84,586 $27,420 $ 43,464 $225,006
Trading liabilities—
Obligation to return
securities received as
collateral 23,877 — — — 23,877
Total $ 93,413 $ 84,586 $27,420 $ 43,464 $248,883
Gross Secured Financing Balances by Class of Collateral
Pledged
$ in millions
At
March 31,
2020
At
December 31,
2019
Securities sold under agreements to repurchase
U.S. Treasury and agency securities $ 77,557 $ 68,895
State and municipal securities 689 905
Other sovereign government obligations 88,871 109,414
ABS 2,278 2,218
Corporate and other debt 7,369 6,066
Corporate equities 12,710 25,563
Other 463 458
Total $ 189,937 $ 213,519
Securities loaned
Other sovereign government obligations $ 4,876 $ 3,026
Corporate equities 10,277 8,422
Other 657 39
Total $ 15,810 $ 11,487
Total included in the offsetting disclosure $ 205,747 $ 225,006
Trading liabilities—Obligation to return securities received as collateral
Corporate equities $ 15,263 $ 23,873
Other 7 4
Total $ 15,270 $ 23,877
Total $ 221,017 $ 248,883
-- 65 of 93 --
Table of Contents
Notes to Consolidated Financial Statements
(Unaudited)
63 March 2020 Form 10-Q
Carrying Value of Assets Loaned or Pledged without
Counterparty Right to Sell or Repledge
$ in millions
At
March 31,
2020
At
December 31,
2019
Trading assets $ 40,345 $ 41,201
Loans (before allowance for credit losses) 1,158 750
Total $ 41,503 $ 41,951
The Firm pledges certain of its trading assets and loans to
collateralize securities sold under agreements to repurchase,
securities loaned, other secured financings and derivatives and
to cover customer short sales. Counterparties may or may not
have the right to sell or repledge the collateral.
Pledged financial instruments that can be sold or repledged by
the secured party are identified as Trading assets (pledged to
various parties) in the balance sheets.
Fair Value of Collateral Received with Right to Sell or
Repledge
$ in millions
At
March 31,
2020
At
December 31,
2019
Collateral received with right to sell
or repledge $ 604,450 $ 679,280
Collateral that was sold or repledged1 483,708 539,412
1. Does not include securities used to meet federal regulations for the Firm’s U.S. broker-
dealers.
Segregated Securities
$ in millions
At
March 31,
2020
At
December 31,
2019
Segregated securities1 35,491 25,061
1. Securities segregated under federal regulations for the Firm’s U.S. broker-dealers are
sourced from Securities purchased under agreements to resell and Trading assets in
the balance sheets.
The Firm receives collateral in the form of securities in
connection with securities purchased under agreements to resell,
securities borrowed, securities-for-securities transactions,
derivative transactions, customer margin loans and securities-
based lending. In many cases, the Firm is permitted to sell or
repledge this collateral to secure securities sold under
agreements to repurchase, to enter into securities lending and
derivative transactions or for delivery to counterparties to cover
short positions.
Customer Margin Lending
$ in millions
At
March 31,
2020
At
December 31,
2019
Customer receivables representing margin
loans $ 26,181 $ 31,916
The Firm provides margin lending arrangements which allow
customers to borrow against the value of qualifying securities.
Receivables under margin lending arrangements are included
within Customer and other receivables in the balance sheets.
Under these agreements and transactions, the Firm receives
collateral, which includes U.S. government and agency
securities, other sovereign government obligations, corporate
and other debt, and corporate equities. Customer receivables
generated from margin lending activities are collateralized by
customer-owned securities held by the Firm. The Firm monitors
required margin levels and established credit terms daily and,
pursuant to such guidelines, requires customers to deposit
additional collateral, or reduce positions, when necessary.
For a further discussion of the Firm’s margin lending activities,
see Note 7 to the financial statements in the 2019 Form 10-K.
The Firm has additional secured liabilities. For a further
discussion of other secured financings, see Note 12.
9. Loans, Lending Commitments and Related
Allowance for Credit Losses
Loans by Type
At March 31, 2020
$ in millions
Loans Held
for Investment Loans Held
for Sale Total Loans
Corporate1 $ 61,474 $ 15,525 $ 76,999
Consumer2 31,948 — 31,948
Residential real estate 31,100 14 31,114
Commercial real estate 7,430 1,823 9,253
Total loans, before allowance 131,952 17,362 149,314
Allowance for credit losses (617) — (617)
Total loans, net $ 131,335 $ 17,362 $ 148,697
Fixed rate loans, net $ 25,155
Floating or adjustable rate loans, net 123,542
Loans to non-U.S. borrowers, net 24,633
-- 66 of 93 --
Table of Contents
Notes to Consolidated Financial Statements
(Unaudited)
March 2020 Form 10-Q 64
At December 31, 2019
$ in millions
Loans Held
for Investment Loans Held
for Sale Total Loans
Corporate1 $ 48,756 $ 10,515 $ 59,271
Consumer2 31,610 — 31,610
Residential real estate 30,184 13 30,197
Commercial real estate 7,859 2,049 9,908
Total loans, before
allowance 118,409 12,577 130,986
Allowance for credit losses (349) — (349)
Total loans, net $ 118,060 $ 12,577 $ 130,637
Fixed rate loans, net $ 22,716
Floating or adjustable rate loans, net 107,921
Loans to non-U.S. borrowers, net 21,617
1. Institutional Securities business segment Corporate loans include relationship and
event-driven loans, secured lending facilities and securities-based lending and other
loans. Wealth Management business segment Corporate loans include securities-
based and other loans, which are classified as Corporate based on the nature of the
borrowing entity or the intended use of the loan proceeds.
2. Wealth Management business segment Consumer loans include securities-based
lending and other loans.
Loans Held for Investment before Allowance by Origination
Year
At March 31, 2020
Corporate
$ in millions AA-A BBB BB Other NIG Total
Revolving
Loans $ 3,418 $ 16,474 $ 19,772 $ 8,193 $ 47,857
2020 YTD 122 671 456 23 1,272
2019 631 1,234 1,940 444 4,249
2018 37 2,083 1,096 493 3,709
2017 358 639 500 82 1,579
2016 74 547 505 60 1,186
Prior 641 311 595 75 1,622
Total $ 5,281 $ 21,959 $ 24,864 $ 9,370 $ 61,474
At March 31, 2020
$ in millions Consumer1
Revolving Loans $ 31,362
2020 YTD 62
2019 382
2018 —
2017 16
2016 57
Prior 69
Total $ 31,948
1. Consumer loans primarily comprise securities-based loans, which are subject to
collateral maintenance provisions, and at March 31, 2020, these loans are
predominantly over-collateralized. For more information on the ACL methodology
related to Consumer loans, see Note 2.
At March 31, 2020
Residential Real Estate
by FICO Scores by LTV Ratio
Total $ in millions 680-739 > 80%
Revolving
Loans $ 103 $ 40 $ 6 $ 149 $ — $ 149
2020 YTD 1,865 369 35 2,143 126 2,269
2019 6,239 1,397 179 7,290 525 7,815
2018 2,699 770 90 3,277 282 3,559
2017 3,248 817 116 3,882 299 4,181
2016 3,924 1,074 152 4,804 346 5,150
Prior 5,659 1,963 355 7,101 876 7,977
Total $ 23,737 $ 6,430 $ 933 $ 28,646 $ 2,454 $ 31,100
At March 31, 2020
Commercial Real Estate
$ in millions AA-A BBB BB Other NIG Total
Revolving
Loans $ 5 $ — $ — $ — $ 5
2020 YTD — — 167 23 190
2019 — 539 2,056 360 2,955
2018 10 723 764 421 1,918
2017 — 217 577 344 1,138
2016 134 100 352 172 758
Prior 10 — 285 171 466
Total $ 159 $ 1,579 $ 4,201 $ 1,491 $ 7,430
YTD–Year to date
Past Due Status of Loans Held for Investment before Allowance
At March 31, 2020
$ in millions Corporate Consumer Residential
Real Estate Commercial
Real Estate
Current $ 61,466 $ 31,948 $ 30,883 $ 7,430
Past due1 8 — 217 —
Total $ 61,474 $ 31,948 $ 31,100 $ 7,430
1. The majority of the amounts are less than 60 days past due as of March 31, 2020.
See Note 2 for a description of the ACL calculated under the
CECL methodology, including credit quality indicators, used
for HFI loans beginning in 2020.
Loans Held for Investment before Allowance1
At December 31, 2019
$ in millions Corporate Consumer Residential
Real Estate Commercial
Real Estate Total
Pass $ 47,681 $ 31,605 $ 30,060 $ 7,664 $117,010
Special
mention 464 — 28 3 495
Substandard 605 5 96 192 898
Doubtful 6 — — — 6
Total $ 48,756 $ 31,610 $ 30,184 $ 7,859 $118,409
1. There were no loans held for investment considered Loss as of December 31, 2019.
-- 67 of 93 --
Table of Contents
Notes to Consolidated Financial Statements
(Unaudited)
65 March 2020 Form 10-Q
Impaired Loans and Lending Commitments before Allowance
At December 31, 2019
$ in millions Corporate Consumer Residential
Real Estate Commercial
Real Estate Total
Loans
With allowance $ 268 $ — $ — $ 85 $ 353
Without
allowance1 32 5 87 — 124
Total impaired
loans $ 300 $ 5 $ 87 $ 85 $ 477
UPB 309 5 90 85 489
Lending commitments
With allowance $ 4 $ — $ — $ 14 $ 18
Without
allowance1 32 — — — 32
Total impaired
lending
commitments $ 36 $ — $ — $ 14 $ 50
1. No allowance was recorded for these loans and lending commitments as the present
value of the expected future cash flows or value of the collateral equaled or exceeded
the carrying value.
Loans and lending commitments in the previous table were
evaluated for a specific allowance. All remaining loans and
lending commitments were assessed under the inherent
allowance methodology.
Impaired Loans before Allowance and Total Allowance by
Region
At December 31, 2019
$ in millions Americas EMEA Asia Total
Impaired loans $ 392 $ 85 $ — $ 477
Total Allowance for credit
losses 270 76 3 349
Troubled Debt Restructurings
$ in millions
At
March 31,
2020
At
December 31,
2019
Loans, before allowance $ 132 $ 92
Lending commitments 33 32
Allowance for credit losses on
Loans and Lending commitments 26 16
Troubled debt restructurings typically include modifications of
interest rates, collateral requirements, other loan covenants and
payment extensions. As of December 31, 2019, impaired loans
and lending commitments classified as held for investment
within corporate loans include TDRs. See Note 2 for further
information on TDR guidance issued by Congress in the CARES
Act as well as by the U.S. banking agencies.
For a discussion of the Firm’s ACL methodology under the prior
incurred loss model, including credit quality indicators, used for
HFI loans as of December 31, 2019, and a further discussion of
the Firm's loans, including loan types and categories, see Notes
2 and 8 in the 2019 Form 10-K.
Allowance for Credit Losses Rollforward—Loans
$ in millions Corporate Consumer Residential
Real Estate Commercial
Real Estate Total
December 31,
2019 $ 241 $ 8 $ 25 $ 75 $ 349
Effect of CECL
adoption (31) (6) 21 25 9
Gross charge-offs (32) — — — (32)
Provision
(release) 215 1 1 75 292
Other — — — (1) (1)
March 31, 2020 $ 393 $ 3 $ 47 $ 174 $ 617
$ in millions Corporate Consumer Residential
Real Estate Commercial
Real Estate Total
December 31,
2018 $ 144 $ 7 $ 20 $ 67 $ 238
Provision
(release) 26 (1) 2 — 27
Other (6) — — — (6)
March 31, 2019 $ 164 $ 6 $ 22 $ 67 $ 259
Inherent $ 150 $ 6 $ 22 $ 67 $ 245
Specific 14 — — — 14
Allowance for Credit Losses Rollforward—Lending
Commitments
$ in millions Corporate Consumer Residential
Real Estate Commercial
Real Estate Total
December 31,
2019 $ 232 $ 2 $ — $ 7 $ 241
Effect of CECL
adoption (53) (1) 3 1 (50)
Provision
(release) 110 — — 5 115
Other (1) — — (1) (2)
March 31, 2020 $ 288 $ 1 $ 3 $ 12 $ 304
$ in millions Corporate Consumer Residential
Real Estate Commercial
Real Estate Total
December 31,
2018 $ 198 $ 2 $ — $ 3 $ 203
Provision
(release) 8 — — 1 9
Other — (1) — — (1)
March 31, 2019 $ 206 $ 1 $ — $ 4 $ 211
Inherent $ 202 $ 1 $ — $ 4 $ 207
Specific 4 — — — 4
The aggregate allowance for loans and lending commitments
increased in the current quarter, principally reflecting a
provision for credit losses within the Institutional Securities
business segment resulting from the economic impact of
COVID-19. This provision was primarily the result of higher
actual and expected future downgrades, an increase in funded
balances, principally in Corporate relationship and event-driven
loans, as well as revisions to our forecasts in light of current and
expected future market and macroeconomic conditions. For a
further discussion of the Firm’s loans, including loan types and
categories, as well as the Firm’s allowance methodology prior
to the adoption of CECL, refer to Notes 2 and 8 to the financial
statements in the 2019 Form 10-K. See Note 4 for further
-- 68 of 93 --
Table of Contents
Notes to Consolidated Financial Statements
(Unaudited)
March 2020 Form 10-Q 66
information regarding Loans and lending commitments held at
fair value. See Note 13 for details of current commitments to
lend in the future.
Employee Loans
$ in millions
At
March 31,
2020
At
December 31,
2019
Currently employed by the Firm1 $ 2,867 N/A
No longer employed by the Firm2 150 N/A
Balance $ 3,017 $ 2,980
Allowance for credit losses3 (180) (61)
Balance, net $ 2,837 $ 2,919
Remaining repayment term,
weighted average in years 5.0 4.8
1. These loans are predominantly current.
2. These loans are predominantly past due for a period of 90 days or more.
3. The change in Allowance for credit losses includes a $124 million increase due to the
adoption of CECL in the first quarter of 2020.
Employee loans are granted in conjunction with a program
established primarily to recruit certain Wealth Management
representatives, are full recourse and generally require periodic
repayments, and are due in full upon termination of employment
with the Firm. These loans are recorded in Customer and other
receivables in the balance sheets. The allowance for credit losses
as of March 31, 2020 was calculated under the CECL
methodology, while the allowance for credit losses at December
31, 2019 was calculated under the prior incurred loss model.
The related provision is recorded in Compensation and benefits
expense in the income statements. See Note 2 for a description
of the CECL allowance methodology, including credit quality
indicators, for employee loans.
-- 69 of 93 --
Table of Contents
Notes to Consolidated Financial Statements
(Unaudited)
67 March 2020 Form 10-Q
10. Other Assets—Equity Method Investments
Equity Method Investments
$ in millions
At
March 31,
2020
At
December 31,
2019
Investments $ 2,413 $ 2,363
Three Months Ended
March 31,
$ in millions 2020 2019
Income (loss) $ 29 $ (10)
Equity method investments, other than investments in certain
fund interests, are summarized above and are included in Other
assets in the balance sheets with related income or loss included
in Other revenues in the income statements. See “Net Asset
Value Measurements—Fund Interests” in Note 4 for the carrying
value of certain of the Firm’s fund interests, which are comprised
of general and limited partnership interests, as well as any related
carried interest.
Japanese Securities Joint Venture
Three Months Ended
March 31,
$ in millions 2020 2019
Income (loss) from investment in MUMSS $ 32 $ 3
The Firm and Mitsubishi UFJ Financial Group, Inc. (“MUFG”)
formed a joint venture in Japan comprising their respective
investment banking and securities businesses by forming two
joint venture companies, Mitsubishi UFJ Morgan Stanley
Securities Co., Ltd. (“MUMSS”) and Morgan Stanley MUFG
Securities Co., Ltd. (“MSMS”) (the “Joint Venture”). The Firm
owns a 40% economic interest in the Joint Venture and MUFG
owns the other 60%.
The Firm’s 40% voting interest in MUMSS is accounted for
under the equity method within the Institutional Securities
business segment, and is included in the equity method
investment balances above. The Firm consolidates MSMS into
the Institutional Securities business segment, based on its 51%
voting interest.
The Firm engages in transactions in the ordinary course of
business with MUFG and its affiliates, for example investment
banking, financial advisory, sales and trading, derivatives,
investment management, lending, securitization and other
financial services transactions. Such transactions are on
substantially the same terms as those that would be available to
unrelated third parties for comparable transactions.
11. Deposits
Deposits
$ in millions
At
March 31,
2020
At
December 31,
2019
Savings and demand deposits $ 188,504 $ 149,465
Time deposits 46,735 40,891
Total $ 235,239 $ 190,356
Deposits subject to FDIC
insurance $ 176,034 $ 149,966
Time deposits that equal or
exceed the FDIC insurance limit $ 12 $ 12
Time Deposit Maturities
$ in millions
At
March 31,
2020
2020 $ 16,656
2021 16,836
2022 4,883
2023 4,070
2024 2,788
Thereafter 1,502
Total $ 46,735
12. Borrowings and Other Secured Financings
Borrowings
$ in millions
At
March 31,
2020
At
December 31,
2019
Original maturities of one year or
less $ 2,211 $ 2,567
Original maturities greater than one year
Senior $ 181,477 $ 179,519
Subordinated 11,168 10,541
Total $ 192,645 $ 190,060
Total borrowings $ 194,856 $ 192,627
Weighted average stated maturity,
in years1 7.6 6.9
1. Only includes borrowings with original maturities greater than one year.
-- 70 of 93 --
Table of Contents
Notes to Consolidated Financial Statements
(Unaudited)
March 2020 Form 10-Q 68
Other Secured Financings
$ in millions
At
March 31,
2020
At
December 31,
2019
Original maturities:
One year or less $ 7,304 $ 7,103
Greater than one year 4,682 6,480
Transfers of assets accounted for as
secured financings 1,072 1,115
Total $ 13,058 $ 14,698
Other secured financings include the liabilities related to certain
ELNs, transfers of financial assets that are accounted for as
financings rather than sales, pledged commodities, consolidated
VIEs where the Firm is deemed to be the primary beneficiary
and other secured borrowings. These liabilities are generally
payable from the cash flows of the related assets accounted for
as Trading assets. See Note 14 for further information on other
secured financings related to VIEs and securitization activities.
For transfers of assets that fail to meet accounting criteria for a
sale, the Firm continues to record the assets and recognizes the
associated liabilities in the balance sheets.
13. Commitments, Guarantees and Contingencies
Commitments
Years to Maturity at March 31, 2020
$ in millions
Less
than 1 1-3 3-5 Over 5 Total
Lending:
Corporate $ 23,055 $28,998 $41,269 $ 3,174 $ 96,496
Consumer 8,112 23 3 — 8,138
Residential and
commercial
real estate 163 1,179 49 252 1,643
Forward-starting
secured financing
receivables 80,666 219 — — 80,885
Central
counterparty1 300 — — 12,344 12,644
Underwriting 206 — — — 206
Investment activities 992 226 58 265 1,541
Letters of credit and
other financial
guarantees 174 2 — 2 178
Total $113,668 $30,647 $41,379 $16,037 $ 201,731
Corporate lending commitments participated to third parties $ 7,226
Forward-starting secured financing receivables settled within
three business days $ 71,096
1. Beginning in the first quarter of 2020, commitments to central counterparties are
presented separately; these commitments were previously included in Corporate
Lending commitments and Forward-starting secured financing receivables depending
on the type of agreement. These commitments relate to the Firm's membership in
certain clearinghouses and are contingent upon the default of a clearinghouse member
or other stress events.
Since commitments associated with these instruments may
expire unused, the amounts shown do not necessarily reflect the
actual future cash funding requirements.
For a further description of these commitments, refer to Note
13 to the financial statements in the 2019 Form 10-K.
Guarantees
Maximum Potential Payout/Notional of Obligations under
Guarantee Arrangements
Years to Maturity at March 31, 2020
$ in millions Less than 1 1-3 3-5 Over 5 Total
Credit derivatives $ 33,900 $ 38,934 $136,167 $ 68,581 $ 277,582
Other credit contracts — — — 107 107
Non-credit derivatives 1,571,566 1,474,498 902,550 769,204 4,717,818
Standby letters of
credit and other
financial guarantees
issued1 1,200 1,006 1,301 3,840 7,347
Market value
guarantees 102 35 — — 137
Liquidity facilities 4,047 — — — 4,047
Whole loan sales
guarantees — — 2 23,193 23,195
Securitization
representations and
warranties — — — 68,881 68,881
General partner
guarantees 59 137 12 92 300
Client clearing
guarantees 17 — — — 17
$ in millions
Carrying
Amount
Asset
(Liability)
Credit derivatives2 $ (9,855)
Other credit contracts (4)
Non-credit derivatives2 (146,854)
Standby letters of credit and other financial guarantees issued1 111
Market value guarantees —
Liquidity facilities 6
Whole loan sales guarantees —
Securitization representations and warranties3 (42)
General partner guarantees (62)
Client clearing guarantees —
1. These amounts include certain issued standby letters of credit participated to third
parties, totaling $0.7 billion of notional and collateral/recourse, due to the nature of
the Firm’s obligations under these arrangements. As of March 31, 2020, the carrying
amount of standby letters of credit and other financial guarantees issued includes an
allowance for credit losses of $57 million.
2. The carrying amounts of derivative contracts that meet the accounting definition of a
guarantee are shown on a gross basis. For further information on derivatives contracts,
see Note 6.
3. Primarily related to residential mortgage securitizations.
The Firm has obligations under certain guarantee arrangements,
including contracts and indemnification agreements, that
contingently require the Firm to make payments to the
guaranteed party based on changes in an underlying measure
(such as an interest or foreign exchange rate, security or
commodity price, an index, or the occurrence or non-occurrence
of a specified event) related to an asset, liability or equity
security of a guaranteed party. Also included as guarantees are
-- 71 of 93 --
Table of Contents
Notes to Consolidated Financial Statements
(Unaudited)
69 March 2020 Form 10-Q
contracts that contingently require the Firm to make payments
to the guaranteed party based on another entity’s failure to
perform under an agreement, as well as indirect guarantees of
the indebtedness of others.
Client Clearing Guarantees. In the first quarter of 2020, FICC’s
sponsored clearing model was updated such that the Firm could
be responsible for liquidation of a sponsored member’s account
and guarantees any resulting loss to the FICC in the event the
sponsored member fails to fully pay any net liquidation amount
due from the sponsored member to the FICC. Accordingly, the
Firm’s maximum potential payout amount as of March 31, 2020
reflects the total of the estimated net liquidation amounts for
sponsored member accounts.
For more information on the nature of the obligations and related
business activities for our guarantees, see Note 13 to the
financial statements in the 2019 Form 10-K.
Other Guarantees and Indemnities
In the normal course of business, the Firm provides guarantees
and indemnifications in a variety of transactions. These
provisions generally are standard contractual terms. Certain of
these guarantees and indemnifications related to indemnities,
exchange and clearinghouse member guarantees and merger and
acquisition guarantees are described in Note 13 to the financial
statements in the 2019 Form 10-K.
In addition, in the ordinary course of business, the Firm
guarantees the debt and/or certain trading obligations (including
obligations associated with derivatives, foreign exchange
contracts and the settlement of physical commodities) of certain
subsidiaries. These guarantees generally are entity or product
specific and are required by investors or trading counterparties.
The activities of the Firm’s subsidiaries covered by these
guarantees (including any related debt or trading obligations)
are included in the financial statements.
Finance Subsidiary
The Parent Company fully and unconditionally guarantees the
securities issued by Morgan Stanley Finance LLC, a wholly
owned finance subsidiary.
Contingencies
Legal
In addition to the matters described in the following paragraphs,
in the normal course of business, the Firm has been named, from
time to time, as a defendant in various legal actions, including
arbitrations, class actions and other litigation, arising in
connection with its activities as a global diversified financial
services institution. Certain of the actual or threatened legal
actions include claims for substantial compensatory and/or
punitive damages or claims for indeterminate amounts of
damages. In some cases, the entities that would otherwise be the
primary defendants in such cases are bankrupt or are in financial
distress. These actions have included, but are not limited to,
residential mortgage and credit crisis-related matters.
While the Firm has identified below any individual proceedings
where the Firm believes a material loss to be reasonably possible
and reasonably estimable, there can be no assurance that material
losses will not be incurred from claims that have not yet been
asserted or are not yet determined to be probable or possible and
reasonably estimable losses.
The Firm contests liability and/or the amount of damages as
appropriate in each pending matter. Where available
information indicates that it is probable a liability had been
incurred at the date of the financial statements and the Firm can
reasonably estimate the amount of that loss, the Firm accrues
the estimated loss by a charge to income.
In many proceedings and investigations, however, it is
inherently difficult to determine whether any loss is probable or
even possible or to estimate the amount of any loss. In addition,
even where a loss is possible or an exposure to loss exists in
excess of the liability already accrued with respect to a
previously recognized loss contingency, it is not always possible
to reasonably estimate the size of the possible loss or range of
loss.
For certain legal proceedings and investigations, the Firm cannot
reasonably estimate such losses, particularly for proceedings
and investigations where the factual record is being developed
or contested or where plaintiffs or government entities seek
substantial or indeterminate damages, restitution, disgorgement
or penalties. Numerous issues may need to be resolved,
including through potentially lengthy discovery and
determination of important factual matters, determination of
issues related to class certification and the calculation of
damages or other relief, and by addressing novel or unsettled
legal questions relevant to the proceedings or investigations in
question, before a loss or additional loss or range of loss or
additional range of loss can be reasonably estimated for a
proceeding or investigation.
For certain other legal proceedings and investigations, the Firm
can estimate reasonably possible losses, additional losses,
ranges of loss or ranges of additional loss in excess of amounts
accrued but does not believe, based on current knowledge and
after consultation with counsel, that such losses will have a
material adverse effect on the Firm’s financial statements as a
whole, other than the matters referred to in the following
paragraphs.
On July 15, 2010, China Development Industrial Bank
(“CDIB”) filed a complaint against the Firm, styled China
Development Industrial Bank v. Morgan Stanley & Co.
Incorporated et al., which is pending in the Supreme Court of
the State of New York, New York County (“Supreme Court of
-- 72 of 93 --
Table of Contents
Notes to Consolidated Financial Statements
(Unaudited)
March 2020 Form 10-Q 70
NY”). The complaint relates to a $275 million CDS referencing
the super senior portion of the STACK 2006-1 CDO. The
complaint asserts claims for common law fraud, fraudulent
inducement and fraudulent concealment and alleges that the
Firm misrepresented the risks of the STACK 2006-1 CDO to
CDIB, and that the Firm knew that the assets backing the CDO
were of poor quality when it entered into the CDS with CDIB.
The complaint seeks compensatory damages related to the
approximately $228 million that CDIB alleges it has already lost
under the CDS, rescission of CDIB’s obligation to pay an
additional $12 million, punitive damages, equitable relief, fees
and costs. On February 28, 2011, the court denied the Firm’s
motion to dismiss the complaint. On December 21, 2018, the
court denied the Firm’s motion for summary judgment and
granted in part the Firm’s motion for sanctions relating to
spoliation of evidence. On January 24, 2019, CDIB filed a notice
of appeal from the court’s December 21, 2018 order, and on
January 25, 2019, the Firm filed a notice of appeal from the same
order. On March 7, 2019, the court denied the relief that CDIB
sought in a motion to clarify and resettle the portion of the court’s
December 21, 2018 order granting spoliation sanctions. On
December 5, 2019, the Appellate Division, First Department
(“First Department”) heard the parties’ cross appeals. Based on
currently available information, the Firm believes it could incur
a loss in this action of up to approximately $240 million plus
pre- and post-judgment interest, fees and costs.
On July 8, 2013, U.S. Bank National Association, in its capacity
as trustee, filed a complaint against the Firm styled U.S. Bank
National Association, solely in its capacity as Trustee of the
Morgan Stanley Mortgage Loan Trust 2007-2AX (MSM
2007-2AX) v. Morgan Stanley Mortgage Capital Holdings LLC,
Successor-by-Merger to Morgan Stanley Mortgage Capital Inc.
and GreenPoint Mortgage Funding, Inc., pending in the
Supreme Court of NY. The complaint asserts claims for breach
of contract and alleges, among other things, that the loans in the
trust, which had an original principal balance of approximately
$650 million, breached various representations and warranties.
The complaint seeks, among other relief, specific performance
of the loan breach remedy procedures in the transaction
documents, unspecified damages and interest. On
November 24, 2014, the court granted in part and denied in part
the Firm’s motion to dismiss the complaint. On April 4, 2019,
the court denied the Firm’s motion to renew its motion to
dismiss. Based on currently available information, the Firm
believes that it could incur a loss in this action of up to
approximately $240 million, the total original unpaid balance
of the mortgage loans for which the Firm received repurchase
demands that it did not repurchase, plus pre- and post-judgment
interest, fees and costs, but plaintiff is seeking to expand the
number of loans at issue and the possible range of loss could
increase.
On September 23, 2014, Financial Guaranty Insurance
Company (“FGIC”) filed a complaint against the Firm in the
Supreme Court of NY styled Financial Guaranty Insurance
Company v. Morgan Stanley ABS Capital I Inc. et al. relating to
the Morgan Stanley ABS Capital I Inc. Trust 2007-NC4. The
complaint asserts claims for breach of contract and fraudulent
inducement and alleges, among other things, that the loans in
the trust breached various representations and warranties and
defendants made untrue statements and material omissions to
induce FGIC to issue a financial guaranty policy on certain
classes of certificates that had an original balance of
approximately $876 million. The complaint seeks, among other
relief, specific performance of the loan breach remedy
procedures in the transaction documents, compensatory,
consequential and punitive damages, attorneys’ fees and
interest. On January 23, 2017, the court denied the Firm’s motion
to dismiss the complaint. On September 13, 2018, the First
Department affirmed in part and reversed in part the lower
court’s order denying the Firm’s motion to dismiss. On
December 20, 2018, the First Department denied plaintiff’s
motion for leave to appeal its decision to the New York Court
of Appeals ("Court of Appeals") or, in the alternative, for re-
argument. Based on currently available information, the Firm
believes that it could incur a loss in this action of up to
approximately $277 million, the total original unpaid balance
of the mortgage loans for which the Firm received repurchase
demands from a certificate holder and FGIC that the Firm did
not repurchase, plus pre- and post- judgment interest, fees and
costs, as well as claim payments that FGIC has made and will
make in the future. In addition, plaintiff is seeking to expand the
number of loans at issue and the possible range of loss could
increase.
On January 23, 2015, Deutsche Bank National Trust Company,
in its capacity as trustee, filed a complaint against the Firm styled
Deutsche Bank National Trust Company solely in its capacity
as Trustee of the Morgan Stanley ABS Capital I Inc. Trust 2007-
NC4 v. Morgan Stanley Mortgage Capital Holdings LLC as
Successor-by-Merger to Morgan Stanley Mortgage Capital Inc.,
and Morgan Stanley ABS Capital I Inc., pending in the Supreme
Court of NY. The complaint asserts claims for breach of contract
and alleges, among other things, that the loans in the trust, which
had an original principal balance of approximately $1.05 billion,
breached various representations and warranties. The complaint
seeks, among other relief, specific performance of the loan
breach remedy procedures in the transaction documents,
compensatory, consequential, rescissory, equitable and punitive
damages, attorneys’ fees, costs and other related expenses, and
interest. On December 11, 2015, the court granted in part and
denied in part the Firm’s motion to dismiss the complaint. On
October 19, 2018, the court granted the Firm’s motion for leave
to amend its answer and to stay the case pending resolution of
Deutsche Bank National Trust Company’s appeal to the Court
of Appeals in another case, styled Deutsche Bank National Trust
Company v. Barclays Bank PLC, regarding the applicable statute
of limitations. On January 17, 2019, the First Department
reversed the trial court’s order to the extent that it had granted
in part the Firm’s motion to dismiss the complaint. On June 4,
2019, the First Department granted the Firm’s motion for leave
-- 73 of 93 --
Table of Contents
Notes to Consolidated Financial Statements
(Unaudited)
71 March 2020 Form 10-Q
to appeal to the Court of Appeals. On March 19, 2020, the Firm
filed a motion for partial summary judgment. Based on currently
available information, the Firm believes that it could incur a loss
in this action of up to approximately $277 million, the total
original unpaid balance of the mortgage loans for which the Firm
received repurchase demands from a certificate holder and a
monoline insurer that the Firm did not repurchase, plus pre- and
post-judgment interest, fees and costs, but plaintiff is seeking to
expand the number of loans at issue and the possible range of
loss could increase.
Tax
In matters styled Case number 15/3637 and Case number
15/4353, the Dutch Tax Authority (“Dutch Authority”) has
challenged, in the District Court in Amsterdam, the prior set-off
by the Firm of approximately €124 million (approximately $137
million) plus accrued interest of withholding tax credits against
the Firm’s corporation tax liabilities for the tax years 2007 to
2013. The Dutch Authority alleges that the Firm was not entitled
to receive the withholding tax credits on the basis, inter alia, that
a Firm subsidiary did not hold legal title to certain securities
subject to withholding tax on the relevant dates. The Dutch
Authority has also alleged that the Firm failed to provide certain
information to the Dutch Authority and keep adequate books
and records. On April 26, 2018, the District Court in Amsterdam
issued a decision dismissing the Dutch Authority’s claims. On
June 4, 2018, the Dutch Authority filed an appeal before the
Court of Appeal in Amsterdam in matters re-styled Case number
18/00318 and Case number 18/00319. On June 26 and July 2,
2019, a hearing of the Dutch Authority’s appeal was held. Based
on currently available information, the Firm believes that it
could incur a loss in this action of up to approximately €124
million (approximately $137 million) plus accrued interest.
14. Variable Interest Entities and Securitization
Activities
Consolidated VIE Assets and Liabilities by Type of Activity
At March 31, 2020 At December 31, 2019
$ in millions VIE Assets VIE Liabilities VIE Assets VIE Liabilities
OSF $ 728 $ 415 $ 696 $ 391
MABS1 368 108 265 4
Other2 934 44 987 66
Total $ 2,030 $ 567 $ 1,948 $ 461
OSF—Other structured financings
1. Amounts include transactions backed by residential mortgage loans, commercial
mortgage loans and other types of assets, including consumer or commercial assets
and may be in loan or security form. The value of assets is determined based on the
fair value of the liabilities and the interests owned by the Firm in such VIEs as the fair
values for the liabilities and interests owned are more observable.
2. Other primarily includes operating entities, investment funds and structured
transactions.
Consolidated VIE Assets and Liabilities by Balance Sheet
Caption
$ in millions
At
March 31,
2020
At
December 31,
2019
Assets
Cash and cash equivalents $ 328 $ 488
Trading assets at fair value 1,234 943
Customer and other receivables 16 18
Intangible assets 107 111
Other assets 345 388
Total $ 2,030 $ 1,948
Liabilities
Other secured financings $ 519 $ 422
Other liabilities and accrued expenses 48 39
Total $ 567 $ 461
Noncontrolling interests $ 245 $ 192
Consolidated VIE assets and liabilities are presented in the
previous tables after intercompany eliminations. Generally,
most assets owned by consolidated VIEs cannot be removed
unilaterally by the Firm and are not available to the Firm while
the related liabilities issued by consolidated VIEs are non-
recourse to the Firm. However, in certain consolidated VIEs,
the Firm either has the unilateral right to remove assets or
provides additional recourse through derivatives such as total
return swaps, guarantees or other forms of involvement.
In general, the Firm’s exposure to loss in consolidated VIEs is
limited to losses that would be absorbed on the VIE net assets
recognized in its financial statements, net of amounts absorbed
by third-party variable interest holders.
-- 74 of 93 --
Table of Contents
Notes to Consolidated Financial Statements
(Unaudited)
March 2020 Form 10-Q 72
Non-consolidated VIEs
At March 31, 2020
$ in millions MABS1 CDO MTOB OSF Other2
VIE assets (UPB) $ 124,211 $ 1,881 $ 6,585 $ 2,263 $ 51,280
Maximum exposure to loss3
Debt and equity
interests $ 15,173 $ 254 $ 277 $ 1,086 $ 10,468
Derivative and other
contracts — — 4,047 — 3,659
Commitments,
guarantees and other 572 — — — 334
Total $ 15,745 $ 254 $ 4,324 $ 1,086 $ 14,461
Carrying value of variable interests—Assets
Debt and equity
interests $ 15,173 $ 254 $ 277 $ 1,084 $ 10,468
Derivative and other
contracts — — 6 — 835
Total $ 15,173 $ 254 $ 283 $ 1,084 $ 11,303
Additional VIE assets owned4 $ 11,024
Carrying value of variable interests—Liabilities
Derivative and other
contracts $ — $ — $ — $ — $ 272
At December 31, 2019
$ in millions MABS1 CDO MTOB OSF Other2
VIE assets (UPB) $ 125,603 $ 2,976 $ 6,965 $ 2,288 $ 51,305
Maximum exposure to loss3
Debt and equity
interests $ 16,314 $ 240 $ — $ 1,009 $ 11,977
Derivative and other
contracts — — 4,599 — 2,995
Commitments,
guarantees and other 631 — — — 266
Total $ 16,945 $ 240 $ 4,599 $ 1,009 $ 15,238
Carrying value of variable interests–Assets
Debt and equity
interests $ 16,314 $ 240 $ — $ 1,008 $ 11,977
Derivative and other
contracts — — 6 — 388
Total $ 16,314 $ 240 $ 6 $ 1,008 $ 12,365
Additional VIE assets owned4 $ 11,453
Carrying value of variable interests—Liabilities
Derivative and other
contracts $ — $ — $ — $ — $ 444
MTOB—Municipal tender option bonds
1. Amounts include transactions backed by residential mortgage loans, commercial
mortgage loans and other types of assets, including consumer or commercial assets.
and may be in loan or security form.
2. Other primarily includes exposures to commercial real estate property and investment
funds.
3. Where notional amounts are utilized in quantifying the maximum exposure related to
derivatives, such amounts do not reflect changes in fair value recorded by the Firm.
4. Additional VIE assets owned represents the carrying value of total exposure to non-
consolidated VIEs for which the maximum exposure to loss is less than specific
thresholds, primarily interests issued by securitization SPEs. The Firm’s primary risk
exposure is to the most subordinate class of beneficial interest and maximum exposure
to loss generally equals the fair value of the assets owned. These assets are primarily
included in Trading assets and Investment securities and are measured at fair value
(see Note 3). The Firm does not provide additional support in these transactions
through contractual facilities, guarantees or similar derivatives.
The majority of the VIEs included in the previous tables are
sponsored by unrelated parties; examples of the Firm’s
involvement with these VIEs include its secondary market-
making activities and the securities held in its Investment
securities portfolio (see Note 7).
The Firm’s maximum exposure to loss is dependent on the nature
of the Firm’s variable interest in the VIE and is limited to the
notional amounts of certain liquidity facilities and other credit
support, total return swaps and written put options, as well as
the fair value of certain other derivatives and investments the
Firm has made in the VIE.
The Firm’s maximum exposure to loss in the previous tables
does not include the offsetting benefit of hedges or any
reductions associated with the amount of collateral held as part
of a transaction with the VIE or any party to the VIE directly
against a specific exposure to loss.
Liabilities issued by VIEs generally are non-recourse to the
Firm.
Detail of Mortgage- and Asset-Backed Securitization Assets
At March 31, 2020 At December 31, 2019
$ in millions UPB
Debt and
Equity
Interests UPB
Debt and
Equity
Interests
Residential mortgages $ 20,460 $ 3,298 $ 30,353 $ 3,993
Commercial mortgages 52,672 3,677 53,892 3,881
U.S. agency
collateralized mortgage
obligations 45,958 6,257 36,366 6,365
Other consumer or
commercial loans 5,121 1,941 4,992 2,075
Total $ 124,211 $ 15,173 $ 125,603 $ 16,314
Transferred Assets with Continuing Involvement1
At March 31, 2020
$ in millions RML CML U.S. Agency
CMO CLN and
Other3
SPE assets (UPB)4 $ 9,501 $ 79,516 $ 15,480 $ 11,109
Retained interests
Investment grade $ 26 $ 780 $ 763 $ —
Non-investment grade 13 238 — 87
Total $ 39 $ 1,018 $ 763 $ 87
Interests purchased in the secondary market
Investment grade $ — $ 65 $ 78 $ —
Non-investment grade 29 68 — —
Total $ 29 $ 133 $ 78 $ —
Derivative assets $ — $ — $ — $ 830
Derivative liabilities — — — 186
-- 75 of 93 --
Table of Contents
Notes to Consolidated Financial Statements
(Unaudited)
73 March 2020 Form 10-Q
At December 31, 20192
$ in millions RML CML U.S. Agency
CMO CLN and
Other3
SPE assets (UPB)4 $ 9,850 $ 86,203 $ 19,132 $ 8,410
Retained interests
Investment grade $ 29 $ 720 $ 2,376 $ 1
Non-investment grade 17 254 — 92
Total $ 46 $ 974 $ 2,376 $ 93
Interests purchased in the secondary market
Investment grade $ 6 $ 197 $ 77 $ —
Non-investment grade 75 51 — —
Total $ 81 $ 248 $ 77 $ —
Derivative assets $ — $ — $ — $ 339
Derivative liabilities — — — 145
Fair Value At March 31, 2020
$ in millions Level 2 Level 3 Total
Retained interests
Investment grade $ 790 $ — $ 790
Non-investment grade 7 83 90
Total $ 797 $ 83 $ 880
Interests purchased in the secondary market
Investment grade $ 141 $ 2 $ 143
Non-investment grade 85 12 97
Total $ 226 $ 14 $ 240
Derivative assets $ 820 $ 10 $ 830
Derivative liabilities 185 1 186
Fair Value at December 31, 2019
$ in millions Level 2 Level 3 Total
Retained interests
Investment grade $ 2,401 $ 4 $ 2,405
Non-investment grade 6 97 103
Total $ 2,407 $ 101 $ 2,508
Interests purchased in the secondary market
Investment grade $ 278 $ 2 $ 280
Non-investment grade 68 58 126
Total $ 346 $ 60 $ 406
Derivative assets $ 337 $ 2 $ 339
Derivative liabilities 144 1 145
RML—Residential mortgage loans
CML—Commercial mortgage loans
1. The Transferred Assets with Continuing Involvement tables include transactions with
SPEs in which the Firm, acting as principal, transferred financial assets with
continuing involvement and received sales treatment.
2. As permitted by applicable guidance, certain transfers of assets where the Firm’s
only continuing involvement is a derivative are only reported in the following Assets
Sold with Retained Exposure table.
3. Amounts include CLO transactions managed by unrelated third parties.
4. Amounts include assets transferred by unrelated transferors.
Transferred assets are carried at fair value prior to securitization,
and any changes in fair value are recognized in the income
statements. The Firm may act as underwriter of the beneficial
interests issued by these securitization vehicles, for which
Investment banking revenues are recognized. The Firm may
retain interests in the securitized financial assets as one or more
tranches of the securitization. These retained interests are
generally carried at fair value in the balance sheets with changes
in fair value recognized in the income statements. Fair value for
these interests is measured using techniques that are consistent
with the valuation techniques applied to the Firm’s major
categories of assets and liabilities as described in Note 2 in the
2019 Form 10-K and Note 4 herein.
Proceeds from New Securitization Transactions and Sales of
Loans
Three Months Ended
March 31,
$ in millions 2020 2019
New transactions1 $ 8,471 $ 4,733
Retained interests 4,088 2,887
Sales of corporate loans to CLO SPEs1, 2 66 —
1. Net gains on new transactions and sales of corporate loans to CLO entities at the time
of the sale were not material for all periods presented.
2. Sponsored by non-affiliates.
The Firm has provided, or otherwise agreed to be responsible
for, representations and warranties regarding certain assets
transferred in securitization transactions sponsored by the Firm
(see Note 13).
Assets Sold with Retained Exposure
$ in millions
At
March 31,
2020
At
December 31,
2019
Gross cash proceeds from sale of assets1 $ 28,213 $ 38,661
Fair value
Assets sold $ 28,068 $ 39,137
Derivative assets recognized
in the balance sheets 862 647
Derivative liabilities recognized
in the balance sheets 1,004 152
1. The carrying value of assets derecognized at the time of sale approximates gross
cash proceeds.
The Firm enters into transactions in which it sells securities,
primarily equities and contemporaneously enters into bilateral
OTC derivatives with the purchasers of the securities, through
which it retains exposure to the sold securities.
For a discussion of the Firm’s VIEs, the determination and
structure of VIEs and securitization activities, see Note 14 to
the financial statements in the 2019 Form 10-K.
15. Regulatory Requirements
Regulatory Capital Framework and Requirements
For a discussion of the Firm’s regulatory capital framework, see
Note 15 to the financial statements in the 2019 Form 10-K.
The Firm is required to maintain minimum risk-based and
leverage-based capital ratios under regulatory capital
requirements. A summary of the calculations of regulatory
capital and RWA follows.
Minimum risk-based capital ratio requirements apply to
Common Equity Tier 1 capital, Tier 1 capital and Total capital
-- 76 of 93 --
Table of Contents
Notes to Consolidated Financial Statements
(Unaudited)
March 2020 Form 10-Q 74
(which includes Tier 2 capital). Capital standards require certain
adjustments to, and deductions from, capital for purposes of
determining these ratios. At March 31, 2020 and December 31,
2019, the Firm's ratios for determining regulatory compliance
are based on the Advanced Approach and the Standardized
Approach rules, respectively.
In the current quarter, the U.S. banking agencies have adopted
an interim final rule altering, for purposes of the regulatory
capital rules, the required adoption time period for CECL. As
of March 31, 2020, the risk-based and leverage-based capital
amounts and ratios, as well as RWA, adjusted average assets and
supplementary leverage exposure are calculated excluding the
effect of the adoption of CECL based on our election to defer
this effect over a five-year transition period in accordance with
the interim final rule.
In addition to the minimum risk-based capital ratio
requirements, the Firm is subject to the following Common
Equity Tier 1 buffers:
• A greater than 2.5% capital conservation buffer;
• The G-SIB capital surcharge, currently at 3%; and
• Up to a 2.5% CCyB, currently set by U.S. banking agencies
at zero.
The Firm’s Regulatory Capital and Capital Ratios
At March 31, 2020
$ in millions
Required
Ratio1 Amount Ratio
Risk-based capital
Common Equity Tier 1 capital 10.0% $ 65,195 15.2%
Tier 1 capital 11.5% 73,896 17.3%
Total capital 13.5% 83,847 19.6%
Total RWA 427,782
Leverage-based capital
Tier 1 leverage 4.0% $ 73,896 8.1%
Adjusted average assets2 910,499
SLR 5.0% 73,896 6.2%
Supplementary leverage
exposure3 1,185,734
At December 31, 2019
$ in millions
Required
Ratio1 Amount Ratio
Risk-based capital
Common Equity Tier 1 capital 10.0% $ 64,751 16.4%
Tier 1 capital 11.5% 73,443 18.6%
Total capital 13.5% 82,708 21.0%
Total RWA 394,177
Leverage-based capital
Tier 1 leverage 4.0% $ 73,443 8.3%
Adjusted average assets2 889,195
SLR 5.0% 73,443 6.4%
Supplementary leverage
exposure3 1,155,177
1. Required ratios are inclusive of any buffers applicable as of the date
presented. Failure to maintain the buffers would result in restrictions on
the Firm’s ability to make capital distributions, including the payment of
dividends and the repurchase of stock, and to pay discretionary bonuses
to executive officers.
2. Adjusted average assets represents the denominator of the Tier 1 leverage
ratio and is composed of the average daily balance of consolidated on-
balance sheet assets for the quarters ending on the respective balance
sheet dates, reduced by disallowed goodwill, intangible assets,
investments in covered funds, defined benefit pension plan assets, after-
tax gain on sale from assets sold into securitizations, investments in the
Firm's own capital instruments, certain defined tax assets and other capital
deductions.
3. Supplementary leverage exposure is the sum of Adjusted average assets
used in the Tier 1 leverage ratio and other adjustments, primarily: (i) for
derivatives, potential future exposure and the effective notional principal
amount of sold credit protection offset by qualifying purchased credit
protection; (ii) the counterparty credit risk for repo-style transactions; and
(iii) the credit equivalent amount for off-balance sheet exposures.
U.S. Bank Subsidiaries’ Regulatory Capital and Capital
Ratios
The OCC establishes capital requirements for the Firm’s U.S.
Bank Subsidiaries and evaluates their compliance with such
capital requirements. Regulatory capital requirements for the
U.S. Bank Subsidiaries are calculated in a similar manner to the
Firm’s regulatory capital requirements, although G-SIB capital
surcharge requirements do not apply to the U.S. Bank
Subsidiaries.
The OCC’s regulatory capital framework includes Prompt
Corrective Action (“PCA”) standards, including “well-
capitalized” PCA standards that are based on specified
regulatory capital ratio minimums. For the Firm to remain an
FHC, the U.S. Bank Subsidiaries must remain well-capitalized
in accordance with the OCC’s PCA standards. In addition,
failure by the U.S. Bank Subsidiaries to meet minimum capital
requirements may result in certain mandatory and discretionary
actions by regulators that, if undertaken, could have a direct
material effect on the U.S. Bank Subsidiaries’ and the Firm’s
financial statements.
At March 31, 2020 and December 31, 2019, the U.S. Bank
Subsidiaries’ risk-based capital ratios are based on the
Standardized Approach rules. At March 31, 2020, the risk-based
-- 77 of 93 --
Table of Contents
Notes to Consolidated Financial Statements
(Unaudited)
75 March 2020 Form 10-Q
and leverage-based capital amounts and ratios are calculated
excluding the effect of the adoption of CECL based on our
election to defer this effect over a five-year transition period.
MSBNA’s Regulatory Capital
At March 31, 2020
$ in millions
Well-Capitalized
Requirement Required
Ratio1 Amount Ratio
Risk-based capital
Common Equity Tier 1
capital 6.5% 7.0% $ 16,839 18.2%
Tier 1 capital 8.0% 8.5% 16,839 18.2%
Total capital 10.0% 10.5% 17,349 18.7%
Leverage-based capital
Tier 1 leverage 5.0% 4.0% $ 16,839 11.2%
SLR 6.0% 3.0% 16,839 8.8%
At December 31, 2019
$ in millions
Well-Capitalized
Requirement Required
Ratio1 Amount Ratio
Risk-based capital
Common Equity Tier 1
capital 6.5% 7.0% $ 15,919 18.5%
Tier 1 capital 8.0% 8.5% 15,919 18.5%
Total capital 10.0% 10.5% 16,282 18.9%
Leverage-based capital
Tier 1 leverage 5.0% 4.0% $ 15,919 11.3%
SLR 6.0% 3.0% 15,919 8.7%
MSPBNA’s Regulatory Capital
At March 31, 2020
$ in millions
Well-Capitalized
Requirement Required
Ratio1 Amount Ratio
Risk-based capital
Common Equity Tier 1
capital 6.5% 7.0% $ 8,487 22.9%
Tier 1 capital 8.0% 8.5% 8,487 22.9%
Total capital 10.0% 10.5% 8,556 23.0%
Leverage-based capital
Tier 1 leverage 5.0% 4.0% $ 8,487 9.7%
SLR 6.0% 3.0% 8,487 9.3%
At December 31, 2019
$ in millions
Well-Capitalized
Requirement Required
Ratio1 Amount Ratio
Risk-based capital
Common Equity Tier 1
capital 6.5% 7.0% $ 7,962 24.8%
Tier 1 capital 8.0% 8.5% 7,962 24.8%
Total capital 10.0% 10.5% 8,016 25.0%
Leverage-based capital
Tier 1 leverage 5.0% 4.0% $ 7,962 9.9%
SLR 6.0% 3.0% 7,962 9.4%
1. Required ratios are inclusive of any buffers applicable as of the date
presented. Failure to maintain the buffers would result in restrictions on
the U.S. Bank Subsidiaries' ability to make capital distributions, including
the payment of dividends.
U.S. Broker-Dealer Regulatory Capital Requirements
MS&Co. Regulatory Capital
$ in millions At March 31, 2020 At December 31, 2019
Net capital $ 10,887 $ 13,708
Excess net capital 6,620 10,686
MS&Co. is a registered U.S. broker-dealer and registered
futures commission merchant and, accordingly, is subject to the
minimum net capital requirements of the SEC and the CFTC.
MS&Co. has consistently operated with capital in excess of its
regulatory capital requirements.
As an Alternative Net Capital broker-dealer, and in accordance
with Securities Exchange Act of 1934 (“Exchange Act”) Rule
15c3-1, Appendix E, MS&Co. is subject to minimum net capital
and tentative net capital requirements. In addition, MS&Co.
must notify the SEC if its tentative net capital falls below certain
levels. At March 31, 2020 and December 31, 2019, MS&Co.
has exceeded its net capital requirement and has tentative net
capital in excess of the minimum and notification requirements.
MSSB Regulatory Capital
$ in millions At March 31, 2020 At December 31, 2019
Net capital $ 2,924 $ 3,387
Excess net capital 2,774 3,238
MSSB is a registered U.S. broker-dealer and introducing broker
for the futures business and, accordingly, is subject to the
minimum net capital requirements of the SEC. MSSB has
consistently operated with capital in excess of its regulatory
capital requirements.
Other Regulated Subsidiaries
MSIP, a London-based broker-dealer subsidiary, is subject to
the capital requirements of the PRA, and MSMS, a Tokyo-based
broker-dealer subsidiary, is subject to the capital requirements
of the Financial Services Agency. MSIP and MSMS have
consistently operated with capital in excess of their respective
regulatory capital requirements.
Certain other U.S. and non-U.S. subsidiaries of the Firm are
subject to various securities, commodities and banking
regulations, and capital adequacy requirements promulgated by
the regulatory and exchange authorities of the countries in which
they operate. These subsidiaries have consistently operated with
capital in excess of their local capital adequacy requirements.
-- 78 of 93 --
Table of Contents
Notes to Consolidated Financial Statements
(Unaudited)
March 2020 Form 10-Q 76
16. Total Equity
Share Repurchases
Three Months Ended
March 31,
$ in millions 2020 2019
Repurchases of common stock under the Firm's Share
Repurchase Program $ 1,347 $ 1,180
The Firm’s 2019 Capital Plan (“Capital Plan”) includes the share
repurchase of up to $6.0 billion of outstanding common stock
for the period beginning July 1, 2019 through June 30, 2020.
Additionally, the Capital Plan includes quarterly common stock
dividends of up to $0.35 per share, beginning with the common
stock dividend announced on July 18, 2019. On March 15, 2020,
the Financial Services Forum announced that each of its eight
member banks, including the Firm, had voluntarily suspended
their share repurchase programs. For information about the
Firm's 2019 Capital Plan, see Note 16 to the financial statements
in the 2019 Form 10-K.
A portion of common stock repurchases was conducted under
a sales plan with MUFG, whereby MUFG sold shares of the
Firm’s common stock to the Firm, as part of the Firm’s Share
Repurchase Program. The sales plan is only intended to maintain
MUFG’s ownership percentage below 24.9% in order to comply
with MUFG’s passivity commitments to the Board of Governors
of the Federal Reserve System and has no impact on the strategic
alliance between MUFG and the Firm, including the joint
ventures in Japan.
Common Stock Dividends per Share
Three Months Ended
March 31,
2020 2019
Dividends declared per common share $ 0.35 $ 0.30
Common Shares Outstanding for Basic and Diluted EPS
Three Months Ended
March 31,
in millions 2020 2019
Weighted average common shares outstanding, basic 1,555 1,658
Effect of dilutive Stock options, RSUs and PSUs 18 19
Weighted average common shares outstanding
and common stock equivalents, diluted 1,573 1,677
Weighted average antidilutive common stock
equivalents (excluded from the computation of diluted
EPS) 12 6
Preferred Stock
Shares
Outstanding Carrying Value
$ in millions,
except per
share data
At
March 31,
2020
Liquidation
Preference
per Share
At
March 31,
2020
At
December 31,
2019
Series
A 44,000 $ 25,000 $ 1,100 $ 1,100
C1 519,882 1,000 408 408
E 34,500 25,000 862 862
F 34,000 25,000 850 850
H 52,000 25,000 1,300 1,300
I 40,000 25,000 1,000 1,000
J 60,000 25,000 1,500 1,500
K 40,000 25,000 1,000 1,000
L 20,000 25,000 500 500
Total $ 8,520 $ 8,520
Shares authorized 30,000,000
1. Series C is composed of the issuance of 1,160,791 shares of Series C Preferred Stock
to MUFG for an aggregate purchase price of $911 million, less the redemption of
640,909 shares of Series C Preferred Stock of $503 million, which were converted to
common shares of approximately $705 million in 2009.
For a description of Series A through Series L preferred stock
issuances, see Note 16 to the financial statements in the 2019
Form 10-K. The preferred stock has a preference over the
common stock upon liquidation. The Firm’s preferred stock
qualifies as and is included in Tier 1 capital in accordance with
regulatory capital requirements (see Note 15).
Preferred Stock Dividends
$ in millions, except per
share data
Three Months Ended
March 31, 2020 Three Months Ended
March 31, 2019
Per Share1 Total Per Share1 Total
Series
A $ 253 $ 11 $ 250 $ 11
C 25 13 25 13
E 445 15 445 15
F 430 14 430 15
G2 — — 414 8
H3 344 18 — —
I 398 16 398 16
J4 — — — —
K 366 15 366 15
L 305 6 — —
Total $ 108 $ 93
1. Dividends on all series are payable quarterly, unless otherwise noted.
2. Series G preferred stock was redeemed during the first quarter of 2020. For further
information, see Note 16 to the 2019 Form 10-K.
3. Series H was payable semiannually until July 15, 2019, and is now payable quarterly.
4. Series J is payable semiannually until July 15, 2020, and then quarterly thereafter.
-- 79 of 93 --
Table of Contents
Notes to Consolidated Financial Statements
(Unaudited)
77 March 2020 Form 10-Q
Accumulated Other Comprehensive Income (Loss)1
$ in millions CTA AFS
Securities
Pension,
Postretirement
and Other DVA Total
December 31, 2019 $ (897) $ 207 $ (644) $ (1,454) $ (2,788)
OCI during the period (141) 1,325 25 3,674 4,883
March 31, 2020 $ (1,038) $ 1,532 $ (619) $ 2,220 $ 2,095
December 31, 2018 $ (889) $ (930) $ (578) $ 105 $ (2,292)
OCI during the period (12) 429 1 (599) (181)
March 31, 2019 $ (901) $ (501) $ (577) $ (494) $ (2,473)
CTA—Cumulative foreign currency translation adjustments
1. Amounts are net of tax and noncontrolling interests.
Components of Period Changes in OCI
Three Months Ended
March 31, 2020
$ in millions
Pre-tax
Gain
(Loss)
Income
Tax Benefit
(Provision)
After-tax
Gain
(Loss)
Non-
controlling
Interests Net
CTA
OCI activity $ (20) $ (112) $ (132) $ 9 $ (141)
Reclassified to earnings — — — — —
Net OCI $ (20) $ (112) $ (132) $ 9 $ (141)
Change in net unrealized gains (losses) on AFS securities
OCI activity $ 1,773 $ (416) $ 1,357 $ — $1,357
Reclassified to earnings (41) 9 (32) — (32)
Net OCI $ 1,732 $ (407) $ 1,325 $ — $1,325
Pension, postretirement and other
OCI activity $ 25 $ (4) $ 21 $ — $ 21
Reclassified to earnings 5 (1) 4 — 4
Net OCI $ 30 $ (5) $ 25 $ — $ 25
Change in net DVA
OCI activity $ 5,015 $ (1,216) $ 3,799 $ 129 $3,670
Reclassified to earnings 5 (1) 4 — 4
Net OCI $ 5,020 $ (1,217) $ 3,803 $ 129 $3,674
Three Months Ended
March 31, 2019
$ in millions
Pre-tax
Gain
(Loss)
Income
Tax Benefit
(Provision)
After-tax
Gain
(Loss)
Non-
controlling
Interests Net
CTA
OCI activity $ (4) $ (18) $ (22) $ (10) $ (12)
Reclassified to earnings — — — — —
Net OCI $ (4) $ (18) $ (22) $ (10) $ (12)
Change in net unrealized gains (losses) on AFS securities
OCI activity $ 570 $ (133) $ 437 $ — $ 437
Reclassified to earnings (10) 2 (8) — (8)
Net OCI $ 560 $ (131) $ 429 $ — $ 429
Pension, postretirement and other
OCI activity $ — $ (1) $ (1) $ — $ (1)
Reclassified to earnings 3 (1) 2 — 2
Net OCI $ 3 $ (2) $ 1 $ — $ 1
Change in net DVA
OCI activity $ (824) $ 201 $ (623) $ (21) $ (602)
Reclassified to earnings 4 (1) 3 — 3
Net OCI $ (820) $ 200 $ (620) $ (21) $ (599)
Cumulative Adjustments to Beginning Retained Earnings
Related to the Adoption of Accounting Updates
Three Months Ended
$ in millions March 31, 2020
Financial Instruments—Credit Losses $ (100)
Three Months Ended
$ in millions March 31, 2019
Leases $ 63
-- 80 of 93 --
Table of Contents
Notes to Consolidated Financial Statements
(Unaudited)
March 2020 Form 10-Q 78
17. Interest Income and Interest Expense
Three Months Ended
March 31,
$ in millions 2020 2019
Interest income
Investment securities $ 445 $ 475
Loans 1,154 1,195
Securities purchased under agreements to resell and
Securities borrowed1 398 947
Trading assets, net of Trading liabilities 749 713
Customer receivables and Other2 757 960
Total interest income $ 3,503 $ 4,290
Interest expense
Deposits $ 406 $ 462
Borrowings 997 1,380
Securities sold under agreements to repurchase and
Securities loaned3 509 600
Customer payables and Other4 235 834
Total interest expense $ 2,147 $ 3,276
Net interest $ 1,356 $ 1,014
1. Includes fees paid on Securities borrowed.
2. Includes interest from Cash and cash equivalents.
3. Includes fees received on Securities loaned.
4. Includes fees received from prime brokerage customers for stock loan transactions
entered into to cover customers’ short positions.
Interest income and Interest expense are classified in the income
statements based on the nature of the instrument and related
market conventions. When included as a component of the
instrument’s fair value, interest is included within Trading
revenues or Investments revenues. Otherwise, it is included
within Interest income or Interest expense.k
18. Income Taxes
The Firm is under continuous examination by the IRS and other
tax authorities in certain countries, such as Japan and the U.K.,
and in states and localities in which it has significant business
operations, such as New York.
The Firm believes that the resolution of these tax examinations
will not have a material effect on the annual financial statements,
although a resolution could have a material impact in the income
statements and on the effective tax rate for any period in which
such resolutions occur.
The Firm has established a liability for unrecognized tax
benefits, and associated interest, if applicable (“tax liabilities”),
that it believes is adequate in relation to the potential for
additional assessments. Once established, the Firm adjusts such
tax liabilities only when new information is available or when
an event occurs necessitating a change.
It is reasonably possible that significant changes in the balance
of unrecognized tax benefits may occur within the next 12
months. At this time, however, it is not possible to reasonably
estimate the expected change to the total amount of
unrecognized tax benefits and the impact on the Firm’s effective
tax rate over the next 12 months.
See Note 13 regarding the Dutch Tax Authority’s challenge, in
the District Court in Amsterdam (matters styled Case number
15/3637 and Case number 15/4353), of the Firm’s entitlement
to certain withholding tax credits, which may impact the balance
of unrecognized tax benefits.
Net Discrete Tax Provisions/(Benefits)
Three Months Ended
March 31,
$ in millions 2020 2019
Recurring1 $ (99) $ (107)
Intermittent (31) (101)
1. Recurring discrete tax items are related to conversion of employee share-based
awards.
The current quarter includes intermittent net discrete tax benefits
associated with the remeasurement of prior years’ tax liabilities.
The prior year quarter includes intermittent net discrete tax
benefits primarily associated with remeasurement of reserves
and related interest as a result of new information pertaining to
the resolution of multi-jurisdiction tax examinations.
19. Segment, Geographic and Revenue
Information
Selected Financial Information by Business Segment
Three Months Ended March 31, 2020
$ in millions IS WM IM I/E Total
Investment banking $ 1,144 $ 158 $ — $ (31) $ 1,271
Trading 3,416 (347) (37) 24 3,056
Investments (25) — 63 — 38
Commissions and fees1 874 588 — (102) 1,360
Asset management1 113 2,680 665 (41) 3,417
Other (1,079) 62 7 (1) (1,011)
Total non-interest
revenues 4,443 3,141 698 (151) 8,131
Interest income 2,423 1,193 8 (121) 3,503
Interest expense 1,961 297 14 (125) 2,147
Net interest 462 896 (6) 4 1,356
Net revenues $ 4,905 $ 4,037 $ 692 $ (147) $ 9,487
Income before provision
for income taxes $ 950 $ 1,055 $ 143 $ (2) $ 2,146
Provision for income taxes 151 191 25 (1) 366
Net income 799 864 118 (1) 1,780
Net income applicable to
noncontrolling interests 42 — 40 — 82
Net income applicable to
Morgan Stanley $ 757 $ 864 $ 78 $ (1) $ 1,698
-- 81 of 93 --
Table of Contents
Notes to Consolidated Financial Statements
(Unaudited)
79 March 2020 Form 10-Q
Three Months Ended March 31, 2019
$ in millions IS WM IM I/E Total
Investment banking $ 1,151 $ 109 $ — $ (18) $ 1,242
Trading 3,130 302 (3) 12 3,441
Investments 81 1 191 — 273
Commissions and fees1 621 406 — (61) 966
Asset management1 107 2,361 617 (36) 3,049
Other 222 80 3 (4) 301
Total non-interest revenues 5,312 3,259 808 (107) 9,272
Interest income 3,056 1,413 4 (183) 4,290
Interest expense 3,172 283 8 (187) 3,276
Net interest (116) 1,130 (4) 4 1,014
Net revenues $ 5,196 $ 4,389 $ 804 $ (103) $10,286
Income before provision for
income taxes $ 1,595 $ 1,188 $ 174 $ (2) $ 2,955
Provision for income taxes 190 264 33 — 487
Net income 1,405 924 141 (2) 2,468
Net income applicable to
noncontrolling interests 34 — 5 — 39
Net income applicable to
Morgan Stanley $ 1,371 $ 924 $ 136 $ (2) $ 2,429
I/E–Intersegment Eliminations
1. Substantially all revenues are from contracts with customers.
For a discussion about the Firm’s business segments, see Note
21 to the financial statements in the 2019 Form 10-K.
Detail of Investment Banking Revenues
Three Months Ended
March 31,
$ in millions 2020 2019
Institutional Securities Advisory $ 362 $ 406
Institutional Securities Underwriting 782 745
Firm Investment banking revenues from
contracts with customers 89% 85%
Trading Revenues by Product Type
Three Months Ended
March 31,
$ in millions 2020 2019
Interest rate $ 1,074 $ 785
Foreign exchange 338 241
Equity security and index1 1,072 1,451
Commodity and other 266 422
Credit 306 542
Total $ 3,056 $ 3,441
1. Dividend income is included within equity security and index contracts.
The previous table summarizes realized and unrealized gains
and losses, from derivative and non-derivative financial
instruments, included in Trading revenues in the income
statements. The Firm generally utilizes financial instruments
across a variety of product types in connection with its market-
making and related risk management strategies. The trading
revenues presented in the table are not representative of the
manner in which the Firm manages its business activities and
are prepared in a manner similar to the presentation of trading
revenues for regulatory reporting purposes.
Investment Management Investments Revenues—Net
Cumulative Unrealized Carried Interest
$ in millions
At
March 31,
2020
At
December 31,
2019
Net cumulative unrealized
performance-based fees at risk of
reversing $ 714 $ 774
The Firm’s portion of net cumulative performance-based fees
in the form of unrealized carried interest (for which the Firm is
not obligated to pay compensation) are at risk of reversing when
the return in certain funds fall below specified performance
targets. See Note 13 for information regarding general partner
guarantees, which include potential obligations to return
performance fee distributions previously received.
Investment Management Asset Management Revenues—
Reduction of Fees Due to Fee Waivers
Three Months Ended
March 31,
$ in millions 2020 2019
Fee waivers $ 11 $ 11
The Firm waives a portion of its fees in the Investment
Management business segment from certain registered money
market funds that comply with the requirements of Rule 2a-7
of the Investment Company Act of 1940.
Certain Other Fee Waivers
Separately, the Firm’s employees, including its senior officers,
may participate on the same terms and conditions as other
investors in certain funds that the Firm sponsors primarily for
client investment, and the Firm may waive or lower applicable
fees and charges for its employees.
Net Revenues by Region
Three Months Ended
March 31,
$ in millions 2020 2019
Americas $ 6,646 $ 7,321
EMEA 1,148 1,702
Asia 1,693 1,263
Total $ 9,487 $ 10,286
For a discussion about the Firm’s geographic net revenues, see
Note 21 to the financial statements in the 2019 Form 10-K.
-- 82 of 93 --
Table of Contents
Notes to Consolidated Financial Statements
(Unaudited)
March 2020 Form 10-Q 80
Revenue Recognized from Prior Services
Three Months Ended
March 31,
$ in millions 2020 2019
Non-interest revenues $ 614 $ 671
The previous table includes revenue from contracts with
customers recognized where some or all services were
performed in prior periods and is primarily composed of
investment banking advisory fees and distribution fees.
Receivables from Contracts with Customers
$ in millions
At
March 31,
2020
At
December 31,
2019
Customer and other receivables $ 2,199 $ 2,916
Receivables from contracts with customers, which are included
within Customer and other receivables in the balance sheets,
arise when the Firm has both recorded revenues and has the right
per the contract to bill the customer.
Assets by Business Segment
$ in millions
At
March 31,
2020
At
December 31,
2019
Institutional Securities $ 707,489 $ 691,201
Wealth Management 233,824 197,682
Investment Management 6,482 6,546
Total1 $ 947,795 $ 895,429
1. Parent assets have been fully allocated to the business segments.
-- 83 of 93 --
Table of Contents
Financial Data Supplement (Unaudited)
81 March 2020 Form 10-Q
Average Balances and Interest Rates and Net Interest Income
Three Months Ended March 31,
2020 2019
$ in millions
Average
Daily
Balance Interest
Annualized
Average
Rate
Average
Daily
Balance Interest
Annualized
Average
Rate
Interest earning assets
Investment
securities1 $ 110,277 $ 445 1.6% $ 94,906 $ 475 2.0%
Loans1 134,441 1,154 3.5 116,698 1,195 4.2
Securities purchased under agreements to resell and Securities borrowed2:
U.S. 121,106 378 1.3 141,806 934 2.7
Non-U.S. 56,865 20 0.1 77,256 13 0.1
Trading assets, net of Trading liabilities3:
U.S. 78,771 626 3.2 74,152 631 3.5
Non-U.S. 22,903 123 2.2 11,861 82 2.8
Customer receivables and Other4:
U.S. 68,772 555 3.2 63,649 697 4.4
Non-U.S. 60,787 202 1.3 55,142 263 1.9
Total $ 653,922 $ 3,503 2.2% $635,470 $ 4,290 2.7%
Interest bearing liabilities
Deposits1 $ 199,574 $ 406 0.8% $181,017 $ 462 1.0%
Borrowings1, 5 192,061 997 2.1 189,181 1,380 3.0
Securities sold under agreements to repurchase and Securities loaned6:
U.S. 31,461 328 4.2 26,615 450 6.9
Non-U.S. 29,682 181 2.5 32,350 150 1.9
Customer payables and Other7:
U.S. 128,744 109 0.3 117,932 554 1.9
Non-U.S. 63,914 126 0.8 65,498 280 1.7
Total $ 645,436 $ 2,147 1.3% $612,593 $ 3,276 2.2%
Net interest income and
net interest rate spread $ 1,356 0.9% $ 1,014 0.5%
1. Amounts include primarily U.S. balances.
2. Includes fees paid on Securities borrowed.
3. Excludes non-interest earning assets and non-interest bearing liabilities,
such as equity securities.
4. Includes Cash and cash equivalents.
5. Includes borrowings carried at fair value, whose interest expense is
considered part of fair value and therefore is recorded within Trading
revenues.
6. Includes fees received on Securities loaned. The annualized average rate
was calculated using (a) interest expense incurred on all securities sold
under agreements to repurchase and securities loaned transactions,
whether or not such transactions were reported in the balance sheets and
(b) net average on-balance sheet balances, which exclude certain
securities-for-securities transactions.
7. Includes fees received from prime brokerage customers for stock loan
transactions entered into to cover customers’ short positions.
-- 84 of 93 --
Table of Contents
Glossary of Common Terms and Acronyms
March 2020 Form 10-Q 82
2019 Form 10-K Annual report on Form 10-K for year
ended December 31, 2019 filed with the
SEC
ABS Asset-backed securities
AFS Available-for-sale
AML Anti-money laundering
AOCI Accumulated other comprehensive income
(loss)
AUM Assets under management or supervision
Balance sheets Consolidated balance sheets
BEAT Base erosion and anti-abuse tax
BHC Bank holding company
bps Basis points; one basis point equals
1/100th of 1%
Cash flow
statements Consolidated cash flow statements
CCAR Comprehensive Capital Analysis and
Review
CCyB Countercyclical capital buffer
CDO Collateralized debt obligation(s),
including Collateralized loan
obligation(s)
CDS Credit default swaps
CECL Current Expected Credit Losses, as
calculated under the Financial
Instruments—Credit Losses accounting
update
CFTC U.S. Commodity Futures Trading
Commission
CLN Credit-linked note(s)
CLO Collateralized loan obligation(s)
CMBS Commercial mortgage-backed securities
CMO Collateralized mortgage obligation(s)
CVA Credit valuation adjustment
DVA Debt valuation adjustment
EBITDA Earnings before interest, taxes,
depreciation and amortization
ELN Equity-linked note(s)
EMEA Europe, Middle East and Africa
EPS Earnings per common share
E.U. European Union
FDIC Federal Deposit Insurance Corporation
FFELP Federal Family Education Loan Program
FFIEC Federal Financial Institutions Examination
Council
FHC Financial Holding Company
FICC Fixed Income Clearing Corporation
FICO Fair Isaac Corporation
Financial
statements Consolidated financial statements
FVA Funding valuation adjustment
GILTI Global Intangible Low-Taxed Income
G-SIB Global systemically important banks
HELOC Home Equity Line of Credit
HQLA High-quality liquid assets
HTM Held-to-maturity
I/E Intersegment eliminations
IHC Intermediate holding company
IM Investment Management
Income
statements Consolidated income statements
IRS Internal Revenue Service
IS Institutional Securities
LCR Liquidity coverage ratio, as adopted by the
U.S. banking agencies
LIBOR London Interbank Offered Rate
M&A Merger, acquisition and restructuring
transaction
MSBNA Morgan Stanley Bank, N.A.
MS&Co. Morgan Stanley & Co. LLC
MSIP Morgan Stanley & Co. International plc
-- 85 of 93 --
Table of Contents
Glossary of Common Terms and Acronyms
83 March 2020 Form 10-Q
MSMS Morgan Stanley MUFG Securities Co.,
Ltd.
MSPBNA Morgan Stanley Private Bank, National
Association
MSSB Morgan Stanley Smith Barney LLC
MUFG Mitsubishi UFJ Financial Group, Inc.
MUMSS Mitsubishi UFJ Morgan Stanley Securities
Co., Ltd.
MWh Megawatt hour
N/A Not Applicable
NAV Net asset value
N/M Not Meaningful
Non-GAAP Non-generally accepted accounting
principles
NSFR Net stable funding ratio, as proposed by
the U.S. banking agencies
OCC Office of the Comptroller of the Currency
OCI Other comprehensive income (loss)
OIS Overnight index swap
OTC Over-the-counter
OTTI Other-than-temporary impairment
PRA Prudential Regulation Authority
PSU Performance-based stock unit
RMBS Residential mortgage-backed securities
ROE Return on average common equity
ROTCE Return on average tangible common
equity
ROU Right-of-use
RSU Restricted stock unit
RWA Risk-weighted assets
SEC U.S. Securities and Exchange Commission
SLR Supplementary leverage ratio
SOFR Secured Overnight Financing Rate
S&P Standard & Poor’s
SPE Special purpose entity
SPOE Single point of entry
TDR Troubled debt restructuring
TLAC Total loss-absorbing capacity
U.K. United Kingdom
UPB Unpaid principal balance
U.S. United States of America
U.S. GAAP Accounting principles generally accepted
in the United States of America
VaR Value-at-Risk
VIE Variable interest entity
WACC Implied weighted average cost of capital
WM Wealth Management
-- 86 of 93 --
Table of Contents
March 2020 Form 10-Q 84
Other Information
None.
Legal Proceedings
The following development has occurred since previously
reporting certain matters in the Firm’s 2019 Form 10-K. See
also the disclosures set forth under “Legal Proceedings” in the
2019 Form 10-K.
Residential Mortgage and Credit Crisis Related Matter
On March 19, 2020, the Firm filed a motion for partial summary
judgment in Deutsche Bank National Trust Company solely in
its capacity as Trustee of the Morgan Stanley ABS Capital I Inc.
Trust 2007- NC4 v. Morgan Stanley Mortgage Capital Holdings
LLC as Successor-by-Merger to Morgan Stanley Mortgage
Capital Inc., and Morgan Stanley ABS Capital I Inc.
Unregistered Sales of Equity Securities and Use
of Proceeds
Issuer Purchases of Equity Securities
Three Months Ended March 31, 2020
$ in millions, except
per share data
Total
Number of
Shares
Purchased1
Average
Price
Paid Per
Share
Total Shares
Purchased as
Part of Share
Repurchase
Program2,3
Dollar Value of
Remaining
Authorized
Repurchase
January 11,966,543 $ 55.82 4,860,960 $ 2,733
February 7,624,176 $ 52.63 7,135,908 $ 2,354
March 17,552,911 $ 40.65 17,278,471 $ 1,653
Total 37,143,630 $ 48.00 29,275,339
1. Includes 7,868,291 shares acquired by the Firm in satisfaction of the tax withholding
obligations on stock-based awards granted under the Firm’s stock-based
compensation plans during the three months ended March 31, 2020.
2. Share purchases under publicly announced programs are made pursuant to open-
market purchases, Rule 10b5-1 plans or privately negotiated transactions (including
with employee benefit plans) as market conditions warrant and at prices the Firm
deems appropriate and may be suspended at any time. On April 18, 2018, the Firm
entered into a sales plan with Mitsubishi UFJ Financial Group, Inc. (“MUFG”). See
Note 16 to the financial statements for further information on the sales plan.
3. The Firm’s Board of Directors has authorized the repurchase of the Firm’s outstanding
stock under a share repurchase program (the “Share Repurchase Program”). The
Share Repurchase Program is a program for capital management purposes that
considers, among other things, business segment capital needs, as well as equity-
based compensation and benefit plan requirements. The Share Repurchase Program
has no set expiration or termination date.
Share repurchases by the Firm are subject to regulatory non-
objection. On June 27, 2019, the Federal Reserve published
summary results of CCAR and and the Firm received a non-
objection to its 2019 Capital Plan. The Firm’s 2019 Capital Plan
includes a share repurchase of up to $6.0 billion of its
outstanding common stock during the period beginning July 1,
2019 through June 30, 2020. On March 15, 2020, the Financial
Services Forum announced that each of its eight member banks,
including the Firm, had voluntarily suspended their share
repurchase programs. For further information, see “Liquidity
and Capital Resources—Regulatory Requirements—Capital
Plans and Stress Tests.”
Controls and Procedures
Under the supervision and with the participation of the Firm’s
management, including the Chief Executive Officer and Chief
Financial Officer, the Firm conducted an evaluation of the
effectiveness of the Firm’s disclosure controls and procedures
(as defined in Rule 13a-15(e) of the Securities Exchange Act of
1934, as amended (the “Exchange Act”)). Based on this
evaluation, the Chief Executive Officer and Chief Financial
Officer concluded that the Firm's disclosure controls and
procedures were effective as of the end of the period covered
by this report.
No change in the Firm’s internal control over financial reporting
(as defined in Rule 13a-15(f) of the Exchange Act) occurred
during the period covered by this report that materially affected,
or is reasonably likely to materially affect, the Firm’s internal
control over financial reporting.
Exhibits
Exhibit Index
Exhibit
No. Description
15 Letter of awareness from Deloitte & Touche LLP,
dated May 5, 2020, concerning unaudited interim
financial information.
31.1 Rule 13a-14(a) Certification of Chief Executive
Officer.
31.2 Rule 13a-14(a) Certification of Chief Financial
Officer.
32.1 Section 1350 Certification of Chief Executive
Officer.
32.2 Section 1350 Certification of Chief Financial
Officer.
101 Interactive Data Files pursuant to Rule 405 of
Regulation S-T formatted in Inline eXtensible
Business Reporting Language (“Inline XBRL”).
104 Cover Page Interactive Data File (formatted in Inline
XBRL and contained in Exhibit 101).
-- 87 of 93 --
Table of Contents
S-1
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act
of 1934, the Registrant has duly caused this report to be
signed on its behalf by the undersigned thereunto duly
authorized.
MORGAN STANLEY
(Registrant)
By: /s/ JONATHAN PRUZAN
Jonathan Pruzan
Executive Vice President and
Chief Financial Officer
By: /s/ PAUL C. WIRTH
Paul C. Wirth
Deputy Chief Financial Officer
Date: May 5, 2020
-- 88 of 93 --
EXHIBIT 15
To the Board of Directors and Shareholders of Morgan Stanley:
We have reviewed, in accordance with the standards of the Public Company Accounting Oversight Board (United States), the
unaudited condensed consolidated interim financial statements of Morgan Stanley and subsidiaries (the “Firm”) for the three-
month periods ended March 31, 2020 and 2019, as indicated in our report dated May 5, 2020; because we did not perform an audit,
we expressed no opinion on that information.
We are aware that our report referred to above, which is included in your Quarterly Report on Form 10-Q for the quarter ended
March 31, 2020, is incorporated by reference in the following Registration Statements of the Firm:
Filed on Form S-3: Filed on Form S-8:
Registration Statement No. 33-57202 Registration Statement No. 33-63024
Registration Statement No. 33-60734 Registration Statement No. 33-63026
Registration Statement No. 33-89748 Registration Statement No. 33-78038
Registration Statement No. 33-92172 Registration Statement No. 33-79516
Registration Statement No. 333-07947 Registration Statement No. 33-82240
Registration Statement No. 333-27881 Registration Statement No. 33-82242
Registration Statement No. 333-27893 Registration Statement No. 33-82244
Registration Statement No. 333-27919 Registration Statement No. 333-04212
Registration Statement No. 333-46403 Registration Statement No. 333-28141
Registration Statement No. 333-46935 Registration Statement No. 333-28263
Registration Statement No. 333-76111 Registration Statement No. 333-62869
Registration Statement No. 333-75289 Registration Statement No. 333-78081
Registration Statement No. 333-34392 Registration Statement No. 333-95303
Registration Statement No. 333-47576 Registration Statement No. 333-55972
Registration Statement No. 333-83616 Registration Statement No. 333-85148
Registration Statement No. 333-106789 Registration Statement No. 333-85150
Registration Statement No. 333-117752 Registration Statement No. 333-108223
Registration Statement No. 333-129243 Registration Statement No. 333-142874
Registration Statement No. 333-131266 Registration Statement No. 333-146954
Registration Statement No. 333-155622 Registration Statement No. 333-159503
Registration Statement No. 333-156423 Registration Statement No. 333-159504
Registration Statement No. 333-178081 Registration Statement No. 333-159505
Registration Statement No. 333-200365 Registration Statement No. 333-168278
Registration Statement No. 333-200365-12 Registration Statement No. 333-172634
Registration Statement No. 333-221595 Registration Statement No. 333-177454
Registration Statement No. 333-221595-01 Registration Statement No. 333-183595
Registration Statement No. 333-188649
Filed on Form S-4: Registration Statement No. 333-192448
Registration Statement No. 333-25003 Registration Statement No. 333-204504
Registration Statement No. 333-237743 Registration Statement No. 333-211723
Registration Statement No. 333-218377
Registration Statement No. 333-231913
We also are aware that the aforementioned report, pursuant to Rule 436(c) under the Securities Act of 1933, is not considered a
part of the Registration Statements prepared or certified by an accountant or a report prepared or certified by an accountant within
the meaning of Sections 7 and 11 of that Act.
/s/ Deloitte & Touche LLP
New York, New York
May 5, 2020
-- 89 of 93 --
EXHIBIT 31.1
Certification
I, James P. Gorman, certify that:
1. I have reviewed this quarterly report on Form 10-Q of Morgan Stanley;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material
fact necessary to make the statements made, in light of the circumstances under which such statements were made, not
misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present
in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the
periods presented in this report;
4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and
procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as
defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be
designed under our supervision, to ensure that material information relating to the registrant, including its
consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in
which this report is being prepared;
b) Designed such internal control over financial reporting, or caused such internal control over financial reporting
to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial
reporting and the preparation of financial statements for external purposes in accordance with generally accepted
accounting principles;
c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report
our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period
covered by this report based on such evaluation; and
d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred
during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual
report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control
over financial reporting; and
5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control
over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or
persons performing the equivalent functions):
a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial
reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize
and report financial information; and
b) Any fraud, whether or not material, that involves management or other employees who have a significant role
in the registrant’s internal control over financial reporting.
Date: May 5, 2020
/s/ JAMES P. GORMAN
James P. Gorman
Chairman of the Board and Chief Executive Officer
-- 90 of 93 --
EXHIBIT 31.2
Certification
I, Jonathan Pruzan, certify that:
1. I have reviewed this quarterly report on Form 10-Q of Morgan Stanley;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material
fact necessary to make the statements made, in light of the circumstances under which such statements were made, not
misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present
in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the
periods presented in this report;
4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and
procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as
defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be
designed under our supervision, to ensure that material information relating to the registrant, including its
consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in
which this report is being prepared;
b) Designed such internal control over financial reporting, or caused such internal control over financial reporting
to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial
reporting and the preparation of financial statements for external purposes in accordance with generally accepted
accounting principles;
c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report
our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period
covered by this report based on such evaluation; and
d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred
during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual
report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control
over financial reporting; and
5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control
over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or
persons performing the equivalent functions):
a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial
reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize
and report financial information; and
b) Any fraud, whether or not material, that involves management or other employees who have a significant role
in the registrant’s internal control over financial reporting.
Date: May 5, 2020
/s/ JONATHAN PRUZAN
Jonathan Pruzan
Executive Vice President and Chief Financial Officer
-- 91 of 93 --
EXHIBIT 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of Morgan Stanley (the “Firm”) on Form 10-Q for the
quarter ended March 31, 2020 as filed with the Securities and Exchange Commission on the date hereof
(the “Report”), I, James P. Gorman, Chairman of the Board and Chief Executive Officer of the Firm,
certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act
of 2002, that:
1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities
Exchange Act of 1934; and
2. The information contained in the Report fairly presents, in all material respects, the financial
condition and results of operations of the Firm.
/s/ JAMES P. GORMAN
James P. Gorman
Chairman of the Board and
Chief Executive Officer
Date: May 5, 2020
-- 92 of 93 --
EXHIBIT 32.2
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of Morgan Stanley (the “Firm”) on Form 10-Q for the
quarter ended March 31, 2020 as filed with the Securities and Exchange Commission on the date hereof
(the “Report”), I, Jonathan Pruzan, Executive Vice President and Chief Financial Officer of the Firm,
certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act
of 2002, that:
1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities
Exchange Act of 1934; and
2. The information contained in the Report fairly presents, in all material respects, the financial
condition and results of operations of the Firm.
/s/ JONATHAN PRUZAN
Jonathan Pruzan
Executive Vice President and
Chief Financial Officer
Date: May 5, 2020
-- 93 of 93 --